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Stellingen 
behorende bij het proefschrift "Tumour promotion by complex mixtures 
of polyhalogenated aromatic hydrocarbons (PHAHs) and the applicability 
of the toxic equivalency factor (TEF) concept" van Simone Antoinette 
van der Plas, te verdedigen op vrijdag 22 december 2000. 
1. De tumor-promoverende potentie van PCB's wordt in ruime mate onderschat door het 
TEF concept, dat wordt toegepast bij de risico-evaluatie van PHAH residuen en 
concentraties in respectievelijk voedingsmiddelen en milieucompartimenten. (dit 
proefschrift) 
2. De verstoring van vitamine A en schildklierhormoon niveau's door PHAH's met een 
lage dioxine-achtige activiteit kan aanzienlijk versterkt worden bij gelijktijdige 
blootstelling aan PHAH's met een hoge dioxine-achtige activiteit, hetgeen moet 
worden toegeschreven aan een verhoogde vorming van OH-PCB's. (ditproefschrift) 
3. Bij de toepassing van flavonoi'den in zogenaamde 'functional foods' wordt teveel 
nadruk gelegd op de anti-oxidant eigenschappen van deze stoffen. 
4. 'Moederlijk gedrag' wordt bei'nvloed door een veelheid van genen en lijkt te worden 
gestimuleerd door de endocriene veranderingen die optreden tijdens zwangerschap en 
geboorte. (Robert S. Bridges, Nature 20, p. 108-109, 1998) 
5. Het totale bestrijdingsmiddelen gebruik in de aardappelteelt in Nederland is eerder toe 
dan afgenomen met de opkomst van biologische aardappelteelt. 
6. Het stimuleren vanuit de overheid van nevenactiviteiten (boerencamping, 
zorgboederij, windmolens etc.) in de landbouw voor het verkrijgen van extra inkomen 
voor boeren, betekent feitelijk dat de landbouw in Nederland als volwaardige 
bedrijfstak geacht wordt te verdwijnen. 
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CHAPTER 1 
General introduction 
In the last half century several cases of accidental food and environmental contamination 
have occurred involving the notorious class of persistent and toxic polyhalogenated aromatic 
hydrocarbons (PHAHs). For example, large-scale food poisoning with polychlorinated 
biphenyls (PCBs) and polychlorinated dibenzofurans (PCDFs) due to contamination of 
cooking oil took place in Japan (1968) and in Taiwan (1979). Exposed individuals suffered 
from a large number of symptoms, including chloracne, reproductive and developmental 
disorders, and are still followed up epidemiologically to investigate possible increases in the 
incidence of several cancer types. In the Seveso accident (1976), an explosion of a reaction 
vessel in a factory producing organochlorine pesticides caused a massive environmental 
contamination with 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) and a consequent syndrome 
of chloracne and related dioxin-like symptoms. In addition to these accidental contaminations, 
there have been many cases of environmental contamination with PHAHs, due to e.g., 
improper industrial processes, waste incineration, bleaching of pulp and paper and spills. In 
1989 the so-called "Lickebaert affair" took place in the Netherlands. Relatively high levels of 
PCDDs and PCDFs were found in milk of cows grazing in the surroundings of waste 
incinerators with relatively high emissions of PHAHs. During that period of time, farmers 
were not allowed to sell their dairy products. There was a high and acute demand for 
PCDD/PCDF analyses to be performed by high resolution-mass spectrometry (HR-MS), while 
the capacity to perform HR-MS analyses was absolutely insufficient for the demand and the 
costs were high. In this time period the project called 'Biological Effect Assays for 
Monitoring' (BEAM) was initiated1. The BEAM project was comprised of two main 
objectives: 
1) To study the predictive value of the toxic-equivalency-factor (TEF) concept for the toxicity 
of complex mixtures of PCBs, PCDFs and PCDDs and in this context, to reveal possible 
antagonistic or synergistic interactions between congeners; 2) To develop a fast and efficient 
bio-assay (Ah receptor-dependent luciferase reporter gene or DR-CALUX bio-assay) for the 
analysis of the toxic potential of complex mixtures of polyhalogenated aromatic hydrocarbons 
(PHAHs). The importance of such a method was only recently demonstrated (1999) when in 
Belgium on a large scale chicken meat appeared to be contaminated with high concentrations 
of PCBs and PCDDs. 
In this thesis the predictive value of the toxic equivalency factor (TEF) concept for the 
toxicity of complex environmental mixtures of PHAHs was studied. Special emphasis was put 
on the tumour promotion potential as a sub-chronic endpoint for the toxicity of PHAHs. 
1
 Department of Toxicology, Wageningen University. In collaboration with RIKILT-DLO. 
Chapter 1 
General properties of PCBs, PCDDs and PCDFs 
Polychlorodibenzo-/>-dioxins (PCDDs), polychloro-dibenzofurans (PCDFs) and 
polychlorinated biphenyls (PCBs) are members of the group of polyhalogenated aromatic 
hydrocarbons (PHAHs) and consist of 75, 135 and 219 different isomers respectively. Their 
chemical structures are shown in figure 1.1. PCDDs and PCDFs are mainly formed as 
unwanted by-products during incomplete combustion processes in the presence of chlorine, 
such as municipal waste burning, and the synthesis of a wide range of organohalogens 
commercial chemicals, as herbicides, fungicides and PCBs (Safe, 1990,1994). Commercial 
polychlorinated biphenyls (PCBs) were widely used as industrial products with diverse 
applications, such as plasticizers, heat transfer fluids, cutting oils, wax extenders, adhesives, 
flame retardants and dielectric fluids for capacitors and transformers. PCBs were produced in 
large quantities since 1929 and their total production is estimated on 1.5 million metric tons 
(De Voogt and Brinkman, 1989; Silberhorn et al, 1990). PCDDs, PCDFs and PCBs are 
highly lipophilic and the degree of lipophilicity is increasing with increased chlorination. In 
addition, these compounds are biologically stable and resistant to breakdown by acids, bases 
and heat. As a result of their lipophilic and persistent nature, PCDDs, PCDFs and PCBs were 
shown to accumulate in the environment and were reported as contaminants in almost every 
component of the global ecosystem, including air, water, fish, wildlife and human adipose 
tissue, milk and serum. PCDDs, PCDFs and PCBs have been shown to elicit a broad spectrum 
of toxic effects and biochemical changes in both animals and human, e.g. body weight loss, 
thymic atrophy, impairment of immune responses, hepatotoxicity, teratogenicity, 
m o o / w \ 
PCDF 
Figure 1.1 The chemical structures of PCBs, PCDDs and PCDFs 
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carcinogenicity and induction of hepatic cytochrome P450 isoenzymes (reviewed by Safe, 
1989, 1990,1994). For this reason, much effort has been put on emission control and other 
measures to reduce the introduction of PCDDs and PCDFs into the environment. In addition, 
from the 1980s onwards PCBs were banned or the production, use and disposal was severely 
restricted in most industrialised countries (Silberhorn et al, 1990; Brouwer et al, 1998a). 
Since then, environmental and dietary levels of PCDDs, PCDFs and PCBs have been found to 
decline in all compartments (CCRX 1993; Liem and Theelen, 1997; Fiirst and Wilmers, 1999; 
Hori et al, 1999; Papke et al, 1999). 
The most toxic PCDDs, PCDFs and PCBs exhibit a planar molecular conformation and 
most if not all of their toxic responses are thought to be mediated by the aryl hydrocarbon 
(Ah) receptor (Safe, 1994). The Ah receptor is present in the cell cytosol as a complex with 
the 90 kDa heat-shock protein (hsp90) (Schmidt and Bradfield, 1996). After binding of TCDD 
or other congeners to the Ah receptor, hsp90 is dissociated from the Ah receptor-ligand 
complex, followed by translocation of the complex to the nucleus and dimerization of the Ah 
receptor with the Ah-receptor translocater (Arnt) protein. The ligand-AhR-Arnt complex 
binds selectively to dioxin-responsive elements (DRE) on the DNA, thereby inducing the 
expression of DRE-regulated genes, such as cytochrome P4501A1 and 1A2 (Schmidt and 
Bradfield 1996). The most potent ligand for Ah receptor binding is 2,3,7,8-TCDD. Binding 
competition studies with 3H-labeled 2,3,7,8-TCDD showed that the 2,3,7,8-substituted tetra-
to hexa CDDs and CDFs are the most competitive ligands for Ah receptor binding. The most 
competitive PCBs are substituted on both para and at least two meta positions, the so called 
non-ortho or planar PCBs. Mono-ortho substituted PCBs exhibit lower competitive binding 
affinities for the Ah receptor and they are considered as 'mixed-type inducers', because of 
their capability to mediate both dioxin-like and non-dioxin-like toxicity (Bandiera et al, 1982; 
Safe, 1990). 
Non-planar PHAH compounds, i.e. di-ortho substituted PCBs, exhibit a so called non-
dioxin-like toxicity. The toxicity of the non-planar PCBs resembles the toxicity of the 
barbiturate phenobarbital, characterised by the induction of cytochrome P4502B1 and 1B2 
(Safe, 1990,1994). The mechanism of cytochrome P4502B induction by di-ortho PCBs is 
unknown. 
The toxic equivalency factor concept 
In environmental matrices and biota PCDDs, PCDFs and PCBs are always present as 
complex mixtures. The complexity of these mixtures complicates the risk evaluation for 
humans as well as for fish and wildlife. The toxic equivalency factor (TEF) concept has been 
developed to aid the risk assessment of complex mixtures of PHAHs and enables the 
calculation of total toxic potencies, expressed as the toxic equivalent (TEQ), of the mixtures. 
The TEF approach is based on the assumptions that all toxic PHAH congeners act through the 
11 
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same dioxin-like Ah receptor-based mechanism of action and that the effects of the individual 
compounds are additive (Safe, 1994; Ahlborg et al, 1994; Van den Berg et al, 1998). TEF 
values for the individual PHAH congeners are derived by calculating the relative toxicity of 
the concerning PHAH congener compared to the toxicity of 2,3,7,8-TCDD. Subsequently, the 
TEQ of a complex PHAH mixture is calculated using the following equation: 
TEQ= I([PCDD; x TEFJJ + I([PCDF, * TEFJJ + Z([PCB, * TEFJJ 
In order to harmonise the risk assessment of PHAHs, consensus TEF values for the dioxin-
like PHAHs were derived at international expert meetings organised by the World Health 
Organisation (WHO) (see Table 1.1). 
No TEF values are defined for the non-dioxin-like PHAHs. In the recent past TEF 
values were available for 2,2',3,3',4,4',5-HCB (PCB 170) and 2,2',3,3',4,4',5,5'-OCB (PCB 
180) (Ahlborg et al, 1994), but these values were withdrawn because an Ah receptor 
mediated response of these congeners could not be confirmed (Van den Berg et al, 1998). 
Although the Ai-ortho substituted PCBs are in general considered to be less toxic and possess 
no or a negligible Ah receptor mediated activity, i.e. a TEF value close to zero, their 
concentration in commercial mixtures, in food and environmental matrices is much higher 
compared to the planar PHAHs. However, till now there is no tool available for risk 
assessment of this class of PHAHs. 
Tolerable Daily Intake and background exposure 
At a WHO consultation in 1990, a tolerable daily intake (TDI) of 10 pg TEQ/kg bw/day 
was established for PCDDs, PCDFs and PCBs, on the basis of the no-observed-adverse-effect 
level (NOAEL) of 1 ng/kg/day for the carcinogenicity of 2,3,7,8-TCDD in rats (data obtained 
from Kociba et al, 1978). Because of new epidemiological and toxicological data a revised 
TDI of 1-4 pg TEQ/kg bw/day was deduced, taking the most sensitive adverse effects in 
consideration, i.e. hormonal and reproductive effects (Van Leeuwen and Younes, 1998). For 
the total PCB intake a TDI of 0.4 ug/kg bw/day was suggested, on the basis of the NOEL of 
40 ug/kg bw/day in monkeys (CCRX 1993). 
Information from food surveys in industrialised countries indicate a daily intake of 
PCDDs and PCDFs in the order of 1-3 pg TEQ kg/bw/day and if dioxin-like PCBs are also 
included, the daily TEQ intake will be a factor 2-3 higher (Van Leeuwen and Younes, 1998). 
In the Netherlands an intake of PCDDs, PCDFs and PCBs of 2.3 pg TEQ/ kg bw/day was 
reported for the early 1990s (Liem and Theelen, 1997). No information is available on the 
total intake of PCBs on a weight basis. Because of the complexity of PCB analysis in 
environmental samples, in most surveys only the so called indicator PCBs (IUPAC NR. 28, 
52,101, 118, 138, 153 and 180) are being analysed. An extensive survey was done in 1994 by 
12 
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Liem and Theelen (1997), who measured 29 PCB congeners in different food items. They 
reported a total intake of 20 ng/kg bw/day (Liem and Theelen, 1997) and given the 
assumption that a level of 20 ng/kg/day in foodstuff covers approximately 20-30% of the total 
dietary intake, a total PCB intake of 60-100 ng/kg bw/day can be estimated. 
Carcinogenicity of PHAHs 
Carcinogenicity is one of the toxic endpoints in risk assessment of PHAHs (WHO 
1992). An extensive evaluation on the carcinogenic properties of PCDDs and PCDFs was 
done by the International Agency for Research on Cancer (IARC, 1997; McGregor et al, 
1998). They found that there is epidemiological evidence in human for an overall increase in 
mortality from all cancers combined in the most highly TCDD exposed industrial cohorts, 
Table 1.1 PCB TEFs for human intake 
Class 
Non-ortho 
Mono-ortho 
Di-ortho 
IUPAC No. 
77 
81 
126 
169 
105 
114 
118 
123 
156 
157 
167 
189 
170 
180 
Structure 
3,3',4,4'-TeCB 
3,4,4',5-TeCB 
3,3',4,4',5-PeCB 
3,3',4,4',5,5'-HxCB 
2,3,3',4,4'-PeCB 
2,3,4,4',5-PeCB 
2,3',4,4',5-PeCB 
2',3,4,4',5-PeCB 
2,3,3',4,4',5-HxCB 
2,3,3',4,4',5'-HxCB 
2,3',4,4',5,5'-HxCB 
2,3,3',4,4',5,5'-HpCB 
2,2',3,3',4,4',5-HpCB 
2,2',3,4,4',5,5'-HpCB 
old WHO 
TEFsa 
0.0005 
-
0.1 
0.01 
0.0001 
0.0005 
0.0001 
0.0001 
0.0005 
0.0005 
0.00001 
0.0001 
0.0001 
0.00001 
new WHO 
TEFs* 
0.0001 
0.0001 
0.1 
0.01 
0.0001 
0.0005 
0.0001 
0.0001 
0.0005 
0.0005 
0.00001 
0.0001 
-
-
"Ahlborg et al. (1994) 
'Van den Berg et al. (1998) 
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while there is less strong evidence of increased risks for cancers of particular sites (IARC, 
1997; McGregor et al, 1998). The conclusion of the IARC was that TCDD has to be 
classified as carcinogenic to humans, but for other PCDDs and PCDFs there is only limited or 
inadequate evidence (IARC, 1997; McGregor et al, 1998). 
PCDDs, PCDFs and PCBs are considered as tumour promoters rather than as initiators of 
carcinogenesis (Safe, 1989; Silberhorn et al, 1990; Whysner and Williams, 1996; IARC, 
1997). In rodents, individual congeners as well as mixtures of PCDDs, PCDFs and PCBs were 
found to exhibit a distinct rumour promotion activity in various two-stage skin- and 
hepatocarcinogenicity bioassays (Poland et al, 1982; Hebert et al, 1990; Table 1.2). 
Although PCDDs, PCDFs and PCBs are considered as non-genotoxic and non-mutagenic 
(Safe, 1989; Silberhorn et al, 1990; Huff ef al, 1994), they may also act as complete 
carcinogens. In several life time carcinogenicity studies in rats, treatment with TCDD or 
commercial PCB mixtures showed an increased incidence of neoplastic lesions in for example 
stomach, intestine, thyroid gland and liver, without prior exposure to an experimental initiator 
(Kimbrough et al, 1975; Kociba, 1978; Norback and Weltman, 1985; Ward, 1985; Mayes et 
al, 1998). Female rats appeared to be much more sensitive to the hepatocarcinogenic activity 
of PCDDs, PCDFs and PCBs than male rats (Kociba et al, 1978; Norback and Weltman, 
1985; Mayes et al, 1998;), which implies that the ovarian hormones, presumably estrogens, 
may influence the carcinogenic response (Lucier et al, 1991). 
Proposed mechanisms for the carcinogenic activity of PCDDs, PCDFs and PCBs include 
alteration of the DNA-damaging potential of endogenous compounds (including estrogens) by 
increased cytochrome P450-mediated metabolic activation, DNA single-strand breaks 
resulting from lipid peroxidation, alterations in cell proliferation and differentiation via 
modifications of growth factor and cytokine pathways, and inhibition of gap-junctional 
intercellular communication and apoptosis (Silberhorn et al, 1990; Huff et al, 1994; 
Grassman et al, 1998; Schwarz et al, 2000). It is assumed that the Ah receptor plays an 
important role in mediating the carcinogenic activity of PHAHs, which was supported by a 
positive correlation between tumour promotion activity of PHAH compounds and their 
affinity for the Ah receptor or Ah receptor mediated toxicological effects, such as CYP1 Al 
induction (Poland and Knutson 1982; IARC, 1997; Schwarz et al, 2000). 
Several non-dioxin-like di-ortho substituted PCBs were shown to possess a tumour 
promotion activity as well (for an overview see Table 1.2). However, it is unlikely that the Ah 
receptor is involved in the tumour promotion activity of di-ortho PCBs. Mechanisms possibly 
involved are for instance the inhibition of intercellular communication and stimulation of cell 
proliferation (Silberhorn et al, 1990). 
Intercellular communication plays an important role in cell growth, differentiation and 
maintenance of cell homeostasis (Loewenstein, 1990; Budunova, 1994). Inhibition of the gap 
junctional intercellular communication (GJIC) is suggested to be an important step in 
carcinogenesis and considered as an in vitro indicator of the tumour promotion capacity of 
chemicals (Mesnil et al, 1993). Both dioxin-like and non-dioxin-like PCBs have been 
14 
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demonstrated to inhibit the intercellular communication in primary liver cells (Swierenga, et 
al, 1990) and hepatoma cells (De Haan et al, 1994b, 1996; Bager et al, 1997) in vitro. On 
the basis of both in vitro and in vivo studies on GJIC, it is hypothesised that different 
mechanisms are involved for the dioxin-like and the non dioxin-like PCBs (De Haan et al., 
1996; Bager et al, 1997). 
Interactions between PHAH compounds 
There is a growing number of experimental data suggesting non-additive interactions 
between PHAHs, mostly between planar and non-planar compounds, on several toxicity 
parameters. Interactive effects were reported on for instance immunotoxicity (Biegel et al, 
1989; Davis and Safe, 1989), teratogenicity (Zhao et al, 1994) hepatotoxicity (Yao and Safe, 
1989; Van Birgelen et al, 1996a) and tumour promotion (Sargent et al, 1991; Bager et al, 
1995, Haag-Gronlund et al, 1998). Only a few studies have shown synergistic interactions 
between PHAHs. Synergism is likely to occur when more than one pathway, i.e. Ah receptor 
independent, may be involved (Safe, 1997/98) like with liver porphyry (Van Birgelen et al, 
1996a) and the promotional effect on the formation of enzyme altered hepatic foci (Bager et 
al, 1995). A toxicokinetic basis was found for the synergistic effect on the ethoxyresorufin-O-
deethylase and aryl hydrocarbon hydroxylation activity in mice co-treated with TCDD and 
2,2',4,4',5,5'-HxCB (PCB 153) (De Jongh et al, 1993a,b, 1995). Antagonistic interactions 
between PHAHs are most frequently observed. Antagonists might be weaker Ah receptor 
agonists or full antagonists. A weaker agonist exhibits a partial agonistic and thus an 
inhibitory activity. Full antagonists on the other hand, might block the formation of the 
transcriptionally active nuclear Ah receptor complex when co-administered with a Ah 
receptor agonist (Aarts et al, 1995). Antagonistic interactions of PHAHs have all been 
observed at relatively high concentrations of both agonist and antagonist, and the importance 
of these interactions at lower, environmental levels is not known. 
Outline of the present study 
The major aim of this project consisted of two main objectives: 1) to examine the tumour 
promotion potential of complex, environmentally relevant mixtures of polyhalogenated 
aromatic hydrocarbons (PHAHs) and 2) to evaluate the applicability of the Toxic Equivalency 
Factor (TEF) concept for the tumour promotion potential of complex PHAH mixtures. In 
addition, the effect of sub-chronic exposure to these complex PHAH mixtures was determined 
on endocrine parameters, i.e. the vitamin A and thyroid hormone status, which play an 
essential role in normal tissue growth and foetal development and are possibly involved in the 
process of carcinogenesis. 
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Experimental approach 
The tumour promotion potential of PHAH mixtures was studied in young female Sprague 
Dawley rats, using a two-stage tumour promotion model introduced by Pitot et al. (1978). 
This model makes it possible to make a clear distinction between the initiation and the 
promotion event during carcinogenesis. The initiation step of the model consisted of a 
nitrosodiethylamine injection 24 hours after a partial hepatectomy, followed by a promotion 
treatment of 20 weeks starting 6 weeks after the initiation procedure. For the tumour 
promotion studies, two environmental relevant mixtures of PHAHs were designed. The first 
mixture was a synthetic mixture, which consisted mainly of dioxin-like PHAH compounds 
and covering over 90% of the TEQs present in Baltic herring. The di-ortho PCB 153 
(2,2',4,4',5,5-HxCB) was added to this mixture to study possible interactive effects with 
dioxin-like congeners. All PHAH compounds in the synthetic mixture were individually 
tested in a similar tumour promotion experimental set-up as used here, by Wasrn et al. (1991), 
Hemming et al. (1993), and Haag-Gronlund et al. (1997a,b). In order to study the contribution 
of non-dioxin-like PCBs to the tumour promotion potential of PHAH mixtures, a second 
mixture was designed in which the focus was on the 2-4 ortho substituted PCBs. For this 
purpose the commercial PCB mixture Aroclor 1260 was fractionated into a dioxin-like and a 
non-dioxin-like fraction. The PCB fractions were tested separately and as a reconstituted 
mixture. 
In chapter 2, the toxic potency of the complex PHAH mixtures and the possibility of 
interactions between PHAH congeners was studied in vitro, using the ethoxyresorufin-0-
deethylase (EROD) and the Ah receptor-dependent Luc-reporter gene (DR-CALUX) bio-
assay, both indicator assays for an Ah receptor mediated dioxin-like toxicity. Preliminary 
results are presented on the inhibition of GJIC by the PHAH mixtures. In chapter 3, the 
toxicokinetic behaviour of the compounds in the dioxin-like PHAH mixture was investigated 
in vivo, in order to get a better understanding of underlying mechanisms of possible 
interactive effects between PHAHs. In chapter 4 the tumour promotion study is described, 
aimed at the predictive value of the TEF concept for the tumour promotion potential of the 
synthetic dioxin-like PHAH mixture. Chapter 5 describes the study on the contribution of the 
non-dioxin-like PCBs to the tumour promotion potential of PHAH mixtures. In chapter 6 
endocrine effects were determined of sub chronic exposure to PHAH mixtures, i.e. effects on 
the thyroid hormone and vitamin A status. In chapter 7, the main conclusions and overall 
impact of the study results are discussed with respect to involved mechanisms, consequences 
for risk assessment and human and environmental relevance. 
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CHAPTER 2 
In vitro interactive effects between planar and non-planar 
polychlorinated aromatic hydrocarbons (PHAHs). 
Abstract 
The aim of this study was to investigate possible interactions between 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) and several mono- or di-ortho polychlorinated biphenyls 
(PCBs) for the induction of the ethoxyresorufin-0-deethylase (EROD) and the Ah receptor 
dependent luciferase reporter gene (DR-CALUX) activity in vitro. In addition, the DR-
CALUX assay was performed to determine the relative toxic potential (REP) of PHAH 
mixtures designed for tumour promotion experiments in vivo. Preliminary results are also 
presented on the inhibition of gap-junctional intercellular communication (GJIC), which is 
seen as an in vitro parameter for tumour promotion, by the PHAH mixtures and combinations 
of TCDD with 2,2',5,5-tetrachlorobiphenyl or Aroclor 1254. Both the mono- and the di-ortho 
PCBs inhibited the EROD and CALUX activity induced by TCDD, possibly via competition 
for Ah receptor binding. No interactions between congeners were seen in a semi-synthetic 
dioxin-like PHAH mixture designed for in vivo tumour promotion studies. To determine the 
contribution of non-dioxin-like congeners to the tumour promotion activity of a complex 
mixture of PHAHs, Aroclor 1260 was fractionated into a 0-, 1- and 2-4 oriho PCB fraction. 
The CALUX activity induced by the 0-ortho fraction was strongly inhibited by its \-ortho but 
especially its 2-4 ortho substituted PCB fraction. For the inhibition of GJIC, combined 
exposure of PHAHs indicated that similar non-additive interactions occurred as observed in 
the EROD and CALUX assay. For the antagonistic interactions, high concentrations (near Ah 
receptor saturation) of the Ah receptor agonists and a large concentration difference between 
the agonists and partial- or non-agonists are required. It is concluded that in environmental 
exposure to PHAHs these conditions will be seldomly reached and therefore antagonistic 
interactions are not likely to play a role in vivo in real life situations. The dioxin-like PHAH 
mixtures were potent inhibitors of the GJIC. The 2-4 ortho fraction appeared to be the most 
potent inhibiting fraction of Aroclor 1260. The in vitro potency of PHAH mixtures to inhibit 
the GJIC was largely in agreement with the tumour promotion properties seen in vivo. Since 
this were preliminary results, more research is needed to elucidate the predictive value of 
GJIC inhibition as an early indicator for the tumour promotion potency in vivo. 
Van der Plas, S.A., Gibbs, CM., De Graaf, I.A.M., Sundberg, H., De Haan, L.H.J., and Brouwer A. 
(2000). Partly based on: Van der Plas, S.A., Gibbs, CM., and Brouwer A. (1998). Antagonistic effects 
of mono- and di-ortho substituted polychlorinated biphenyls in the ethoxyresorufin-O-deethylase 
activity and the luciferase reporter gene assay in vitro. Organohalogen Compounds 37, p. 183-186. 
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Introduction 
Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs), 
polychlorinated dibenzofurans (PCDFs) and other polyhalogenated aromatic hydrocarbons 
(PHAHs) are ubiquitously present in the environment. They elicit a broad spectrum of 
toxicological and biochemical responses, including dermal toxicity, endocrine disruption, 
impairment of immune responses, adverse effects on reproduction and development, and 
carcinogenicity (Kimbrough, 1974; Safe, 1990; Van den Berg et al, 1998; Brouwer et al, 
1999). 
In environmental matrices and biota, PCBs, PCDDs and PCDFs are always present as 
complex mixtures. To enable risk assessment of complex mixtures of PHAHs the toxic 
equivalency factor (TEF) concept has been developed, where the toxicity of PHAHs is being 
expressed relative to the toxicity of the most toxic congener 2,3,7,8-TCDD. The TEF concept 
is based on the assumptions that 1) all dioxin-like congeners act through the same Ah receptor 
based mechanism, 2) that the effects of individual congeners are additive and 3) that the 
compounds are persistent and accumulate in the environment (Safe, 1990, 1994; Van den 
Berg et al, 1998). Although there is experimental evidence supporting these assumptions 
(Safe 1990, 1994), there is also a growing number of studies suggesting non-additive 
interactions between PHAHs on several toxicity parameters including immunotoxicity (Biegel 
et al, 1989; Davis and Safe, 1989), teratogenicity (Zhao et al, 1994), hepatotoxicity (Yao and 
Safe, 1989; Van Birgelen et al, 1996a) and tumour promotion (Sargent et al., 1991; Bager et 
al, 1995, Haag-Gr6nlund et al, 1998). Antagonistic interactions between PHAHs were most 
frequently observed. Antagonists might be weak partial or full Ah receptor antagonists. 
Synergism is likely to occur when more than one pathway, i.e. Ah receptor independent, may 
be involved in the development of the toxic response, like with liver porphyria and the 
promotional effect on the formation of enzyme altered hepatic foci (Bager et al, 1995; Van 
Birgelen et al, 1996a; Safe, 1997/98). 
Carcinogenicity is one of the key toxic endpoints in risk assessment of PHAHs. PHAHs 
may act as complete carcinogens (Kimbrough et al, 1975; Kociba et al, 1978; Mayes et al, 
1998) but are generally considered as tumour promoters (Silberhorn et al, 1990). Individual 
PHAH congeners as well as mixtures of PCDDs, PCDFs and PCBs were found to exhibit a 
distinct rumour promotion activity in various two-stage hepatocarcinogenicity bioassays (Pitot 
et al, 1980; Oesterle and Demi, 1983; Waern et al, 1991; Hemming et al, 1993; Bager et al, 
1995; Haag-Gronlund et al, 1997a,b, 1998). It is assumed that the Ah receptor pathway plays 
an important role in mediating the carcinogenic activity of PHAHs (Poland et al, 1982; 
Silberhorn et al, 1990; Schwarz et al, 2000). However, both in vitro and in vivo studies 
suggest also a tumour promotion capacity of several non-dioxin-like di-ortho substituted 
PCBs (Preston et al, 1985; Hemming et al, 1993; De Haan et al, 1996), where it is unlikely 
that the Ah receptor is involved. One of the mechanisms possibly involved in the 
carcinogenicity of both the dioxin-like and-non-dioxin-like PCBs is the inhibition of 
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intercellular communication (Silberhorn et ah, 1990). Intercellular communication plays an 
important role in cell growth, differentiation and maintenance of cell homeostasis 
(Loewenstein, 1990; Budunova, 1994). Therefore inhibition of the gap junctional intercellular 
communication (GJIC) is suggested to be an early step in the development of tumours. 
The aim of our project was to examine the tumour promotion potential of complex, 
environmentally relevant mixtures of PCBs, PCDDs and PCDFs containing both dioxin- and 
non dioxin-like congeners, and, to evaluate the applicability of the Toxic Equivalency Factor 
(TEF) concept for the tumour promotion potential of complex mixtures of PCBs, PCDDs and 
PCDFs. In this manuscript in vitro data are presented on the interactive effects between planar 
and non-planar PHAH congeners on the Ah receptor-dependent induction of ethoxyresorufin-
O-deethylase (EROD) and luciferase, in the EROD and reporter gene (DR-CALUX) bio-
assays. In addition, preliminary results are presented on the inhibition of GJIC by combined 
exposure of individual PHAHs as well as PHAH mixtures originally designed for rumour 
promotion experiments in vivo. 
Materials and Methods 
Chemicals 
Aroclor 1254 and 1260 were kindly provided by Dr. M. Van den Berg (Research 
Institute of Toxicology, University of Utrecht, The Netherlands). 2,3,7,8-TCDD was obtained 
from Radian CIL, Inc. (USA). 2,2',4,4'-TeCB (PCB 47), 2,2',5,5'-TeCB (PCB 52), 2,2',4,5,5'-
PeCB (PCB 101), 2,3,3',4,4'-PeCB (PCB 105), 2,3,4,4',5-PeCB (PCB 114), 2,3',4,4',5-PeCB 
(PCB 118), 2,2',3,3',4,4'-HxCB (PCB 128), 2,2',4,4',5,5'-HxCB (PCB 153), 2,3,3',4,4',5-HxCB 
(PCB 156), and 2,2',3,4,4',5,5'-HeCB (PCB 180) were from Schmidt B.V. (Amsterdam, The 
Netherlands) and Ultra Scientific (North Kingstown, Ireland). All PHAH stock solutions were 
dissolved in dimethyl sulfoxide (DMSO 99.9%; Janssen Chimica, Geel, Belgium). 
Minimal essential medium (alfa-MEM) and foetal calf serum for cell culture were 
obtained from Gibco (Rockville, Maryville, USA). Resorufin was obtained from Janssen 
Chimica (Geel, Belgium) and ethoxyresorufin and penthoxyresorufin were synthesised 
according to Mayer et al. (1977). NADPH (98%) was from Boehringer (Mannheim, 
Germany). A Bradford Protein Assay kit was obtained from Bio-rad (Hercules, California, 
USA). Phosphate buffered saline (Dulbecco's 'A', pH 7.3; PBS) was purchased from Oxoid 
(London, UK), NaCl and Tris were from Merck (Darmstadt, Germany). Luciferin assay mix 
was from Promega (Madison, Wisconsin, USA). Lucifer Yellow CH (98%) was purchased 
from Sigma Chemical Co. (St. Louis, MO, USA). All other compounds were of analytical 
grade. 
Ethoxyresorufin-O-deethylase assay 
The induction of ethoxyresorufin-O-deethylase (EROD) activity was analysed in the 
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wild type mouse hepatoma cell line Hepalclc7 as described by De Haan et al. (1996). Cells 
were seeded in 96-wells plates (Greiner) and grown in minimal essential medium (alfa-MEM) 
with 10% foetal calf serum. After culturing for 24 hours under standard conditions (37 °C, 5% 
C02), the cells were exposed to the test compounds during another 24 hours. Then the 
medium was removed from the cells, the cells were rinsed with 0.5><PBS buffer, lysed with 20 
ul distilled water and frozen at -80 °C for at least 10 minutes. For the analysis of the EROD 
activity cells were thawn at room temperature. Then cells were pre-incubated at 37 °C in the 
presence of 50 ul Tris-sucrose buffer (50 mM/0.1 M) with dicumarol (0.04 mM) and 25 ul 20 
uM 7-ethoxyresorufin solution. Subsequently the reaction was started after addition of 25 ul 
1.0 mM NADPH. After incubation at 37 °C for 1 hour, resorufin concentrations were 
measured with a fluoro spectrophotometric plate reader (CytoFluor 2530, Millipore). The 
protein content in the wells was analysed with a Bradford Protein Assay kit. 
Each concentration of a sample was tested at least in ten wells per experiment and each 
experiment was repeated twice. DMSO and TCDD were incorporated as a negative and a 
positive control respectively on each plate. The DMSO concentration in the cell medium did 
not exceed 0.1%. 
Ah receptor-dependent H4IIE-Luc reporter gene assay (DR-CALUX) 
To exclude the possibility of competitive inhibition of PHAH congeners with 
ethoxyresorufin in the EROD assay (as observed by Besselink et al, 1998), which would 
result in an underestimation of the Ah receptor-based potency of mixtures, combinations of 
PHAH congeners were also tested in the DR-CALUX assay. The DR-CALUX assay was 
performed according to Aarts et al. (1995) adapted for a 96-wells plate as described by Murk 
et al. (1998). Recombinant mouse hepatoma Hepalclc7 cells and rat H4IIE.pGudlucl.l cells 
were prepared as previously described (Aarts et al, 1995; Garrison et al, 1996). Cells were 
seeded in 96-wells plates (Packard, Meriden, CT, USA) and grown in minimal essential 
medium (alfa-MEM) with 10% heat inactivated foetal calf serum. After culturing for 24 hours 
under standard conditions (37 °C, 5% C02) the cells were exposed to the test compounds. 
After 24 hours incubation the medium was removed from the cells, the cells were rinsed with 
0.5xPBS buffer, treated with lysis buffer (10 mM Tris, 2 mM dithiolthreitol and 2 mM 1,2-
diaminocyclohexane-N,N,N',N'-tetra-acetic acid, pH 7.8) and after adding the luciferin assay 
mix the light signal was measured in a Luminometer plate reader (Luminometer, Labsystem). 
Each concentration of a sample was tested at least in triplicate and each experiment was 
repeated twice. DMSO and TCDD were incorporated as a negative and a positive control 
respectively on each plate. The DMSO concentration in the cell medium did not exceed 0.1%. 
Analysis of the gapjunctional intercellular communication 
The inhibition of gapjunctional intercellular communication (GJIC) was analysed in the 
wild type mouse hepatoma cell line Hepalclc7 as described by De Haan et al. (1996). Cells 
were seeded in petri dishes (3.5 cm2; Greiner) and grown in minimal essential medium (alfa-
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MEM) with 10% foetal calf serum. After culturing for 24 hours under standard conditions (37 
°C, 5% C02), culture medium was replaced by exposure medium. Cells were exposed to the 
test compounds for 24 hours. Micro-injection experiments were performed in confluent, or 
nearly confluent cell cultures by a dye transfer technique as described by De Haan et al. 
(1994b). In each petri dish at least 20 injections with a 10% lucifer yellow CH solution in 0.33 
M lithium chloride using a vertical injection system (Olympus IMT-2-SYF, PAES Ned.) were 
done. The injected cells were morphologically examined by phase contrast and fluorescence 
microscopy, directly after micro-injection. The number of fluorescent (communicating) cells 
was counted by eye using fluorescence microscopy, 10-15 minutes after lucifer yellow 
injection. Each individual exposure level was tested in duplicate or triplicate and at least two 
independent tests were done. The DMSO concentration in the cell medium never exceeded 
0.1%. 
Test compounds and mixtures 
Two sets of experiments were performed. In the first set of experiments the interaction 
between PCBs and 2,3,7,8-TCDD was analysed in the EROD and DR-CALUX assay. 
Individual PCB congeners and the commercial PCB mixture Aroclor 1254 in concentration 
ranges of 0-66 uM, were co-administered with 50 pM TCDD. A concentration of 50 pM 
TCDD was chosen, because at this concentration nearly 90% of the maximum EROD and 
CALUX induction by TCDD was achieved. The following mono- and di-ortho PCB 
congeners were tested: PCB 105, PCB 114, PCB 118, PCB 156, PCB 47, PCB 52, PCB 101, 
PCB 128, PCB 153 and PCB 180. In addition to the combination experiments with 50 pM 
TCDD, PCB 114 was tested also with 5, 10 and 27 pM TCDD in order to study the inhibitory 
behaviour of a mono-ortho PCB with lower concentrations of TCDD. To study the possibility 
of interactive effects on the inhibition of GJIC two experiments were performed: 50 pM 
TCDD was co-administred with increasing concentrations of PCB 52 or Aroclor 1254. 
In the second set of experiments induction of the CALUX activity and inhibition of 
GJIC by complex PHAH mixtures was tested. Because these mixtures were designed for rat 
experiments (Van der Plas et al, 1999 Chapter 4, 2000a Chapter 5), the rat hepatoma cell line 
H4IIE.luc was chosen to determine the toxic equivalency (TEQ) in the CALUX assay. All 
PHAH mixtures were tested in a concentration range of 0-250 uM. 
Two synthetic dioxin-like PHAH mixtures were studied, a PHAH+ and a PHAH-
mixture, covering >90% of the TEQ in Baltic herring. The PHAH- mixture contained six 
congeners; 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 2,3,4,7,8-PeCDF, PCB 126, PCB 118 and PCB 
156 in relative concentration ratios of 1, 3.3,17, 61, 12800 and 1888 respectively. The 
PHAH+ mixture consisted of the PHAH- mixture to which PCB 153 was added, in order to 
study possible interactive effects with a di-ortho, non-dioxin-like PCB congener. The relative 
ratio of PCB 153:2,3,7,8-TCDD was 20000:1. The PHAH mixtures are described in detail by 
Van der Plas et al. (1999 Chapter 4). 
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The other tested PHAH mixtures were the commercial PCB mixture Aroclor 1260 and 
fractions thereof. Aroclor 1260 was fractionated into three fractions according to a method 
described by Athanasiadou et al. (1991) with slight modifications as described by Van der 
Plas et al. (2000a Chapter 5). Three fractions were obtained; a 2-4 ortho non-dioxin-like 
fraction (-90.3% of the total mass), a 1- ortho fraction (-6.6% of the total mass) containing 
mono and a trace of Ai-ortho PCBs and a 0- ortho dioxin-like fraction (~3.1% of the total 
mass) containing mainly non-ortho PCBs with a trace of mono-ortho PCBs. 
Statistics 
To calculate EC50 and IC50 values, a dose-response curve was fitted to the data using a 
the 1 -site ligand binding equation y=a0x/(a,+x). For all curve fitting the program Slide Write 
4.0 was used. The calculation of relative potencies (REPs) for the PHAH mixtures was 
calculated on the basis of the CALUX data by interpolation of the dose-response curves of the 
mixtures on a standard curve of TCDD, according to Murk et al. (1996). 
Data were analysed with the statistical package SPSS-PC 7.5. A Student Newman Keuls 
(SNK) test was used to analyse statistical significant differences between dose levels. 
Results 
EROD assay 
In figure 2.1 the EROD dose-response curve for TCDD is presented. Data are expressed 
as percentage relative to the induction at 1 nM, which was 25.5 pmol resorufin/minxmg 
protein. On the basis of the dose-response curve a concentration of 50 pM was chosen for the 
combination experiments. A concentration of 1 nM was used as a positive control in the 
consecutive experiments. 
Mono-ortho PCBs 
All tested mono-ortho PCBs induced the EROD activity up to a plateau level of 
approximately 40-60% of the maximum induction reached by TCDD, with EC50 values 
ranging between 1 and 33 uM (Table 2.1). When the PCBs were co-administered with TCDD, 
the TCDD induced EROD activity was partially inhibited by the mono-ortho PCBs down to 
approximately the maximum induction level of the PCB itself. This is clearly illustrated in 
figure 2.2A, showing the dose-response curves of the EROD induction by PCB 118 alone and 
in the presence of TCDD. These 'mirror'-like curves as shown for PCB 118 were also 
observed for the other mono-ortho PCBs. IC50 values (Table 2.1) showed that PCB 105 and 
PCB 118 had the greatest inhibitory potency while PCB 156 was the least potent inhibitor of 
the mono-ortho PCBs tested. The order with which the tested mono-ortho PCBs were capable 
of inhibiting the TCDD induced EROD activity reflected their own potency to induce the 
EROD activity. 
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Figure 2.1 Dose effect 
curve of the EROD 
induction by 2,3,7,8-TCDD 
inhepalclc7 cells. 
Data are presented as mean 
±SE. 
In order to study interactive effects at lower concentrations of TCDD and thus at lower 
parts of the EROD dose-response curve, TCDD concentrations ranging from 5 to 50 pM were 
co-administered with increasing concentrations of PCB 114 (Figure 2.2B). At the lowest 
concentrations of both TCDD and PCB 114, the effects of the individual compounds appeared 
to be additive. However, when the concentration difference between PCB 114 and TCDD 
became larger, the shape of the curve became similar to the curve of individually dosed PCB 
114. From 27 pM TCDD onwards, the shape of the curve differed from the response curve of 
individually dosed PCB 114 and an antagonistic interactive effect was clearly visible. 
Di-ortho PCBs 
No EROD activity was found after exposure to any of the di-ortho PCBs (Table 2.1). 
However, all di-ortho PCBs antagonised the TCDD-induced EROD activity in a dose-
dependent manner and with different potencies (Figure 2.2C, Table 2.1). IC50 values (Table 
2.1) showed that the di-ortho substituted PCB 153 was the least potent inhibitor whereas PCB 
128 was the most potent inhibitor of TCDD mediated EROD induction. 
CALUX assay 
To exclude the possibility of competitive inhibition of PHAH congeners with 
ethoxyresorufin in the EROD assay (as observed by Besselink et ah, 1998) some of the 
combined exposures were also tested in the CALUX assay. In addition, the CALUX assay was 
used to determine the relative toxic potency of the PHAH mixtures, designed for in vivo 
testing. 
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Table 2.1 EC50 values of mono-ortho and di-ortho PCBs for the induction of EROD activity 
and IC50 values for the inhibition of the EROD activity induced by 50 pM TCDD 
PCB (IUPAC) 
2,3,3',4,4'-PeCB (105) 
2,3,4,4',5-PeCB(114) 
2,3',4,4,,5-PeCB(118) 
2,3,3',4,4',5-HxCB(156) 
2,2',4,4'-TeCB (47) 
2,2',5,5'-TeCB (52) 
2,2',4,5,5'-PeCB (101) 
2,2',3,3',4,4'-HxCB (128) 
2,2',4,4',5,5'-HxCB (153) 
2,2',3,4,4',5,5'-HeCB(180) 
Aroclor 1254 
bC 5 0 
(uM) 
3 
2 
2 
33 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
3 
EROD 
ic50, 
(uM) 
1 
4 
1 
22 
60 
12 
52 
2 
82 
45 
2 
[PCB]/[TCDD] 
2xl03 
4xl04 
4xl03 
4xl05 
6.3x10s 
2xl04 
2.5xl05 
6xl03 
6x10s 
1x10s 
2xl04 
n.d.=not detectable; n.a.=not analysed; IC50 is defined as the concentration inhibiting 50% 
of the EROD activity induced by 50 pM TCDD; [PCB]/[TCDD] is the concentration 
difference required for a significant inhibition of TCDD induced EROD activity. 
Mono- and di-ortho PCBs 
The tested mono-ortho PCBs all induced the CALUX activity (Figure 2.3A-C). 
Although the maximum induction of the CALUX activity reached by PCB 105 and PCB 118 
was lower as compared to the maximum EROD activity induced by these congeners, the same 
trend was observed for the inhibition of the CALUX activity induced by TCDD. 
The di-ortho PCB 180 induced the CALUX activity dose-dependent up to almost 16% 
of the maximum activity induced by TCDD, at the highest test dose of 40 uM (not shown). 
The other di-ortho PCBs tested did not show any activity for the CALUX induction. The 
CALUX activity induced by TCDD was antagonised by all di-ortho PCBs tested, with 
different potencies (Figure 2.3D). 
PHAH mixtures 
The CALUX activity of the dioxin-like PHAH mixtures (see 'Materials and methods' 
section for the composition) is shown in figure 2.4. Both the PHAH- mixture, without PCB 
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Table 2.2 EC50 values and relative potencies of the PHAH mixtures, Aroclor 1260 and its 
fractions for the CALUX activity. 
Mixture 
PHAH- mixture 
PHAH+ mixture 
Aroclor 1260 
0-4 ortho fraction 
0-1 ortho fraction 
0- ortho fraction 
1- ortho fraction 
2-4 ortho fraction 
LC50 
(ug/ml) 
9.3 x 10"3 
15.0 x 10"3 
0.9 
n.d. 
1.7 
0.8 
1 
n.d. 
CALUX REP 
3.3 x 10"4 
2.0 x 10"4 
1.7 x 10"7 
n.d. 
8.2 x 10"7 
2.5 x 10"6 
2.2 x 10-7 
n.d. 
Literature TEF 
value" 
9.7 x 10"4 
4.4 x 10"4 
4.6 x 10"6 
4.6 x 10"6 
4.6 x 10"6 
0.2 x 10-* 
4.4 x 10"6 
-
n.d. = not possible to determine." TEF values for the individual congeners are based on WHO-TEFs 
of 1997 (Van den Berg et al., 1998). PCB concentrations in Aroclor 1260 are when possible based on 
Van der Plas et al. (2000a Chapter 5) and otherwise on Leonards et al. (1995). 
153, and the PHAH+ mixture, with PCB 153, induced the CALUX activity up to the 
maximum inducible level by TCDD. The REPCALUX of the PHAH+ and PHAH- mixture was 
very close to the literature TEF value for these mixtures, within a factor of 3 (Table 2.2). 
Apparently, there were no interactive effects between the PHAH congeners in the synthetic 
PHAH mixtures. 
Aroclor 1260 induced the CALUX activity to a maximum level of approximately 10% 
of the maximum activity induced by TCDD (Figure 2.5). No plateau was reached since a 
further increase of the Aroclor 1260 concentration resulted in cell death. A completely 
different picture is demonstrated with the separate fractions of Aroclor 1260. The 0-ortho 
fraction showed the highest CALUX activity. At the highest concentration tested the 0-ortho 
fraction showed an activity of 40% of the maximum induced activity by TCDD. The 1-ortho 
fraction showed an induction of 8% at the highest dose tested, while the 2-4 ortho fraction did 
not show any activity at all. Reconstitution of the fractions to the 0-4 ortho fraction, resulted 
clearly in an inhibitory effect of the CALUX activity by both the 1- and 2-4 ortho fraction. 
The reconstituted 0-4 ortho fraction had a similar dose-response curve as compared to Aroclor 
1260, except that the induction of the 0-4 ortho fraction is a factor of 3 lower. The difference 
in induction between Aroclor 1260 and the 0-4 ortho fraction can possibly be explained by the 
absence of impurities such as PCDFs, which are lost during the fractionation of Aroclor 1260 
(Athanasiadou et al, 1991). Due to its low induction, no relative toxic potency (REPCALUX) 
could be calculated for the 0-4 ortho fraction. The REPCALUX for Aroclor 1260 and its fractions 
are shown in table 2.2. The REP values do not correspond with the literature TEF values, 
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which were based on GCMS-data (Van der Plas et al., 2000a Chapter 5). This may be partly 
explained by the interactions between congeners in the fractions. 
Micro-injection 
In the microinjection experiments 1 nM TCDD was incorporated as a positive control 
on the basis of experiments of De Haan et al. (1994b, 1996), which were also performed at 
our laboratory. A GJIC dose-response curve of TCDD is presented in figure 2.6. In our 
experiments inhibition of the GJIC by TCDD at a dose level of 1 nM, ranged from 37% to 
39% as compared to the vehicle control. An exception was the experiment with the 0-4 ortho 
fraction of Aroclor 1260, with an inhibition of the GJIC of only 27% (not shown). 
Combination experiments 
The inhibition of GJIC by individual PHAH congeners was determined by De Haan et 
al. (1994b, 1996), who observed GJIC inhibition by PCB 77 (3,3',4,4'-TeCB), 126, 169 
(3,3',4,4',5,5-HxCB), 105, 114, 118, 156, 52, 128 and 153 (Table 2.3). For the combination 
experiments 50 pM TCDD was co-administred with increasing concentrations PCB 52 or 
Aroclor 1254. PCB 52 was chosen because it was shown to be a potent inhibitor of GJIC (De 
Haan et al, 1996) and a strong antagonist of the EROD activity induced by TCDD. Aroclor 
1254 had a weak partial agonisitic activity in the EROD assay (maximum induction of 22% 
compared to TCDD) and a strong partial antagonistic effect on the EROD activity induced by 
TCDD. 
Individually dosed PCB 52 inhibited the GJIC down to 67% of the vehicle control 
(Figure 2.7A). Co-administration of PCB 52 and 50 pM TCDD resulted in a further reduction 
of the GJIC at the highest test concentrations of PCB 52, as compared to individually dosed 
PCB 52 or TCDD. However, the effect was not additive. Since the concentration difference 
between PCB 52 and TCDD was not high enough for antagonistic interactions (Table 2.1) 
between the congeners, it does not seem to be likely that the observed non-additivity is due to 
competition for Ah receptor binding. Aroclor 1254 appeared to be a weak inhibitor of GJIC 
(Figure 2.7B) with a maximum inhibition of approximately 20%. Co-administration of TCDD 
and Aroclor 1254 showed a reduction of the induced inhibition by TCDD, towards the 
maximum of Aroclor 1254. 
PHAH mixtures 
Both the synthetic PHAH mixtures were capable of inhibiting the GJIC (Figure 2.8). 
The PHAH- mixture showed a reduction of the GJIC of almost 40% at a dose level of 1000 
nM (-331 ug/ml). The PHAH+ mixture showed a stronger inhibitory effect on the GJIC as 
compared to the PHAH- mixture and even exceeded the maximum inhibition of the GJIC by 
TCDD. The PHAH+ mixture inhibited the GJIC down to 55% of the control at the highest test 
dose of 2000 nM. The IC50 values for the PHAH- and the PHAH+ mixture were difficult to 
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Table 2.3 EC50 values and relative potencies of inhibition of GJIC 
Congener 
3,3',4,4'-TeCB (77)* 
3,3',4,4',5-PeCB (126)' 
3,3',4,4',5,5'-HxCB (169)' 
2,3,3',4,4'-PeCB (105)c 
2,3,4,4',5-PeCB(114)e 
2,3',4,4',5-PeCB(118)c 
2,3,3',4,4',5-HxCB(156)c 
2,2',5,5'-TeCB (52)c 
2,2',3,3',4,4'-HxCB (128)c 
2,2',4,4',5,5'-HxCB(153)': 
PHAH- mixture 
PHAH+ mixture 
0-1 ortho fraction 
2-4 ortho fraction 
0-4 ortho fraction 
ic5 0 
(nM) 
5.5 
0.7 
11 
100 
117 
2.5 
28 
54 
2.5 
>104 
30 
30-95 
> l e 
2' 
>6e 
inhepalclc7 cells 
REPa 
0.25 
0.21 
0.013 
0.0014 
0.0011 
0.06 
0.005 
0.003 
0.06 
< 2 x 10"4 
0.0016-0.0047 d 
0.00055-0.0047 d 
< 1.6 x 10"5 
8x 10"6-24x l0-6rf 
< 2.7 x 10'6 
" Relative potency with regard to TCDD. EC50 values were used for the calculation.b Derived from 
De Haan et al. (1994b).c Derived from De Haan et al. (1996). a Based on an EC50 value for TCDD 
ranging from 0.05-0.15 nM (De Haan e? al, 1994b, 1996). fug/ml 
determine because no plateau was reached. The IC50 for the PHAH- was estimated on 30 nM. 
For the PHAH+ mixture the IC50 was estimated between 30 and 95 nM. Assuming an IC50 
ranging from 0.05-0.15 nM for TCDD (De Haan et al, 1994b; 1996), REP values can be 
estimated for the PHAH mixtures ranging from 1.6 x 10~3 to 4.7 x 10~3 for the PHAH- mixture 
and from 5.5 x 10" to 4.7 x 10"3 for the PHAH+ mixture (Table 2.3). 
The 0-1 ortho fraction (Figure 2.9) of Aroclor 1260 did not inhibit the GJIC at 
concentrations up to 906 ng/ml (equivalent to 25 uM Aroclor 1260), at which dose level only 
a marginal CALUX induction was observed (Figure 2.5). The 2-4 ortho fraction showed a 
reduction of the GJIC with 25% at the highest test dose of 17 ng/ml (equivalent to 50 uM 
Aroclor 1260) and the reconstituted 0-4 ortho fraction showed a slight inhibition of 15% as 
compared to the control at the highest test dose of 6.2 ug/ml (equivalent to 16 uM Aroclor 
1260). It is likely that a stronger inhibitory effect could have been found when higher test 
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doses were been used. However, it is noted that in the CALUX assay with the H4IIE cell line, 
cytotoxicity was observed > 5 ug/ml 0-4 ortho fraction. Although no morphological signs of 
cytotoxicity were observed in the micro-injection assay, it can not be excluded. 
Discussion 
The aim of the study presented here was to investigate the interactive effects between 
PHAHs in vitro on the EROD and CALUX activity, both based on an Ah receptor mediated 
mechanism of action, and on the GJIC, an in vitro parameter for tumour promotion. In 
addition, the relative toxic potency (REP) of complex PHAH mixtures originally designed for 
tumour promotion experiments (Chapter 4,5) was determined, as well as their ability to 
inhibit GJIC. 
Interactions between individual congeners 
Ah receptor based interactive effects between individual PHAH congeners were studied 
in the EROD and CALUX Ah-receptor reporter gene assay. For the interaction experiments 
50 pM TCDD was co-administered with different concentrations of individual mono- and di-
ortho PCBs. All tested mono- and di-ortho PCBs were found to inhibit the TCDD induced 
EROD and CALUX activity, with different potencies. The shape of the dose-response curves 
at different concentrations of TCDD suggests that antagonistic interactions observed between 
the mono-ortho PCBs and TCDD are based on competition at the Ah receptor level. The 
occurrence of antagonistic interactions between potent and less potent PHAH congeners was 
also found by others (Haake et al, 1987; Astroff and Safe, 1989) and is consistent with results 
obtained for other ligand-induced transcription factors such as the steroid hormone receptors 
(Safe 1997/1998). Antagonism may only occur under the condition that the receptor is almost 
saturated with the ligand. This is illustrated by the experiments where different concentrations 
of TCDD were co-administered with PCB 114. The antagonistic effect between PCB 114 and 
TCDD is only clearly visible at the highest test dose of 50 pM TCDD, which induces the 
EROD activity up to 90% of the maximum TCDD inducible activity. In vivo antagonistic 
interactions were also observed at high concentrations of both the agonist and the partial 
agonist (Bannister et al, 1987a; Haake et al, 1987; Davis and Safe, 1989; Biegel et al, 
1989). 
All tested di-ortho PCBs appeared to be capable of antagonising the EROD and 
CALUX activity induced by TCDD, despite the fact that they do not induce any activity by 
themselves. In agreement with our results, Aarts et al. (1995) demonstrated that PCB 52 
(2,2',5,5'-TeCB) antagonised the in vitro luciferase expression (CALUX) and EROD activity 
induced by PCB 77 (2,2',3,3',4,4'-HxCB). Their results suggest that the antagonist blocks 
formation of the transcriptionally active nuclear AhR complex (Aarts et al, 1995). Wolfle 
(1997/98) reported on antagonistic interactions between TCDD and PCB 153 for the 
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enhancement in vitro (promotion) of malignant transformation of carcinogen-initiated 
C3H/M2 mouse fibroblasts. In this tumour promotion assay individually dosed TCDD or PCB 
153 both induced a maximal effect, probably via Ah receptor dependent and independent 
mechanisms respectively (Wolfle, 1997/98). The antagonistic interaction between TCDD and 
PCB 153 in this tumour promotion assay is not understood. 
In the microinjection assay for analysing inhibition of GJIC, combined exposure was 
performed with TCDD and PCB 52. PCB 52 was demonstrated to be a potent inhibitor of the 
GJIC in vitro (De Haan et al, 1996) as well as a tumour promoter in vivo (Preston et ah, 
1985). Combined exposure of PCB 52 and TCDD did result in a further decrease of the GJIC 
rather than in inhibition of the effect induced by TCDD. Although in the microinjection assay 
the concentration difference between PCB 52 and TCDD is <2><104, which is probably to low 
for antagonistic interactions between these congeners (see EROD results), it does not seem to 
be likely that at higher concentrations of PCB 52 the inhibition of GJIC by TCDD will be 
antagonised. Even at concentration levels where there is competition between TCDD and 
PCB 52 for Ah receptor binding, the inhibition of GJIC will possibly be at a maximum due to 
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the GJIC inhibitory potential of PCB 52 itself. Co-administration of Aroclor 1254 and TCDD 
in the microinjection assay did show an antagonistic interactive effect, probably due to the 
low inhibitory potency of Aroclor 1254. Antagonising properties of Aroclor 1254 have been 
found before both in vitro and in vivo on several parameters, such as enzyme induction, 
immunotoxicity and teratogenicity (Bannister et ah, 1987a; Davis and Safe, 1989; Haake et 
al, 1987). 
Interactions between congeners in mixtures 
In the CALUX assay no interactive effects were observed between the compounds in the 
synthetic dioxin-like PHAH-mixture (for the composition see materials and methods), neither 
was there an effect of PCB 153 on the CALUX activity induced by the PHAH+ mixture. In 
addition, it can be calculated on the basis of the minimum concentration difference needed 
between TCDD and the mono- or di-ortho PCB to antagonise the EROD activity induced by 
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TCDD, that antagonistic interactive effects between the partial and full agonists in the PHAH 
mixtures were not likely to occur. In the microinjection assay the synthetic PHAH+ mixture 
showed a larger inhibition on the GJIC compared to theoretically equipotent levels of the 
PHAH- mixture or TCDD. However, PCB 153 was found to be a very weak inhibitor of the 
GJIC (De Haan et al., 1996) and at the dose levels tested the concentration of PCB 153 in the 
PHAH+ mixture is certainly not high enough to induce an effect on the GJIC. Also in vivo the 
PHAH+ mixture had a stronger effect on the development of altered hepatic foci as compared 
to the PHAH- mixture, which could not fully be explained by the tumour promotion potency 
of PCB 153 itself (Van der Plas et al, 1999 Chapter 4). In this in vivo experiment PCB 153 
was also found to increase the hepatic retention of the PHAH congeners in the mixture, 
thereby increasing the target dose (Van der Plas et al, 1998b Chapter 3, 1999 Chapter 4). 
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The 0- and the 1- ortho fraction of the commercial PCB mixture Aroclor 1260, both 
showed a higher induction of the CALUX activity as compared to Aroclor 1260 itself. 
Reconstitution of the fractions clearly resulted in a strong antagonising effect of the 1- ortho 
and especially of the 2-4 ortho fraction on the planar 0- ortho fraction. In the microinjection 
assay no interactive effects were observed between the fractions of the Aroclor 1260. It is 
concluded that the low maximum response induced in EROD and CALUX assays by Aroclor 
1260 in vitro, is caused by antagonistic interactions between dioxin-like and non-dioxin-like 
congeners in the mixture. In a sub-chronic study in rats no such interactions between the 
different Aroclor 1260 fractions were observed (Van der Plas et al, 2000a,b Chapter 5, 6). 
This was probably because the TEF value of the 0-1 ortho fraction and Aroclor 1260 mixture 
was to low to induce a strong effect on the EROD activity (Van der Plas et al, 2000a Chapter 
5) and thus to create a condition under which competition between congeners for Ah receptor 
binding might occur. However, another important observation in this respect is that in vivo the 
hepatic retention as percentage of the given dose differs between PHAH congeners (Abraham 
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et al, 1989; Waern et al, 1991; Hemming et al, 1993; Van der Plas et al, 1998b Chapter 3). 
This is explained by differences in affinity between the PHAH congeners for the hepatic 
binding protein CYP1A2 (Kedderis et al, 1993; Andersen et al, 1993; Van den Berg et al, 
1994; DeVito et al, 1998; Diliberto et al, 1999). The consequence of differences in hepatic 
retention between PHAH congeners is that the initial relative concentrations in a mixture will 
change in favour of the Ah receptor agonists at the target tissue level. Thus the conditions 
under which antagonistic interactive effects between PHAHs will occur, are more difficult to 
reach in vivo as compared to the in vitro situation. 
Inhibition ofGJIC by PHAH mixtures 
In the microinjection assay both synthetic PHAH mixtures had a strong inhibitory effect 
on the GJIC, at least 50% inhibition at 1-2 uM concentrations. Although it was difficult to 
calculate an EC50 value, the data suggest that the observed potency to inhibit the GJIC was 
within a factor of 10 of the theoretical potency, which was predicted on the basis of the TEF 
concept. In addition, the maximum GJIC inhibition of the PHAH mixtures was close to the 
maximum effect induced by TCDD. Also in vivo the dioxin-like PHAH mixtures were shown 
to be potent tumour promoters, within a factor of 2 of what was expected on the basis of the 
TEF concept (Van der Plas et al, 1999 Chapter 4). 
Only a small inhibitory effect on the GJIC could be found for the 2-4 ortho and the 0-4 
ortho fractions (-25% inhibition), while the 0-1 ortho fraction had no effect on the GJIC. This 
suggests that the observed GJIC inhibition by the 0-4 ortho fraction is caused by the 2-4 ortho 
PCBs, which is in agreement with the results observed in a rat tumour promotion experiment 
performed by Van der Plas et al. (2000a Chapter 5). Van der Plas and co-workers (2000a 
Chapter 5) showed that the 2-4 ortho PCBs were responsible for approximately 80% of the 
tumour promotive capacity of Aroclor 1260. In the CALUX assay the 0- ortho fraction 
induced the CALUX activity up to 40%, indicating that this fraction and thus also the 0-1 
ortho fraction contains dioxin-like compounds. It is therefore assumed that at higher doses of 
the 0-1 ortho fraction an effect on the GJIC would have been observed. 
Inhibition ofGJIC by di-ortho substituted PCBs was also demonstrated by others 
(Swierenga et al, 1990; Hemming et al, 1991; De Haan et al, 1994b, 1996). In hepalclc7 
cells the relative potency for inhibiting the GJIC of for instance PCB 52 and PCB 128 
(2,2',3,3',4,4'-HxCB) was shown to be in the same order as for the mono- and non-ortho PCBs 
(De Haan et al, 1996). In addition, some of the methyl-sulfonyl metabolites of PCBs, which 
may be formed from the 2-4 ortho PCBs, were found to inhibit the intercellular 
communication in vitro (Kato et al, 1998). It is assumed that the Ah receptor pathway is 
involved in inhibition of the GJIC by TCDD and dioxin-like compounds (De Haan et al, 
1994b; Baker et al, 1995). However, there is evidence that the mono- and di-ortho PCBs 
modulate their effect on GJIC via a different, Ah receptor independent, pathway (Swierenga et 
al, 1990; Hemming et al, 1991; De Haan et al, 1996; Bager et al, 1997). The mechanism of 
this non-Ah receptor pathway is unclear at the moment. The in vitro results are in accordance 
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with the observation that both dioxin-like and non-dioxin-like PCBs, often referred to as 
phenobarbital-like, can act as tumour promoters in vivo (Preston et al., 1985; Hemming et al, 
1993; Bager et al., 1995; Haag-Gronlund et al, 1997a, 1997b, 1998). In addition to data from 
De Haan et al. (1996) on the inhibition of the GJIC by PHAHs, our data suggest that the 
hepalclc7 cell line might be a useful in vitro model for studying the capacity of both 
individual and complex mixtures of PHAHs to act as a tumour promoter in vivo. However, the 
in vitro data presented here are only preliminary data and more experiments would be 
necessary to draw firm conclusions. 
In summary, in vitro non-additive antagonistic interactions (on the EROD and CALUX 
activity as well GJIC inhibition) occurred between agonists and partial or non-agonists, 
possibly at Ah receptor level. These non-additive antagonistic interactions seem to be only 
possible in case the compound concentrations are high enough to induce at least a sub-
maximal effect (i.e. induction of EROD and CALUX activity or inhibition of GJIC) and, 
when the concentration difference between the potent and less potent agonist is large enough 
for competition for Ah receptor binding. In environmental exposure to PHAHs these 
conditions will be seldomly reached and therefore antagonistic interactions are not likely to 
play a role in vivo in real life situations. In case both PHAH congeners are strong inducers of 
an effect, whether or not via different mechanisms, additivity is more likely to occur. The in 
vitro potency of PHAH mixtures to inhibit the GJIC was largely in agreement with the tumour 
promotion properties in vivo. However, more research is needed to elucidate the predictive 
value of this parameter for the tumour promotion potency in vivo. 
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Toxicokinetics of an environmentally relevant mixture of dioxin-like 
polyhalogenated aromatic hydrocarbons (PHAHs) with or without a 
non-dioxin-like PCB in a sub-chronic exposure study in female 
Sprague Dawley rats 
Abstract 
Female Sprague Dawley rats were treated subcutaneously for 20 weeks with an 
environmentally relevant mixture of dioxin-like PHAHs with (PHAH+) or without (PHAH-) 
2,2',4,4',5,5'-hexachlorobiphenyl. The hepatic retention (% of given dose) of the various 
PHAH congeners differed considerably and in the following order: 2,3,4,7,8-
pentachlorodibenzofuran (30.5-43.1%), 3,3',4,4',5-pentachlorobiphenyl (12.8-17.6%), 
1,2,3,7,8-pentachlorodibenzo-p-dioxin (6.9-10.8%), 2,3,7,8-tetrachlorodibenzo-^-dioxin (3.2-
4.5%), 2,3,3',4,4',5-hexachlorobiphenyl (1.0-1.7%), 2,2',4,4',5,5'-hexachlorobiphenyl (0.5-
0.8%) and 2,3',4,4',5-pentachlorobiphenyl (0.2-0.4%). A decrease of the hepatic retention of 
2,3,7,8-TCDD, 1,2,3,7,8-PeCDD and 2,3,4,7,8-PeCDF was found at increasing doses of the 
PHAH+ mixture. 2,2',4,4',5,5'-Hexachlorobiphenyl increased the hepatic retention (1.3-2 
times) of all congeners in the PHAH+ group, compared to the TEQ equivalent dosed PHAH-
group. No interactions were observed on the ethoxyresorufin-O-deethylase activity. 
Based on: Van der Plas, S.A., De Jongh, J., Faassen-Peters, M., Scheu, G., Van den Berg, M., and 
Brouwer, A. (1998). Toxicokinetics of an environmentally relevant mixture of dioxin-like PHAHs with 
or without a non-dioxin-like PCB in a semi-chronic exposure study in female Sprague-Dawley rats. 
Chemosphere37, 1941-1955. 
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Introduction 
Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs), 
polychlorinated dibenzofurans (PCDFs) and other polyhalogenated aromatic hydrocarbons 
(PHAHs) are ubiquitously present in the environment. Their toxicity, which is characterized 
by, e.g. body weight loss, thymic atrophy, impairment of immune responses, hepatotoxicity, 
teratogenicity and carcinogenicity (Safe, 1990), was intensively studied over the last 25 years. 
PCBs and PCDDs have been considered to be weak complete hepatocarcinogens 
(Kimbrough et al, 1975; Kociba et al, 1978). More recent studies primarily showed a potent 
tumour promoter activity for several chlorinated biphenyls, dioxins and furans (Pitot et al, 
1980; Silberhorn et al, 1990; Wasrn et al, 1991; Hemming et al, 1993; Haag-Gronlund et 
al, 1997a,b). Most studies performed to date have focussed on the exposure to single 
congeners with a dioxin-like, Ah receptor mediated toxicity. However, also some of the non-
dioxin-like, di-ortho substituted PCBs were found to possess a tumour promoting activity in 
the liver (Hemming et al, 1993). In addition, interactive effects on tumour promoting activity 
were reported between non-dioxin-like and planar, dioxin-like PHAH congeners (Sargent et 
al, 1991; Bager et al, 1995). Interactions between congeners have also been reported by 
several other investigators with respect to, e.g. immunotoxicity (Biegel et al, 1989; Davis and 
Safe, 1989), teratogenicity (Zhao et al, 1994) and hepatotoxicity (Yao and Safe, 1989; Van 
Birgelen et al, 1996a). It is suggested that some of the observed interactive effects may be 
due to changes in liver deposition as a result of interactions between congeners at the 
toxicokinetic level (Biegel et al, 1989; De Jongh et al, 1993a,b). 
The overall objective of our studies is to determine the tumour promotion capacity of 
complex mixtures of PCDDs, PCDFs and PCBs, relevant for human exposure. To study the 
possible interactive effects of di-ortho PCBs with the tumour promotion activity of planar 
PHAHs, a mixture was designed covering over 90% of the total dioxin-like toxicity (TEQs) in 
Swedish herring. This dioxin-like PHAH mixture was combined with or without 2,2',4,4',5,5'-
hexachlorobiphenyl (PCB 153) as a di-ortho PCB following 20 weeks of treatment. Here we 
will discuss the toxicokinetic data and ethoxyresorufin-O-deethylase (EROD) activity as an 
indication for dioxin-like effects in the liver. 
Materials and Methods 
Chemicals 
N-nitrosodiethylamin (NDEA) was obtained from Fluka (Fluka Chemie, Buchs, 
Switzerland). 3,3',4,4',5-Pentachlorobiphenyl (PCB 126), 2,3',4,4',5-pentachlorobiphenyl 
(PCB 118), 2,3,3',4,4',5-hexachlorobiphenyl (PCB 156) and 2,2'4,4',5,5'-hexachlorobiphenyl 
(PCB 153) were kindly provided by Prof. Bergman (Department of Environmental Chemistry, 
Stockholm University, Stockholm, Sweden). l,2,3,7,8-Pentachlorodibenzo-p-dioxin(PeCDD) 
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was obtained from Wellington Laboratories (Canada), 2,3,4,7,8-pentachlorodibenzofuran 
(PeCDF) was a gift from Prof. S.H. Safe (college of Veterinary Physiology and 
Pharmacology, Texas, A&M University, USA) and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) was purchased from RADIAN CIL, inc. (USA). All compounds had a purity > 99%. 
For animal exposure all compounds were dissolved in corn oil (Albert Heijn, the 
Netherlands). 
2,3,7,8-[13C]-TCDD and 3,3',4,4',5-[13C]-pentachlorobiphenyl ([13C]-PCB 126) were 
commercially obtained from Cambridge Isotope Laboratories (Woburn, MS, USA) and 
1,2,3,7,8-PeCDF, 2,3',4,4',5,5'-hexachlorobiphenyl (PCB 167) and 2,3,3',5,6-
pentachlorobiphenyl (PCB 112) from Ehrenstorfer (Augsburg, Germany). Hexane, toluene, 
dichloromethane and nonane, used for the extraction and clean up procedure of the GC-MS 
analysis were of nanograde quality and obtained from J.T. Baker (Deventer, The Netherlands). 
Silica gel 60 extra pure 70-230 mesh ASTM, NaOH and Na2S04 were obtained from E. 
Merck (Darmstadt, Germany). Aluminum B super I was bought from ICN Biomedicals 
(Eschwege, Germany). 
NADPH was obtained from Boehringer Mannheim (Mannheim, Germany), bovine-
serum-albumin (BSA) was from Sigma Chemical Company (St. Louis, MO, USA). Resorufin 
was obtained from Janssen Chimica (Geel, Belgium) and ethoxyresorufin was synthesised 
according to Mayer et al. (1977). A Bradford Protein Assay kit was obtained from Bio-rad 
(Hercules, California, USA). 
Mixtures 
The mixture containing solely the dioxin-like PHAHs is referred to as PHAH-. This 
PHAH- mixture was composed of 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 2,3,4,7,8- PeCDF, PCB 
126, PCB 118 and PCB 156 in a relative ratio based on Swedish herring (Table 3.1). PCB 153 
was added to an aliquot of the PHAH- mixture which is referred to as the PHAH+ mixture 
(Table 3.1). Both mixtures covered more than 90% of the TEQ in Swedish herring. The 
concentrations of the individual congeners in the mixture were confirmed by gas 
chromatography/mass spectrometry (GC-MS) by the State Institute for Quality Control of 
Agricultural Products (RIKILT-DLO) Wageningen, the Netherlands. 
Animal experiment 
The treatment protocol used in this study was based on the altered hepatic foci (AHF) 
tumour promotion protocol introduced by Pitot et al. (1978). Young female Sprague Dawley 
rats (Mollegaard Breeding Centre Ltd., Denmark), about three weeks old at the day of arrival, 
were kept in wire bottom, stainless steel cages in groups of four animals under standard 
conditions (12 hr light/dark cycle, temperature 22 °C, humidity 55%) and fed ad libitum. After 
three weeks of acclimatisation the tumour initiation treatment was started by removing 2/3 of 
the liver (partial hepatectomy; PH) under ether anaesthesia followed by an i.p. injection with 
NDEA (30 mg/kg) 24 hours after PH. 
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Table 3.1 Composition of the PHAH mixtures 
Congener 
2,3,7,8-TCDD 
1,2,3,7,8-PeCDD 
2,3,4,7,8-PeCDF 
PCB 126 
PCB 118 
PCB 156 
PCB 153 
Relative level (weight base); 
PHAH- mixture 
PCB 153 
1 
3.3 
17 
61 
12800 
1888 
-
PHAH+ mixture 
+ PCB 153 
1 
3.3 
17 
61 
12800 
1888 
20000 
TEFa 
1 
1 
0.1 
0.1 
0.0001 
0.0005 
0.00005 
The composition of the mixtures is based on Swedish herring oil and covers more than 90% of the 
TEQs in Swedish herring. ° TEF values for 1,2,3,7,8-PeCD, 2,3,4,7,8-PeCDD, PCB 126 and PCB 153 
were based on tumour promotion data (Waern et al., 1991; Hemming et al., 1993, 1995 ). TEF values 
for PCB 118 and PCB 156 were based on a report of a WHO meeting in 1993 (Ahlborg et al., 1994). 
The tumour promotion treatment was started six weeks after the initiation treatment and 
consisted of a weekly subcutaneous (s.c.) injection with the test compounds during twenty 
weeks. One group (n=18) was dosed with corn oil as a vehicle control (1 ml/kg bw/week) and 
one group (n=12) with 2,3,7,8-TCDD (1 ug TEQ/kg bw/week) as a positive control. The 
experimental groups (n=10) were given the PHAH+ mixture at a dose level of 2, 1 or 0.5 fig 
TEQ/kg bw/week, or the PHAH- mixture at a dosage level of 0.93 ug TEQ/kg bw/week. The 
first dose was a loading dose which was five times higher than the maintaining dose as 
indicated before. Bodyweight, food and water consumption were recorded weekly. 
One week after the last injection the animals were sacrificed under ether anaesthesia by 
using orbital punction for blood collection, followed by decapitation. The liver was collected, 
part of the liver was stored at -80 °C for gas chromatography and mass spectrometry (GC-MS) 
analysis, whereas the rest of the liver was stored at -80 °C for biochemical analysis or fixed 
for immunohistochemistry. The thymus, spleen, kidneys, heart, lungs and the brains were 
collected and stored at -80 °C until further analysis. 
Extraction and Clean up procedure 
Liver tissue (1 to 2 grams) was freeze dried for 24 hours and Soxhlet extracted for 20 
hours. After Soxhlet extraction 3 or 30 ng 13C 2,3,7,8-TCDD, 120 ng 1,2,3,7,8-PeCDF, 300 
ng l3C PCB 126, 1500 ng PCB 167 and 2000 ng PCB 112 were added as internal standards. 
Lipid content was determined by drying the Soxhlet residue at 100 °C for 30 minutes. This 
Soxhlet extract was dissolved in 5 ml hexane. 
The first clean up column (30 x 0.9 id.) consisted of 1 gram 33% NaOH and 3 gram 
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22% H2S04 on silica and 1 gram NajSO,,. The Soxhlet extract was added to the column and 
eluted with an additional 30 ml hexane. This hexane fraction was evaporated under a gently 
nitrogen flow and the residue was again dissolved in a small volume (< 0.5 ml) toluene. This 
extract was directly used for GC-MS analysis after adding 40 ng PCB 118 as an external 
standard. Some extracts were not sufficiently clean to directly for GC-MS analysis in which 
cases a second clean up column was used. This second column (30 x 0.9 id.) consisted of 5 
gram aluminum oxide and 1 gram Na2S04. The aluminum oxide was activated by heating at 
180 °C during 16 hours. The earlier obtained extract from column 1 was dissolved in 5 ml 
hexane and added to the column. Subsequently, the PCB fraction was eluted from the column 
with 20 ml hexane/dichloromethane (95:5 v/v) and the dioxin/dibenzofuran fraction with 50 
ml hexane/dichloromethane (60:40 v/v). After adding a few drops of nonane both fractions 
were allowed to evaporate, 1.9 ml toluene was added to the PCB fraction with PCB 169 (10 
ng/ul) used as an external standard. The dioxin and dibenzofuran fraction was dissolved in 50 
ul toluene with PCB 154 (10 ng/u.1) added as an external standard. Different PCB standards 
had to be used because of differences in retention time and the time windows selected during 
GC-MS analysis. 
GC-MS analysis. 
All compounds were analysed on a Carlo Erba QMD 1000 high resolution 
gaschromatograph/low resolution quadruple mass spectrometer operating in the electron 
impact mode (70 eV, dwell time 0.1-0.05 s, span 0.5 amu). Source temperature 225 °C. For 
each congener the M+, M+2 and M+4 were scanned on the selective ion mode. A J&W fused 
silica capillary column was used with stationary phase DB 5.625 (30 m, 0.32 mm id., film 
thickness 0.35 microns). The following temperature program was used: T, 120 °C for 1 
minute, rate 20 °C/min, T2 280 °C for 4 minutes. Helium was used as a carrier gas at 50 Kpa. 
Preparation of liver microsomes, protein measurements andEROD activity 
Livers were homogenised on ice in a Potter tube (±10 strokes) with 0.01 M Tris-HCl 
buffer, pH 7.4. Microsomes were prepared by differential centrifugation of liver homogenates 
at 9,000 g for 30 minutes, the resulting supernatant was centrifuged at 105,000 g for 90 
minutes, and the pellet was resuspended in a 0.01 M Tris-HCl buffer, pH 7.4. Microsomes 
were stored at -80 °C until further analysis. 
Protein concentrations in the microsomes were determined according to the method of 
Bradford (1976), adapted for 96-well plates. A BSA standard curve was made with protein 
concentrations ranging from 5 to 40 ug/ml. Hundred sixty microliters of standard solution 
(blank) or microsomes and 80 ul of a diluted Bradford Protein Assay reagens were pipetted in 
each well and after 10 minutes the absorbance was read at 595 nm in a Molecular Devices 
Micro plate Reader. 
Ethoxyresorufin-O-deethylase (EROD) activity was measured in liver microsomes 
according to Burke et al. (1977), adapted for use with 96-well plates and a fluoro 
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spectrophotometric plate reader (Cyto Fluor 2350, Millipore) as described by Morse et al. 
(1996b). 
Statistical analysis 
Data were analysed by one-way ANOVA and the Student-Newman-Keulman test 
(SNK) to determine the statistical significance of differences among individual group means, 
with the statistical package SPSS/PC+. 
In order to study possible interactive effects of the congeners administered in the 
mixtures, Partial Least Squares (PLS) Analysis was performed using the Software for 
Chemometric Analysis (version 1.1, Minitab, State College, PA, USA). Hepatic 
concentrations of all individual congeners as well as liver fat content and administered dose 
were used as descriptors. Hepatic retention, expressed as compound in liver as fraction of the 
dose, was chosen as the dependent variable. 
Results 
Liver weights and fat content 
One animal of the mixture group with PCB 153 (PHAH+) dosed at 2 ug TEQ/kg 
bw/week, died during the treatment period but this did not seem to be related with the 
treatment. A significant treatment related effect was observed on body weight gain (26% 
reduction) for the highest dosed PHAH+ group compared to the corn oil group (data not 
shown). No other obvious signs of toxicity were observed. The liver weights of all treatment 
groups were significant increased compared to the corn oil group (Table 3.2) and a dose 
dependent increase of the liver weight was found in the groups treated with increasing doses 
of the PHAH+ mixture. The liver fat content in the PHAH treated groups was found to be 
significantly increased, 1.5-2 times, as compared to corn oil controls. The highest fat 
concentrations of 76 and 72 mg/g liver were observed in the PHAH+ groups dosed at 1 and 2 
ug TEQ/kg bw/week, respectively. 
Liver retention of the PHAH congeners 
Remarkable differences were observed among the PHAH congeners in liver deposition 
presented as percentage of the given dose (Table 3.3). The hepatic retention was lowest for the 
mono- and di-ortho substituted PCBs, 0.2-0.4% for PCB 118, 0.5-0.8% for PCB 153 and 1-
1.7% for PCB 156. The planar PCB 126 showed a much higher hepatic retention (12.8-
17.6%) as compared to the other PCB congeners and was even higher than the deposition of 
TCDD (3.2-4.5%) and PeCDD (6.9-10.8%). The highest hepatic retention was observed for 
the PeCDF congener, 30.5-43.1%. 
The PHAH+ mixture was tested in three different doses, 0.5, 1, and 2 ug TEQ/kg 
bw/week. An increase of the total amount of PHAH congeners in the liver was observed with 
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increasing doses of PHAH+ mix (Table 3.2). However, a decrease of the hepatic retention as 
percentage of the given dose was observed for 2,3,7,8-TCDD, 1,2,3,7,8- PeCDD and 
2,3,4,7,8-PeCDF with increasing doses of PHAH+ mix (Table 3.3). 
A comparison between the equivalent dosed PHAH+ and the PHAH- group (~1 ug 
TEQ/kg bw/week), showed a 1.2-3 times higher amount of all congeners in the liver in the 
PHAH+ group compared to the PHAH- group (Table 3.2). The hepatic retention as precentage 
of the given dose of all PHAH congeners, except for 2,3,7,8-TCDD, was increased significant 
1.3-2 times in the group given the PHAH+ mixture compared to the PHAH- group (Table 
3.3). 
Partial Least Square (PLS) analysis of the data from the individual animals exposed to 
the PHAH+ mixture confirms the decrease of hepatic retention as % of the given dose of all 
congeners with increasing doses of 0.5, 1 or 2 ug TEQ/kg/week (Table 3.4). The 
concentration of PCB 153 in the liver is positively correlated with the hepatic retention of all 
compounds except PCB 156, on which its effect seems not substantial. PeCDF and PCB 126 
concentrations generally show a positive correlation with hepatic retention of all congeners. 
The correlation of PCB 118 concentrations with hepatic retention of other congeners is also 
positive but much smaller than observed for PeCDF and PCB 126. In contrast, hepatic 
concentrations of TCDD and PCB 156 are negatively correlated with hepatic retention of all 
other congeners. The correlation of PeCDD with hepatic retention varies for each congener in 
direction as well as strength. 
Lipid content of the liver is positively correlated with the hepatic retention for PCBs 
118, 126 and 156, but not for TCDD, PeCDF and PeCDD. 
EROD activity 
EROD activity was increased in all PHAH treated groups as compared to the corn oil 
control group (Figure 3.1). A 90-fold induction was found for both the PHAH+ and PHAH-
treated animals dosed at 1 ug TEQ/kg bw/week. The EROD inducing potency of the PHAH 
mixtures did not differ significantly from the equipotently dosed 2,3,7,8-TCDD group. The 
EROD activity in the highest dose PHAH+ group (2 ug TEQ/kg bw/week) was significantly 
increased compared to the other groups. 
In order to evaluate a correlation between the internal TEQ dose in the liver and the 
EROD activity on an individual animal base, relative potencies for all congeners were 
calculated based on internal congener liver concentrations and liver microsome EROD 
activity as reported by Waern et al. (1991), Hemming et al. (1993) and Haag-Gronlund et al. 
(1997a,b). There was however only a very weak correlation, R=0.2, between the internal TEQ 
dose in the liver and the EROD activity of the individual PHAH+ exposed animals (results not 
shown). 
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Figure 3.1 Liver microsomal EROD activity in female Sprague Dawley rats after different PHAH 
treatments; Corn oil (control), TCDD, PHAH+ mixture with PCB 153, PHAH- mixture without PCB 
153. Statistical differences were tested with the Student-Newman-Keulman-test. * Significant 
different from the corn oil control group (p<0.05). $ Significant different from the PHAH+ group 
dosed at 2 ug TEQ/kg bw/week (p<0.05). 
Discussion 
This study was focussed on possible interactions between dioxin-like PHAHs and the 
non-dioxin-like PHAH 2,2',4,4',5,5-HxCB (PCB 153). In addition it was investigated whether 
the total toxic potency of a mixture of dioxin-like PHAHs would match the effect of an 
equipotent dose of 2,3,7,8-TCDD as a single congener. We observed remarkable differences 
in hepatic retention as percentage of the given dose, among the PHAH congeners of the 
PHAH mixture groups, with highest retention for 2,3,4,7,8-PeCDF (30.5-43.1%) and lowest 
for PCB 118 (0.5-0.8%). A decrease was observed in the hepatic retention (% of the given 
dose) of some of the PHAH congeners with increasing exposure doses of the PHAH+ mixture 
(with PCB 153). A comparison between the equipotently dosed PHAH+ and PHAH- groups 
showed an increase of the hepatic deposition of all PHAH congeners after co-exposure with 
PCB 153. The EROD activity was significantly enhanced in all groups treated with PHAHs 
and no differences were observed between the equipotent dosed PHAH+, PHAH- and 2,3,7,8-
TCDD group. 
Differences between single congeners in the hepatic deposition as percentage of the 
given dose were reported by other authors as well (Wsern et al, 1991; Hemming et al, 1993; 
Haag-Gronlund et al, 1997b). This phenomenon can probably be explained by differences in 
affinity between the congeners for hepatic binding sites, e.g. CYP1A2, rather than by liver fat 
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concentrations (Van den Berg et al, 1994; De Jongh et al, 1995). 
In the experimental groups receiving the mixture with PCB 153 (PHAH+) the liver 
retention, expressed as percentage of the given dose, decreased significantly at increasing 
exposure levels for TCDD, PeCDD and PeCDF whereas for the PCBs no clear tendency was 
observed. Analysis of the data with the Partial Least Square (PLS) method confirmed the 
negative correlation between the given TEQ dose and the hepatic retention of all congeners. In 
similar exposure studies with individual congeners a slight decrease as percentage of the given 
dose was observed for 2,3,7,8-TCDD and 2,3,4,7,8-PeCDF whereas an increase was found for 
1,2,3,7,8-PeCDD (Waern et al, 1991), PCB 126 and 2,3,7,8-TCDD (Hemming et al, 1995). 
A dose dependent increase of TCDD in the liver as percentage of the given dose has been 
reported by some other authors as well, both after a single injection (Abraham et al, 1989; 
Kedderis et al, 1993) and sub-chronic exposure (Van der Kolk et al, 1992). 
Andersen et al (1993) described a receptor-mediated physiologically based 
pharmacokinetic (PB-PK) model for the tissue distribution of TCDD, based on data of 
Abraham et al (1988), and calculated a bell shape curve for the retention of TCDD as 
percentage of the dose in the liver. This model suggests a slow saturation of the liver with 
increasing doses of TCDD and consequently a decrease of the percentage of the dose 
deposited in the liver after a certain maximum. A similar model would fit for other congeners 
with saturation maxima at different congener concentrations (Andersen et al, 1993). 
Deposition of PHAHs in the liver depends on the solubility of the congeners in liver fat and 
the induction of and/or binding to hepatic binding proteins (Leung et al, 1988), of which 
CYP1A2 is assumed to be an important inducible binding site for PHAHs in the liver 
(Andersen et al, 1993; Kedderis et al, 1993). Since the animals in our experiment were 
exposed to relative high amounts of PHAH congeners, the observed decrease of hepatic 
retention of the congeners in our experiment might probably be explained by saturation of the 
hepatic binding proteins rather than saturation of the liver fat. However, since CYP1A2 levels 
were not determined here, a discussion of the presently observed phenomenon must remain 
speculative and a possible explanation can only be given in the light of previous results on 
interactive effects on hepatic retention between PCDD/Fs and PCBs in rats and mice (De 
Jongh etal, 1993a,b, 1995). 
A comparison between the mixture group with PCB 153 (PHAH+) and the mixture 
group without PCB 153 (PHAH-) both dosed at ~1 ug TEQ/kg bw/week, resulted in a 
significantly higher retention of all PHAH congeners in the PHAH+ group except for 2,3,7,8-
TCDD. Interactive effects of PCB 153 on the liver retention of other PHAH congeners have 
been observed by other authors as well. De Jongh et al (1993b) found an increase of about 
8% of the liver retention after a single exposure of 1,2,3,7,8- PeCDD co-administered with 
PCB 153 in C57BL/6J mice. A combination of PeCDD, 1,2,3,6,7,8-HxCDD, 2,3,4,7,8-
PeCDF and PCB 153 resulted even in a stronger increase on deposition of PeCDD in the liver. 
In a similar experiment the retention of PCB 156 co-administered with PCB 153 was twice 
the retention of PCB 156 single dosed (De Jongh et al, 1993a). PCB 153 was found to be 
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capable of inducing both CYP1A2 activity and protein levels in C57BL/6J mice (De Jongh et 
al, 1995). Although all congeners in this study are CYP1A2 inducers, PCB 153 is the only 
one which induces this protein without binding to it and this may readily explain its effect on 
hepatic retention of the other compounds. All other congeners competitively bind to CYP1A2 
and complex interactive effects in binary, ternary and quaternary mixtures of PCB 153, 
TCDD, PeCDF, PeCDD or PCB 156 have been reported (De Jongh et al, 1993a,b, 1995). 
The EROD activity in the liver was enhanced in all PHAH treated groups. No 
differences were observed between the equipotent dosed PHAH+, PHAH- and 2,3,7,8-TCDD 
groups. The EROD activity in the highest dose PHAH+ group (2 u.g TEQ/kg bw/week) was 
significantly increased compared to the other groups. Since it was observed that the 
proportion (% of the given dose) of the indvidual PHAH congeners in the liver differed 
considerably, TEFs based on liver tissue concentrations were used to calculate internal TEQ 
values. However, there was only a very weak correlation (R=0.2) between the internal TEQ 
dose in the liver and the EROD activity of the individual PHAH+ exposed animals, probably 
due to a maximum induction of CYP1A1 in the PHAH treated groups. In addition, no 
correlation was found between the volume fraction of the liver occupied by altered hepatic 
foci and the EROD activity, while there was a weak correlation (R=0.38) between the volume 
fraction and the internal TEQ dose in the liver (Van der Plas et al, 1999 Chapter 4). 
In summary, we observed a decrease of the liver retention of TCDD, PeCDD and PeCDF at 
increasing dose of the PHAH+ mixture. In addition, the results of the PLS analysis suggest 
that hepatic lipids are more important for hepatic retention of PCBs than for hepatic retention 
of either TCDD, PeCDF or PeCDD. Thus, a possible explanation for the observed decrease of 
the hepatic retention of TCDD, PeCDF and PeCDD might be a saturation of hepatic binding 
proteins, of which CYP1A2 seems to be an important representative. PCB 153 was found to 
increase the liver retention for all PHAH congeners in the PHAH+ mix group compared to the 
TEQ equivalent dosed PHAH- group. However, this was not reflected in the EROD activity in 
the liver microsomes, probably because a maximum EROD effect was already achieved. 
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Induction of altered hepatic foci by a mixture of dioxin-like 
compounds with and without 2,2',4,4',5,5'-hexachlorobiphenyl in 
female Sprague-Dawley rats 
Abstract 
The hepatic tumour promoting activity of a mixture of polyhalogenated aromatic 
hydrocarbons (PHAHs) was studied in a medium term two-stage initiation/promotion 
bioassay in female Sprague-Dawley rats. The PHAH mixture contained 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD), 
2,3,4,7,8-pentachlorodibenzofuran (PeCDF), 3,3',4,4',5-pentachlorobiphenyl (PCB 126), 
2,3',4,4',5-pentachlorobiphenyl (PCB 118), 2,3,3',4,4',5-hexachlorobiphenyl (PCB 156), 
2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) and covered > 90% of the total toxic equivalents 
(TEQ) present in Baltic herring. To determine possible interactive effects of di-ortho 
substituted PCBs, the PHAH mixture was tested with (PHAH+) and without (PHAH-) PCB 
153. Rats were initiated by a diethylnitrosamin injection (i.p. 30 mg/kg body weight) 24 hours 
after a partial % hepatectomy. Six weeks after initiation the PHAH mixtures were 
administered once a week by subcutaneous injections for 20 weeks. Treatment with the 
PHAH mixtures caused liver enlargement and an increased activity of the hepatic cytochrome 
P4501A1/2 and P4502B1/2. All PHAH exposure groups exhibited an increased occurrence of 
hepatic foci positive for the placental form of glutathione-S-transferase. In the PHAH- group 
dosed 1 u.g TEQ/kg body weight/week, the volume fraction of the liver occupied by foci was 
significantly lower compared to the TEQ equivalent dosed TCDD group (3.8% v.s. 8.7%). 
The volume fraction was significantly increased in the groups treated with 0.5, 1 or 2 ug 
TEQ/kg body weight/week of the PHAH+ mixture (4.5%, 5.2% and 6.6% respectively) 
compared to the corn oil group (2.0%), but to a lower extent than expected on basis of the 
TEQ doses. Overall, the TEQ-based administered dose overestimated the observed tumour 
promoting effects of this PHAH mixture. The applicability of the TEF concept, the role of 
differences in toxicokinetic properties and interactive effects of PCB 153 on hepatic 
deposition of the dioxin-like congeners are discussed. 
Based on: Van der Plas, S.A., Haag-Gronlund, M., Scheu, G., Warngard, L, Van den Berg, M., 
Wester, P., Koeman, J.H., and Brouwer, A. (1999). Induction of altered hepatic foci by a mixture of 
dioxin-like compounds with and without 2,2',4,4',5,5'-hexachlorobiphenyl in female Sprague Dawley 
rats. Toxicology and Applied Pharmacology\56, 30-39. 
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Introduction 
Polychlorinated biphenyls (PCBs), polychlorodibenzo-/?-dioxins (PCDDs), 
polychlorinated dibenzofiirans (PCDFs) and other polyhalogenated aromatic hydrocarbons 
(PHAHs) are ubiquitously present in the environment. Residues have been detected in fish, 
wildlife species and human adipose tissue, milk and serum (Safe, 1990). The most toxic 
PHAH compounds exhibit a planar molecular conformation and most of their toxic responses 
are believed to be mediated by the aryl hydrocarbon (Ah) receptor (Safe, 1994). PCBs, 
PCDDs and other PHAHs elicit a broad spectrum of toxic effects and biochemical changes, 
e.g. body weight loss, thymic atrophy, impairment of immune responses, hepatotoxicity, 
teratogenicity, carcinogenicity and induction of hepatic cytochrome P450 isoenzymes (Safe, 
1990, 1994). 
In environmental matrices and biota PCBs, PCDDs and PCDFs are always present as 
complex mixtures. The toxic equivalency factor (TEF) concept has been developed to aid the 
risk assessment of complex mixtures of PHAHs and enable the calculation of total toxic 
potencies, expressed as the toxic equivalent (TEQ), of the mixtures. The TEF approach is 
based on the assumptions that PHAH congeners act through the same dioxin-like Ah receptor-
based mechanism of action and that the effects of the individual compounds are additive 
(Safe, 1994; Ahlborg etal, 1994). 
Carcinogenicity is one of the main toxic endpoints in risk assessment of PCBs, PCDDs 
and PCDFs (WHO, 1992). A no observed adverse effect level (NOAEL) of 1 ng 2,3,7,8-
TCDD has been established after re-evaluation of the 2 year carcinogenicity study as reported 
by Kociba et al. (1978). In a recent WHO/ICPS-expert meeting (summarised by Van Leeuwen 
and Younes, 1998) it was concluded that the use of TCDD alone as a measure of exposure to 
PCDDs, PCDFs and PCBs would severely underestimate the risk from exposure to these 
compounds. Therefore it was proposed to express the daily intake (TDI) of PCDDs, PCDFs, 
non-ortho and mono-ortho PCBs in TEQs, i.e. allowing the TEF-concept as a method to 
predict the total carcinogenic potency of PHAHs. However, there is current debate on the role 
of the Ah receptor and thus the relevance of the TEF concept for risk assessment of 
carcinogenicity caused by PHAH mixtures. Both in vitro and in vivo data suggest a tumour 
promotion activity of several di-ortho substituted PCBs, although they possess no or a 
negligible Ah receptor mediated activity i.e. a TEF value close to zero. Both 2,2',3,3',4,4'-
hexachlorobiphenyl (PCB 128) and 2,2',5,5'-tetrachlorobiphenyl (PCB 52) (De Haan et al, 
1996) as well as 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (Bager et al, 1997) were shown 
to be potent inhibitors of the gapjunctional intercellular communication in vitro, an indicator 
of tumour promotion capacity. In vivo, 2,2',5,5'-tetrachlorobiphenyl (PCB 52) and 2,2',4,4'-
tetrachlorobiphenyl (PCB 47) were shown to be tumour promoters in female Sprague-Dawley 
rats (Preston et al, 1985) as was 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (Hemming et 
al, 1993), one of the major PHAH congeners in the human diet. In addition there are some 
data suggesting both synergistic and antagonistic interactions between dioxin-like Ah receptor 
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agonists and some non-planar PCB congeners on several toxicity parameters, e.g. 
immunotoxicity (Biegel et al, 1989), teratogenicity (Zhao et al, 1994, 1997), and 
hepatotoxicity (Yao and Safe, 1989; Van Birgelen et al, 1996a) as well as tumour promotion 
(Sargent et al, 1991; Bager et al, 1995, Haag-Gronlund et al, 1998). Also antagonistic 
effects of several complex PCB mixtures on immunotoxicity (Bannister et al, 1987a; Davis 
and Safe, 1989) and teratogenicity have been observed (Haake et al, 1987). 
However, most toxicity studies have been performed with individual PHAH congeners 
or with combinations of two compounds, whereas humans are exposed to complex mixtures 
of PHAHs in the diet. Therefore, we performed a study on the tumour promotion capacity of a 
complex mixture of PHAHs resembling the composition of the PHAH mixture present in fish, 
which is one of the main contributors of PHAHs to the human diet (WHO, 1992). The 
mixture contained 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-
pentachlorodibenzo-p-dioxin (PeCDD), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), 
3,3',4,4',5-pentachlorobiphenyl (PCB 126), 2,3',4,4',5-pentachlorobiphenyl (PCB 118) and 
2,3,3',4,4',5-hexachlorobiphenyl(PCB 156) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) 
in relative concentrations as found in fish (Table 4.1) covering >90% of the total TEQs 
present in Baltic herring (personal communication, Cynthia De Wit, Institute of Applied 
Environmental Research, Stockholm University, Sweden). To determine the interactive effect 
of the non-planar, di-ortho substituted PCB 153, the PHAH mixture was also tested without 
this congener. A medium-term two-stage initiation/promotion protocol (Pitot et al, 1978) was 
used to study the tumour promotion potential of these PHAH mixtures, measuring the 
development of glutathione S-transferase-p (GST-p) positive altered hepatic foci (AHF) as 
being one of the most efficient markers of AHF (Maronpot et al, 1989). The tumour 
promotion potential as well as the predictability by the TEF concept of the total tumour 
promotion potential of these PHAH mixtures is discussed. 
Materials and methods 
Chemicals 
N-nitrosodiethylamin (NDEA) was obtained from Fluka (Fluka Chemie, Buchs, 
Switzerland). 3,3',4,4',5-Pentachlorobiphenyl (PCB 126), 2,3',4,4',5-pentachlorobiphenyl 
(PCB 118), 2,3,3',4,4',5-hexachlorobiphenyl (PCB 156) and 2,2',4,4',5,5'-hexachlorobiphenyl 
(PCB 153) were kindly provided by Prof. Bergman (Department of Environmental Chemistry, 
Stockholm University, Sweden). 1,2,3,7,8-Pentachlorodibenzo-p-dioxin (PeCDD) was 
obtained from Wellington Laboratories (Canada), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) 
was a gift from Prof. S.H. Safe (College of Veterinary Physiology and Pharmacology, Texas, 
A&M University, USA) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased 
from RADIAN CIL, inc.(U.S.A.). All compounds had a purity > 99%. 
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The primary antibody for glutathione-S-transferase-p (GST-p) staining was a GST Yp 
rabbit anti-rat serum, purchased from Biotrin International (Dublin, Ireland). The second 
antibody was a peroxidase conjugated swine anti-rabbit immunoglobulin (P217) from Dako 
(Glostrup Denmark). Bovine serum albumin (BSA) was obtained from Sigma Chemical 
Company (St. Louis, MO, USA), diaminobenzidin tetrahydrochloride (DAB) from Sigma (St. 
Louis, U.S.A.) and NADPH was from Boehringer Mannheim (Mannheim, Germany). 
Phosphate buffered saline (Dulbecco's 'A', pH 7.3; PBS) was bought from Oxoid (London, 
U.K.), NaCl and Tris were from Merck (Darmstadt, Germany). 
Resorufin was obtained from Janssen Chimica (Geel, Belgium) and ethoxyresorufin and 
penthoxyresorufin were synthesised according to Mayer et al (1977). A Bradford Protein 
Assay kit was obtained from Bio-rad (Hercules, California, USA). A commercial ELISA kit 
for analysis of cytochrome P450 2B1/2 was from Amersham (Buckinghamshire, England). A 
commercial kit from Roche diagnostic Ltd. (Basel, Switzerland) was used for analysis of 
alanine aminotransferase (Unimate 5 ALT) and aspartate aminotransferase (Unimate 5 AST). 
2,3,7,8-[13C]-TCDD and [13C]-PCB 126 were commercially obtained from Cambridge 
Isotope Laboratories (Woburn, MS, USA) and 1,2,3,7,8-PeCDF, 2,3',4,4',5,5'-
hexachlorobiphenyl (PCB 167) and 2,3,3',5,6-pentachlorobiphenyl (PCB 112) from 
Ehrenstorfer (Augsburg, Germany). Hexane, toluene, dichloromethane and nonane, used for 
the extraction and clean-up procedure of the GC-MS analysis were of nanograde quality and 
obtained from J.T. Baker (Deventer, The Netherlands). Silica gel 60 extra pure 70-230 mesh 
ASTM, NaOH and NajSC^ were obtained from E. Merck (Darmstadt, Germany). Aluminum 
B super I was bought from ICN Biomedicals (Eschwege, Germany). 
Animal mixtures 
Two PHAH mixtures, a PHAH- mixture without the di-ortho PCB 153 and a PHAH+ 
mixture with PCB 153 were composed, containing 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 
2,3,4,7,8-PeCDF, PCB 126, PCB 118 and PCB 156 in relative concentration levels as shown 
in table 4.1. For calculations of the relative concentration levels of the congeners in the PHAH 
mixtures, concentration data in six-year-old Baltic herring caught close to the town of 
Karlskrona in southern Sweden were used. The congeners in the PHAH mixtures covered > 
90% of the TEQ in Baltic Herring. For the TEQ calculation of the PHAH mixtures, TEF 
values based on tumour promotion data were used if available. Because these are not officially 
published WHO-ECEH TEF values, the term 'relative potency' (REP) will be used instead. 
The reason for this is that a WHO consultation (Bilthoven, 9-10 August, 1996) recommended 
not to use the term TEF for estimations based on a single study, but only for consensus value 
based on all available literature. Exposure levels were chosen on the basis of earlier performed 
tumour promotion experiments (Waern et al., 1991; Hemming et al., 1993, 1995) such, that 
no severe liver toxicity was expected at the highest concentrations tested and the expected 
effects on tumour promotion of the lower test concentrations were increased compared to the 
control. 
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Table 4.1 Composition of the PHAH mixtures based on the relative levels in Baltic herring 
Congener (CI substitution) 
Relative level (weight base) 
PHAH- mixture PHAH+ mixture Potency factor 
TCDD (2,3,7,8) 
PeCDD (1,2,3,7,8) 
PeCDF (2,3,4,7,8) 
PCB 126 (3,3',4,4',5) 
PCB118 (2,3',4,4',5) 
PCB 156 (2,3,3',4,4',5) 
PCB 153 (2,2',4,4',5,5') 
1 
3.3 
17 
61 
12800 
1888 
_ 
1 
3.3 
17 
61 
12800 
1888 
20000 
1 
\" 
0.1" 
0.1' 
o.ooo r 
0.0005c 
0.00005'' 
° REP value based on a tumour promotion study performed by Waern et al. (1991) 
' REP value based on a tumour promotion study performed by Hemming et al. (1995) 
c
 TEF value as proposed by the World Health Organization (Ahlborg et al. 1994) 
d
 REP value based on a tumour promotion study performed by Hemming et al. (1993) 
The concentrations of the compounds in the mixture were reconfirmed by gas 
chromatography/mass spectrometry (GC-MS) by RIKILT-DLO (Wageningen, the 
Netherlands). 
For animal exposure the mixtures were dissolved in food-grade corn oil. 
Animal experiment 
Young female Sprague-Dawley rats (Nfollegaard Breeding Centre Ltd., Denmark), about 
three weeks old at the day of arrival, were kept in wire bottom, stainless steel cages in groups 
of three or four animals under standard conditions (12 hr light/dark cycle, temperature 22 °C, 
humidity 55%). They were fed ad libitum with standard semi-synthetic rodent chow (RMH-B, 
Hope Farms Woerden, The Netherlands) and had free access to tap water. After three weeks 
of acclimatisation the initiation treatment was started by removing two thirds of the liver 
(partial hepatectomy; PH) under ether anaesthesia followed by an i.p. injection with NDEA 
(30 mg/kg) 24 hours after PH. About five weeks after PH the animals were divided in 
treatment groups; a negative control group (n=18), a positive control group (n=12) and four 
experimental groups (n=10). The promotion treatment was started six weeks after the 
initiation procedure and consisted of a weekly s.c. injection with the test compounds during 
twenty weeks. The vehicle control group was dosed with corn oil (1 ml/kg bw/week), the 
positive control group with 2,3,7,8-TCDD (1 u.g/kg bw/week) and the experimental groups 
with the PHAH+ mixture at a dose level of 0.5 (j.g TEQ/kg bw/week, 1 (xg TEQ/kg bw/week 
or 2 ng TEQ/kg bw/week or the PHAH- mixture at a dosage level of 1 ng TEQ/kg bw/week 
(composition shown in Table 4.1). The first dose was a loading dose which was five times 
higher than the maintenance dose (Flodstrom and Ahlborg, 1989; Krowke et al., 1989) as 
indicated before. Body weight, food and water consumption were recorded weekly. 
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One week after the last exposure the animals were euthanised under ether anaesthesia by 
orbita puncture for blood collection (heparinised), followed by decapitation. The liver was 
taken out and a part of the lateral and caudal liver lobe were fixed in ice-cold acetone (4 °C), 
and imbedded in paraffin 24 hours after fixation. A part of the lateral liver lobe was stored at -
80 °C for gas chromatography and mass spectrometry (GC-MS) analyses, whereas the rest of 
the liver was homogenised on ice in a Potter tube with 0.01 M Tris-HCl-buffer and 0.25 M 
sucrose (pH 7.4). The homogenate was stored at -80 °C until preparation of microsomes. 
Thymus, spleen, lungs, heart, brain, kidneys and some adipose tissue were collected and 
stored at -80 °C until further analysis. 
Staining and analyses of altered hepatic foci 
Sections (4 um) of acetone fixed tissue were stained for gluthatione-S-transferase-p 
(GST-p) positive foci as described by Haag-Gronlund et a/.(1997a). Slices were 
deparaffinised in xylene and air dried. The endogenous peroxidase activity was blocked with a 
fresh solution of 0.5% H202 in methanol (10 min). Unspecific binding sites were then blocked 
with a 2.5% BSA solution in PBS (30 min). Slices were incubated overnight at room 
temperature with the GST-p primary antibody (dilution 1:2000) followed by incubation with 
peroxidase conjugated secondary antibody (dilution 1:100) for 2/4 hours. GST-p positive cells 
were stained for 5 minutes with DAB. Foci were analysed in the right lateral lobe of the liver 
using a Leica Aristoplan microscope connected to a Quantimet 570 Image Processing and 
Analysis system (Leica Cambridge Ltd. England). The methods used for stereological 
evaluation of altered hepatic foci have been reported previously (Flodstrom et al., 1988). A 
total sectional area of approximately 3 cm2 was analysed for each animal. The smallest group 
of GST-p positive cells scored as a focus had a radius of 35 urn (cut off limit). 
Preparation of microsomes 
Microsomes were prepared by differential centrifugation of liver homogenates at 9,000 g 
for 30 minutes, the resulting supernatant was centrifuged at 105,000 g for 90 minutes, and the 
pellet was resuspended in a 0.01 M Tris-HCl buffer, pH 7.4. Microsomes were stored at -80 
°C until further analysis. 
Protein and cytochrome P450 enzyme assays 
The protein concentration in the microsomes was measured using the commercial 
available Bradford Protein Assay reagens with crystalline BSA as a standard. 
The total cytochrome P450 content in liver microsomes was analysed according to the 
method of Omura and Sato (1964) with modifications of Rutten et al. (1987). The difference 
spectrum was measured of microsome samples (protein concentration ±1 mg/ml) saturated 
with CO (60 seconds) followed by dithionite reduction of P450. 
Activities of ethoxyresorufin-O-deethylase (EROD) and penthoxyresorufin-0-
depenthylase (PROD) were measured in liver microsomes according to Burke et al. (1977), 
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adapted for use with 96-well plates and a fluoro spectrophotometric plate reader (CytoFluor 
2530, Millipore) as described by Morse et al. (1996b). A preincubated mixture of microsomes 
(protein concentrations 100-400 ug/ml), BSA (4 mg/ml) and ethoxy- or penthoxyresorufin (8 
uM) was incubated for 5 minutes at 37 °C after adding of 0.4 mM NADPH. Resorufin 
concentrations were measured after the reaction was stopped with 1 M NaOH. 
Cytochrome P4502B protein was measured by an ELISA method using a commercially 
available kit. 
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured 
using Roche Cobas Mira as equipment and a commercial kit based on the measurement of the 
oxidation of NADH into NAD+. The oxidation can be followed by a spectrophotometer at 
340 nM. 
GC-MS analysis 
The individual PHAH congener concentrations in the liver were analysed by gas 
chromatography and mass spectrometry as described in more detail by Van der Plas et 
a/.(1998b Chapter 3). Freeze dried liver tissue was soxhlet extracted and dissolved in hexane 
after adding 2,3,7,8-[13C]-TCDD, 1,2,3,7,8-PeCDF, [13C]-PCB 126, PCB 167andPCB 112 as 
internal standards. A two step clean-up procedure was performed using a silica column and an 
aluminium oxide column. After evaporation the fractions were dissolved in toluene and 
analysed on a Carlo Erba QMD 1000 high resolution gaschromatograph/low resolution 
quadruple mass spectrometer. A J&W fused silica capillary column was used with a stationary 
phase DB 5.625 (30 m, 0.32 mm id., film thickness 0.35 microns) 
Statistical analysis 
Data were analysed with the statistical package SPSS-PC. Foci data were log 
transformed in order to obtain a normal distribution of the data and a homogeneous variance 
between the groups. A One-Way Anova and a Tukey's Honestly Significant Difference test 
was used to perform a multiple comparison on statistical differences between groups. One 
outlier was removed from the group treated with 1 |ig TEQ/kg bw/week of the PHAH+ 
mixture, because it exceeded abundantly the mean volume fraction plus two times the 
standard deviation. Differences between congener concentrations in the liver of the PHAH+ (1 
ug TEQ/kg bw/week) and the PHAH- group were analysed with an independent t-test. 
Results 
Clinical observations 
No obvious PHAH related clinical signs of toxicity were observed throughout the study. 
One animal died during the treatment period in the group that received the highest dose, 2 ug 
TEQ/kg bw/week, of the PHAH mixture with PCB 153 (PHAH+) but this did not seem to be 
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Table 4.2 Body, liver and thymus weights of female Sprague-Dawley rats following sub-
chronic exposure to PHAH mixtures 
Groups 
dose/kg bw/wk 
Corn oil (n=18) 
1ml 
TCDD (n=12) 
lugTEQ 
PHAH- (n=10) 
lugTEQ 
PHAH+ (n=10) 
0.5ugTEQ 
PHAH+ (n=10) 
lugTEQ 
PHAH+ (n=9) 
2ugTEQ 
Body weight" 
g 
314.0(6.1) 
314.0(6.8) 
318.8(5.8) 
314.1 (5.6) 
306.8 (5.8) 
299.0 (4.5) 
Body weight gain 
g 
73.5 (4.0) 
65.5 (3.4) 
71.8(2.7) 
70.2(1.8) 
61.2(4.5) 
54.7(3.8)* 
Relative liver 
weight 
g/kgbw 
27.9 (0.6) 
34.9 (0.9)*c 
33.6 (1.0)*e 
33.5 (0.3)*c 
38.0 (1.2)* 
40.8 (1.4)* 
Relative thymus 
weight 
g/kgbw 
0.58 (0.04) 
0.35 (0.05) 
0.37 (0.05) 
0.40 (0.05) 
0.35 (0.04) 
0.34 (0.08) 
Data are given as arithmetic mean ± SE. Doses are given per kg body weight per week. PHAH+ is the 
mixture with PCB 153 given in three different dosages and PHAH- is the mixture without PCB 153 
(see Table 4.1 for the composition). " Body weight one week after the last exposure. * Statistically 
different from the com oil group (p<0.05).' Statistically different from the mixture group with PCB 
153, dosed with 2 ug TEQ/kg bw/week and 1 ug TEQ/bw/week (p<0.05). 
related to the treatment. 
Compared to the corn oil control group, a slight treatment and dose dependent decrease 
in body weight gain was observed in all treatment groups, which was only significantly 
different for the 2 ug TEQ/kg bw/week PHAH+ group (Table 4.2). No statistical differences 
in body weights were found at the end of the treatment period between the groups. All treated 
groups showed an increased relative liver weight, which was almost up to 150% of the control 
in the 2 ug TEQ/kg bw/week PHAH+ group. The relative thymus weights in the treated 
groups were reduced compared to the corn oil control levels. However, due to high 
interindividual variability the observed thymus weight reduction was not statistically different 
from the corn oil control group. No effects on organ weights were found on the other organs 
examined (data not shown). 
Liver toxicity parameters 
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were 
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measured in the plasma as indicators for liver toxicity. Compared to the corn oil control group 
a slight, but not significant, increase of the ALT activity was found in the group treated with 
TCDD and the highest dose of the PHAH+ mixture (Table 4.3). A dose dependent increase of 
the AST activity was measured in the PHAH+ mixture groups. The AST activity of the 
PHAH+ mixture group dosed at 2 ug TEQ/kg bw/week was significantly, 2-fold increased 
compared to the corn oil control group. 
A preliminary histopathological evaluation of the liver slides did reveal only small 
pathological changes in the PHAH exposed groups compared to the corn oil group. In 
addition, no obvious differences in morphology were observed between the different exposure 
groups. 
Liver cytochrome P450 enzyme induction 
The total cytochrome P450 concentration (Table 4.3) in liver microsomes of all PHAH 
treated groups showed a statistically significant at least two fold increase as compared to the 
corn oil treated controls. The increase in total cytochrome P450 was lowest in the TCDD 
treated group and was dose dependent in the groups treated with the PHAH+ mixture. The 
total cytochrome P450 concentration was also significantly increased in the PHAH+ group 
dosed with 2 ug TEQ/kg bw/week compared to the TCDD treated, positive control group. 
The EROD activity (Table 4.3) was highly increased, 75-112 fold, in all PHAH treated 
groups compared to the corn oil controls. The PHAH+ mixture groups showed a dose 
dependent increase with the highest activity, 112-fold induction, at 2 ug TEQ/kg bw/week. 
This was significantly different from the TCDD group and the group exposed to 0.5 ug 
TEQ/kg bw/week of the PHAH+ mix. 
PROD was used as an indicator of CYP2B activity. The PROD activities were 
significantly increased in all treated groups compared to the control. The increase was dose-
dependent in the PHAH+ mixture groups. An increased PROD activity of three times the 
control level was also measured for TCDD, which is normally not considered to induce 
CYP2B. To check if this increased PROD activity corresponded to an increased enzyme 
protein level, the P4502B1/2 protein concentration was measured. No induction of the protein 
was found in the group exposed to TCDD as compared to corn oil treated controls whereas an 
almost two-fold, significant, increase was found in the highest PHAH+ dose group (Table 
4.3). A slight, dose dependent increase of the P4502B1/2 protein was found in the lower 
PHAH dose groups, which however did not differ significantly from the corn oil group. 
Foci induction 
Altered hepatic foci (AHF) data are presented in figure 4.1A to 4.1C. All groups showed 
large numbers, 3500-5000/cm3, of GST-p positive foci in the liver with a slight, but not 
significant increase in the TCDD exposed group compared to the control (Figure 4.1 A). The 
mean foci volume (Figure 4. IB) as well as the volume fraction of the liver occupied by GST-p 
positive foci (Figure 4.1C) was significantly increased in all treated groups compared to the 
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Figure 4.1A-C Occurrence of GST-p positive foci in liver tissue of female Sprague Dawley rats after 
20 weeks of exposure to corn oil (negative control), 2,3,7,8-TCDD (positive control), the PHAH-
mixture (without PCB 153) or different doses of of the PHAH+ mixture (with PCB 153). A. Number 
of foci per cm3 liver. B. Mean foci volume (mm3x 103). C. Volume fraction of the liver occupied by 
foci (%). * Statistically different (Tukey, p<0.05) from the corn oil group (negative control). 
$ Statistically different (Tukey, p<0.05) from the TCDD exposed group. 
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corn oil control group. 2,3,7,8-TCDD caused a 3.7 fold and a 4.3 fold increase in the mean 
foci volume and the volume fraction respectively. The increase in mean foci volume and the 
volume fraction for the PHAH- was significantly smaller than in the TEQ equivalent dosed 
TCDD group. Addition of PCB 153 to the PHAH mixture (PHAH+) caused higher, though 
not significant mean foci volume and volume fraction as compared to the PHAH- group. 
However the increase caused by the PHAH+ mix was still somewhat lower than the effect of 
1 ug TCDD/kg bw/week alone. Thus, the foci growth response was not identical between 
groups given TEQ equivalent doses. The observed differences in foci induction between the 
TCDD and the TEQ equivalent dosed PHAH mixture groups was not reflected in the EROD 
activity (Table 4.3). 
Liver retention of the congeners 
The concentrations of the PHAH congeners in the liver are shown in table 4.4. These 
results have been discussed in detail elsewhere (Van der Plas et ah, 1998b Chapter 3). 
Considerable differences in hepatic concentration were observed, due to large differences in 
relative levels of the congeners in the administered PHAH mixture. However, the relative 
levels of congeners in the liver was different compared to the originally given mixture (Table 
4.1). The relative hepatic levels of PeCDD, PeCDF and PCB 126 to TCDD increased 
approximately 2, 10 and 4 times respectively compared to the relative levels in the original 
mixtures. Opposite effects were found for PCB 118, PCB 156 and PCB 153, their relative 
levels decreased on average 12, 3 and 6 times respectively. An interesting result was that the 
concentrations of all congeners, except TCDD, were significantly higher in the PHAH+ group 
dosed at 1 ug TEQ/kg bw/week, compared to the TEQ equivalent dosed PHAH- group. 
Discussion 
The major aim of this study was to determine the integral tumour promotion potential of 
complex mixtures of PHAHs, and to evaluate the applicability of the TEF concept in terms of 
predicting the effects of PHAH mixtures as present in the human diet. For this purpose the 
development of altered hepatic foci (AHF) as a measure of the tumour promotion capacity of 
a PHAH mixture covering >90% of the TEQ in Baltic herring was studied and compared to 
the effects of a TEQ equivalent dose of 2,3,7,8-TCDD alone. The PHAH mixture used 
consisted of 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 2,3,4,7,8-PeCDF, PCB 126, PCB 118, PCB 
156 and PCB 153 in relative concentrations as indicated in table 4.1. The PHAH mixture was 
also studied at one dose level without the di-ortho substituted PCB 153 (PHAH-) in order to 
determine possible interactive effects of this congener. The PHAH mixtures used in this study 
significantly enhanced the development of GST-p positive AHF, compared to corn oil treated 
rats, but to a lower extent than in the TEQ equivalent dosed TCDD group. 
Selective proliferation of initiated cells may indirectly be stimulated by cytotoxic events, 
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therefore it is important to consider cytotoxic properties of promotive substances (Butterworth 
et al, 1992). In this study the plasma alanine aminotransferase (ALT) and the plasma 
aspartate aminotransferase (AST) levels were only slightly, not significantly, increased for all 
PHAH treated groups. A statistically significant two-fold increase of the AST level in the 
plasma was found only in animals treated with the highest dose of the PHAH+ mixture. The 
histopathologic evaluation revealed only minor pathological changes in the exposure groups. 
Therefore it was concluded that there was no severe hepatotoxicity at the administered PHAH 
doses. 
With respect to the foci data several explanations could be discussed for the observed 
difference between the treatment with TCDD and the TEQ equivalent PHAH+ and PHAH-
mixture. The TEQ value calculated for the mixtures could have been overestimated by using 
conservative TEF values. The REPs for PeCDD, PeCDF, PCB 126 and PCB 153 used for the 
calculation of doses in this study were based on tumour promotion studies performed by 
Waern et al. (1991) and Hemming et al. (1993; 1995). The REPs for PCB 118 and PCB 156 
based on tumour promotion data were not available until recently (Haag-Gronlund et al, 
1997a,b), therefore WHO-ECEH TEF values were used for PCB 156 and PCB 118. PCB 118 
was found to be less potent than expected on the basis of the official TEF of 0.0001 proposed 
by WHO-ECEH and IPCS (Ahlborg et al, 1994), which was used for the TEQ calculations in 
this study. Based on tumour promotion data a REP for PCB 118 was estimated to be less than 
0.00002 (Haag-Gronlund et al, 1997a) and for PCB 156 a range was derived of 0.0001-0.001 
(Haag-Gronlund et al, 1997b). A recalculation of the toxic potency of the PHAH mixture 
using the REPs based on only tumour promotion data would lower the TEQ value of the 
PHAH mixtures only slightly with 0.5 to 12%. Using the international TEF values for all 
congeners in the mixture as proposed by the Nordic Council (Ahlborg et al, 1988) and WHO-
ECEH and IPCS (Ahlborg et al, 1994) would result in a 27% higher TEQ value for the 
PHAH mixtures thus a larger overestimation of the tumour promotion effect. The 
conservative TEFs and the uncertainty in the REPs used for dose setting could at least partly 
explain the difference in foci occurrence between TEQ equivalent groups. 
Secondly, the hepatic deposition of the PHAH congeners in the liver as percentage of 
the given dose differed considerably (Table 4.4), which was observed by others as well 
(Abraham et al, 1989; Waern et al, 1991; Hemming et al, 1993; De Jongh et al, 1993b). 
This highly influences the concentration ratios between the PHAH congeners and possibly the 
toxic potency of the mixture in the liver. In addition, several authors (De Jongh et al., 
1993a,b; Rozman et al, 1995) reported on small kinetic interactions between congeners after 
administration of PHAH mixtures. Also in this experiment the possibility of kinetic 
interactions influencing the toxicity of the mixture in the liver can not be excluded. However, 
differences in deposition may play a role in the toxic potency of the mixture in the liver, 
which is illustrated by the following calculation of the TEQ of the hepatic mixture. Because 
international TEF values are intake values and may not be appropriate for body burden 
assessments (Ahlborg et al, 1994), internal REPs based on hepatic concentrations (IREPs) 
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Figure 4.2 Hepatic dose of congeners expressed as internal toxic equivalency 
(ITEQ) per total liver. Dose levels are per kg body weight per week. 
were used to calculate an internal toxic equivalent (ITEQ). IREPs based on tumour promotion 
data for PeCDD (0.1), PeCDF (0.01), PCB 126 (0.01), PCB 156 (0.0002-0.002) and PCB 153 
(0.0001-0.001) were calculated by Waern et al. (1991), Hemming et al. (1993) and Haag-
Gronlund et al. (1997b). The IREP for PCB 118 (<0.0003) was deduced on basis of a study of 
Haag-Gronlund et al. (1997a) (unpublished data). The ITEQs were calculated by multiplying 
the congener liver concentration with the IREP values. In case a range was given 
for the IREP, the middle of the range was used. Figure 4.2 shows the ITEQs calculated as 
indicated above. The calculations suggest that although the groups administered 1 u.g TEQ/kg 
bw/week were TEQ equivalent dosed, the ITEQ is lower in the groups exposed to the PHAH 
mixtures compared to the TCDD group and is more in line with the foci induction than the 
externally administered TEQ dose. In addition, the ratio between the congener levels in the 
PHAH mixture seems to be changed. In the original PHAH+ mixture, PeCDD was 
responsible for approximately 22% of the total TEQ but in the hepatic mixture only for about 
8% of the total ITEQ. The TEQ for PCB 153 turned out to be less in the original mixture than 
in the hepatic mixture; 7% of the total TEQ v.s. 16-22% of the total ITEQ. For PCB 126 the 
contribution to the TEQ changed from 40% externally to approximately 30% internally and 
for PeCDF from 11% externally to 19% internally. 
Non-additivity due to partial receptor agonism of some congeners in the mixture could 
be another explanation for the observed difference between the treatment with TCDD alone 
and the TEQ equivalent PHAH+ and PHAH- mixture groups. High concentrations ofortho-
substituted PCBs, e.g. PCB 118 and PCB 156, which have a relatively low affinity for the 
receptor and generally a lower toxic potency and maximum effect than the dioxin-like PCBs, 
could compete with PCDDs, PCDFs and the dioxin-like non-ortho PCBs for receptor binding 
(Van den Berg et al., 1994) and thus lowering the observed toxic or biochemical effect. Partial 
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antagonistic effects of both individual PCBs and commercial PCB mixtures on TCDD 
induced effects e.g. EROD activity (Biegel et al, 1989; Aarts et al, 1995), immunotoxicity 
(Davis and Safe, 1989; Davis and Safe, 1990) and teratogenicity (Haake et al, 1987) were 
reported by several authors. Also some furans were found to partially antagonise TCDD 
induced EROD activity (Bannister and Safe, 1987; Astroff and Safe, 1989). The Ah receptor 
affinity of compounds determined in in vitro competitive binding studies showed a correlation 
between the competitive displacement of TCDD from the Ah receptor and in vivo activity of 
congeners as partial antagonists (Astroff and Safe, 1989; Aarts et al, 1995). However, it is not 
clear whether or not this effect plays a role in our observations. 
PCB 153 increased the hepatic congener concentrations of all congeners, except for 
TCDD, present in the mixture (Table 4.4). An increase of the liver retention of several PHAH 
congeners when co-administered with PCB 153, was reported also by De Jongh et al. 
(1993a,b; 1995). The interaction of PCB 153 with the hepatic deposition of PCDDs, PCDFs 
and some PCBs has been explained by its capacity to induce Ah-receptor levels in the liver 
(Denomme et al, 1986; Bannister and Safe, 1987; De Jongh et al. 1993a) and to induce 
indirectly the activity and protein level of CYP1A2 (Kuroki et al, 1986; Voorman and Aust, 
1987, 1989; De Jongh et al, 1995), which is assumed to be an important hepatic binding site 
for PHAH congeners (Kedderis et al, 1993; Andersen et al, 1993). This PCB 153 correlated 
change in congener-retention may explain the small difference in AHF level between the 
PHAH+ group compared to the TEQ equivalent dosed PHAH- group. A second explanation 
for the observed difference in AHF development between the PHAH+ and the PHAH- group 
is the tumour promoting activity of PCB 153 itself, which has been demonstrated by several 
others (Hemming et al, 1993; Bager et al, 1995; Berberian et al, 1995) even at such a low 
dose of PCB 153 (Hemming et al, 1993) as used in our study. It should be noted that the 
additive effects of PCB 153 on AHF development by the dioxin-like compounds in rats does 
not preclude that different effects may occur in different species. 
The proposed mechanisms of partial antagonism and toxicokinetic interactions to 
explain the differences between the TEQ equivalent dosed groups on the AHF development 
are not supported by the observed EROD activities. The EROD activity in the PHAH+ and 
PHAH- group was even slightly, although not significant, higher compared to the TEQ 
equivalent dosed TCDD group. No correlation between volume fraction and EROD induction 
was found. A potentiation of the EROD activity by PCB 153 when co-administered with other 
congeners has been observed by others and could be explained by biochemical and/or 
toxicokinetic interactions (Bannister et al, 1986, 1987b; Leece et al, 1987; De Jongh et al, 
1993a,b). In our study however, no significant increase of the EROD activity in the PHAH+ 
group compared to the TEQ equivalent PHAH- group was observed. A possible reason could 
be that at the exposure levels utilised in this study, maximum EROD activity was already 
nearly achieved. A higher exposure of the animals may therefore result in a relatively small 
increase of the EROD activity. 
The PROD activity was increased in all treatment groups including TCDD, which was 
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somewhat surprising. However, the increase in PROD activity did not correspond to an 
increase in enzyme protein levels. In our laboratory we have observed a similar increasing 
effect of PCB 126 on the PROD activity without any induction on CYP2B protein or mRNA 
levels. This TCDD and PCB 126 induced PROD activity possibly reflects induction of 
CYP1A as penthoxyresorufin is also moderately metabolised by CYP1A (Burke et ai, 1994). 
Based on the weekly administered dose a REP for the PHAH+ and the PHAH- mixture 
of approximately 0.00026 and 0.00033 respectively was deduced. This is somewhat lower 
than the expected REPs of 0.00044 and 0.00097 for the PHAH+ and PHAH- mixture. The 
TEF concept was developed to facilitate risk assessment of complex mixtures of PCDDs, 
PCDFs and dioxin-like PCBs. Information from food surveys in industrialised countries 
indicate a daily intake of PCDDs, PCDFs and dioxin-like PCBs in the order of 100-600 pg 
TEQ/person/day (Van Leeuwen and Younes, 1998), which is a factor 40-1000 lower 
compared to the levels used in this study. Baltic herring and other fish species are among the 
main contributors of these substances to the human diet, the major source of human 
background exposure. This study confirmed that the international TEFs are conservative for 
evaluation of tumour promoting effects of mixtures similar to that in Baltic herring, resulting 
in risk assessments with large safety margins. REPs derived from tumour promotion studies 
would result in better, although still conservative, risk assessments of tumour promotive 
effects of these mixtures. 
In conclusions, the dioxin-like PHAH mixtures used in this study enhanced the 
promotion of GST-p positive AHF significantly in female Sprague-Dawley rats but to a lower 
extent than expected based on the TEF concept. The conservative international TEFs (WHO 
1993) and the uncertainty in the REPs used for the calculation of the composition and doses of 
the PHAH mixtures, may partly explain the observed differences in foci induction between 
the rats exposed to TCDD and the PHAH- mixture. However, differences in toxicokinetic 
properties of the congeners and interactive effects on deposition of the congeners may have 
influenced the predicted toxic potency of the mixture as well. Overall our study indicates that 
the TEF approach predicts the tumour promotion potency for dioxin-like dietary relevant 
mixtures of PHAHs quite well, i.e. within a factor of two. 
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Contribution of planar (0-1 ortho) and non-planar (2-4 ortho) 
fractions of Aroclor 1260 to the induction of altered hepatic foci in 
female Sprague-Dawley rats 
Abstract 
The hepatic tumour promoting activity of the planar 0-1 ortho (-9.7% w/w) and the non-
planar 2-4 ortho (-90.3% w/w) fraction of the commercial PCB mixture Aroclor 1260 was 
studied using a medium term two-stage initiation/promotion bioassay in female Sprague-
Dawley rats. Fractionation was carried out on an activated charcoal column. The composition 
of the effluent from the column was tested by GC-ECD. The absence of planar compounds in 
the 2-4 ortho fraction was confirmed by GC-MS analysis. The dioxin-like toxic potency of the 
fractions was determined with the DR-CALUX assay. The animal experiment was started 
with the initiation procedure (i.p. diethylnitrosamin injection, 30 mg/kg body weight, 24 hours 
after 2/3 hepatectomy), followed six weeks later by the promotion treatment which consisted of 
a weekly subcutaneous injection during 20 weeks. Exposure groups (n=10) received the 
following treatments (dose/kg body weight/week): Aroclor 1260 (10 mg), 0-1 ortho fraction 
(0.97 mg), 2-4 ortho fraction (1, 3 or 9 mg), a reconstituted 0-4 ortho fraction (9.97 mg), 
2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153; 1 or 9 mg), 2,3,7,8-TCDD (1 ug; positive control) 
or corn oil (1 ml; vehicle control). One group did not receive a promotion treatment. All 
exposure groups exhibited a significantly increased volume fraction of the liver occupied by 
hepatic foci positive for the placental form of glutathione-S-transferase-p compared to the 
corn oil control, except for the groups treated with 0-1 ortho fraction and 1 mg PCB 153/kg 
bw/week. Approximately 80% of the total tumour promoting capacity of the reconstituted 0-4 
ortho fraction, could be explained by the 2-4 ortho PCB fraction while the 0-1 ortho fraction 
had only a negligible contribution. These results suggest that the majority of the tumour 
promotion potential of PCB mixtures resides in the non-dioxin like fraction, which is not 
taken into account in the Toxic Equivalency Factor (TEF) approach for risk assessment of 
PCBs. This may result in an underestimation of the tumour promotion potential of 
environmental PCB mixtures. 
Based on: Van der Plas, S.A., Sundberg, H., Van den Berg H., Scheu, G., Wester, P., Jensen, S., 
Bergman, A., De Boer, J., Koeman, J.H., and Brouwer, A. (2000). Contribution of planar (0-1 ortho) 
and non-planar (2-4 ortho) fractions of Aroclor 1260 to the induction of altered hepatic foci in female 
Sprague-Dawley rats. Toxicology and Applied Pharmacology \n press. 
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Introduction 
Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs), 
polychlorinated dibenzofurans (PCDFs) and other polyhalogenated aromatic hydrocarbons 
(PHAHs) are ubiquitously present in the environment. Their toxicity, which is characterised 
by effects such as body weight loss, endocrine disruption, impairment of immune responses, 
hepatotoxicity, reproductive effects, teratogenicity and carcinogenicity (Kimbrough, 1974; 
Safe, 1990; Brouwer et ah, 1999), has been intensively studied over the last 25 years. The 
most toxic PHAH compounds exhibit a planar molecular conformation with lateral chlorine 
substitution. Most if not all of their toxic responses are thought to be mediated by the aryl 
hydrocarbon (Ah) receptor. However, for the in general less toxic non-planar PCBs, other till 
now unknown mechanisms have been suggested (Safe, 1994) 
In environmental matrices and biota, PCBs, PCDDs and PCDFs are always present as 
complex mixtures. The toxic equivalency factor (TEF) concept has been developed to aid in 
the risk assessment of complex mixtures of PHAHs and to enable the calculation of total 
dioxin-like toxic potencies, expressed as the TCDD equivalence (TEQ) of a mixture. The TEF 
approach is based on the assumptions that all PCBs, PCDDs and PCDFs that can assume a 
coplanar conformation act through the Ah receptor-based mechanism of action similar to 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In addition, the TEF concept assumes that the 
effects of the individual compounds are additive (Safe, 1994; Ahlborg et ah, 1994). 
Carcinogenicity is one of the toxic endpoints considered in risk assessment of PCBs, PCDDs 
and PCDFs (WHO, 1992). The TEF concept is therefore also considered to be a valid method 
to estimate the total carcinogenic potency of mixtures of PHAHs as they occur in food or 
environmental matrices. 
PCBs, PCDDs and PCDFs have been found to be potent promoters of liver tumour 
formation in rodents (Safe, 1989; Silberhorn et ah, 1990; Whysner and Williams, 1996). 
Individual congeners as well as mixtures of PCBs, PCDDs and PCDFs have been reported to 
promote the development of enzyme altered hepatic foci in rats (Pitot et ah, 1980; Oesterle 
and Demi, 1983; Waern et ah, 1991; Hemming et ah, 1993; Bager et ah, 1995; Haag-
Gronlund et ah, 1997a,b, 1998; Van der Plas et ah, 1999 Chapter 4). In addition, several 
PCBs, PCDDs and PCDFs have been shown to inhibit the gap junctional intercellular 
communication (GJIC) in vitro in the mouse hepalclc7 liver tumour cell line (De Haan et ah, 
1996). Inhibition of GJIC has been suggested to be an in vitro indicator of the tumour 
promotion capacity of chemicals. Although the exact mechanism by which tumour promotion 
of these PHAHs occurs is unclear, it is assumed that the Ah receptor plays an important role 
(Safe, 1989, 1994). 
However, both in vitro and in vivo studies suggest a tumour promotion capacity of 
several non-dioxin-like di-ortho substituted PCBs as well. 2,2',3,3',4,4'-Hexachlorobiphenyl 
(PCB 128), 2,2',5,5'-tetrachlorobiphenyl (PCB 52) (De Haan et ah, 1996) and 2,2',4,4',5,5'-
hexachlorobiphenyl (PCB 153) (Bager et ah, 1997) (IUPAC PCB nos., Ballschmiter et al., 
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1992) have been shown to be potent inhibitors of the GJIC in vitro. 2,2',5,5'-
Tetrachlorobiphenyl (PCB 52), 2,2',4,4'-tetrachlorobiphenyl (PCB 47) and 2,2',4,4',5,5'-
hexachlorobiphenyl (PCB 153) have been found to stimulate the growth of altered hepatic foci 
(AHF) in female Sprague-Dawley rats (Preston et al., 1985; Hemming et al., 1993). In 
addition, some studies have suggested both synergistic and antagonistic interactions between 
PHAHs and some non-planar di-ortho PCB congeners, or PCB mixtures on several toxicity 
parameters, including immunotoxicity (Biegel et al, 1989; Davis and Safe, 1989), 
teratogenicity (Zhao et al, 1994), hepatotoxicity (Yao and Safe, 1989; Van Birgelen et al., 
1996a) and tumour promotion (Sargent et al., 1991; Bager et al., 1995, Haag-Gronlundefa/., 
1998). Although di-ortho chlorinated PCBs are generally considered to be less toxic and 
possess no or negligible Ah receptor mediated activity, and thus have no TEF value, their 
concentration in commercial mixtures, food and environmental matrices is much higher 
compared to the planar PCBs. 
In a previous experiment the tumour promotion capacity (AHF induction) of a PHAH 
mixture covering >90% of the TEQ in Baltic herring was determined (Van der Plas et al, 
1999 Chapter 4). It was shown that the TEF approach predicted the tumour promotion 
potency for this mixture quite well, i.e. within a factor of two. There was however some 
evidence for an interactive effect on the liver retention of dioxin-like congeners by addition of 
the di-ortho PCB 153 (Van der Plas et al, 1998b Chapter 3), an effect which was also 
observed by De Jong et al. (1993a,b; 1995). The aim of the study presented here, was to 
determine the relative contribution of the dioxin-like PCBs and non-dioxin-like PCBs to the 
tumour promotion potential of a complex PCB mixture. As a surrogate mixture for the human 
diet the commercial PCB mixture Aroclor 1260 was chosen, on the basis of the congener 
pattern of the higher chlorinated, non-planar congeners. Aroclor 1260 was fractionated in a 0-
1 ortho fraction and a fraction containing all 2-4 ortho substituted PCBs. The tumour 
promotion capacity of the separate fractions and their relative contribution to the effect of the 
complete mixture was studied in the rat liver tumour promotion model of Pitot et al. (1978). 
Material and Methods 
Chemicals 
N-nitrosodiethylamine (NDEA) was obtained from Fluka (Fluka Chemie, Buchs, 
Switzerland). 
Aroclor 1260 was kindly provided by Dr. M. Van den Berg (Research Institute of 
Toxicology, University of Utrecht, The Netherlands) and 2,2',4,4',5,5'-Hexachlorobiphenyl 
(PCB 153) was synthesised by Prof. A. Bergman (Department of Environmental Chemistry, 
Stockholm University, Sweden) and was > 99% pure. 
Minimal essential medium (alfa-MEM) and foetal calf serum for cell culture were 
obtained from Gibco (Rockville, Maryville, USA). 96-Well culture view-plates were from 
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Packard (Meriden, CT, USA) and luciferin assay mix was from Promega (Madison, 
Wisconsin, USA). 
GST Yp rabbit anti-rat serum was used as the primary antibody for gluthatione-S-
transferase-p (GST-p) staining and was purchased from Biotrin International (Dublin, 
Ireland). The secondary antibody was peroxidase conjugated swine anti-rabbit 
immunoglobulin (P217) (Dako, Glostrup, Denmark). Bovin serum albumin (BSA) and 
diaminobenzidine tetra hydrochloride (DAB) were obtained from Sigma Chemical Company 
(St. Louis, MO, USA) and NADPH was from Boehringer Mannheim (Mannheim, Germany). 
Phosphate buffered saline (Dulbecco's 'A', pH 7.3; PBS) was purchased from Oxoid 
(London, UK), NaCl and Tris were from Merck (Darmstadt, Germany). 
Resorufin was obtained from Janssen Chimica (Geel, Belgium) and ethoxyresorufin and 
penthoxyresorufin were synthesised according to Mayer et al. (1977). Protein was assessed 
using a Bradford Protein Assay kit obtained from Bio-rad (Hercules, California, USA). All 
other compounds were of analytical grade. 
Animal mixtures 
The commercial PCB mixture Aroclor 1260 was fractionated into three fractions 
according to the method described by Athanasiadou et al. (1991) with slight modifications. 
The method is based on a charcoal column procedure where the PCB congeners are eluted 
strictly according to the number of ortho chlorine's, i.e. higher ortho chlorinated congeners 
eluting first. Fractions are obtained containing two to four, one and no chlorine's substituted 
in the ortho positions. An additional fraction was obtained containing PCDFs and PCNs. Gas 
chromatography (GC) was performed according to Athanasiadou et al. (1991), but in addition 
to the DB-5 column a BPX5 column (25m x 0.22 i.d., SGE international Pty. Ltd) was used in 
order to get a full separation between two critical pairs of congeners that co-elute on the DB-5 
column. These pairs are PCB 149 (2,2',3,4',5',6) from PCB 118 (2,3',4,4',5) and PCB 132 
(2,2',3,3',4,6') from PCB 105 (2,3,3',4,4'). 
5.0 g Aroclor 1260 was dissolved in 170 ml of a heptane:benzene mixture (95:5) and 
transferred to a wet packed charcoal column (72 g charcoal) at a speed of 10 ml per hour 
followed by the same solvent mixture at 30 ml per hour up to 3500 ml sampled in 500 ml sub-
fractions. The first 1500 ml eluate from the charcoal column contained 90.3% of the total 
PCB mass and the next 2000 ml 6.6%. The charcoal column was rinsed for planar PCBs not 
eluted by the heptane:benzene mixture. This was done in a Wallenberg-extractor (described 
by Athanasiadou et al, 1991) using three 150 ml portions of recycling boiling toluene for 5 
hours each. The combined extracts from the Wallenberg extractor contained 3.1% of the total 
PCB mass. Finally the composition of the different fractions was qualitatively analysed by 
GC-ECD. Three fractions were obtained with a total recovery of 99.1%; a 2-4 ortho non-
dioxin-like fraction (-90.3% of the total mass), a 1-2 ortho fraction (-6.6% of the total mass) 
containing mono and di-ortho PCBs and a 0-1 ortho dioxin-like fraction (-3.1% of the total 
mass) containing mainly non-ortho PCBs with a trace of mono-ortho PCBs. 
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Table 5.1 Test compounds and treatment 
Test compound 
- (untreated) 
Corn oil 
2,3,7,8-TCDD 
0-1 ortho fraction 
2-4 ortho fraction 
0-4 ortho fraction 
Aroclor 1260 
PCB 153 
number of 
animals per 
group 
10 
18 
10 
10 
10 
10 
10 
10 
10 
10 
10 
groups used in 
maintenance" 
dose per kg 
bw/week 
-
1ml 
1 Hg 
1 mg 
1 mg 
3mg 
9mg 
10 mg 
10 mg 
lmg 
9mg 
the tumour promotion experiment 
\ig TEQ per kg 
bw/week 
-
no activity 
1 
0.0008 
no activity 
no activity 
no activity 
0.0008 
0.0017 
no activity 
no activity 
equivalent to 
amount of 
Aroclor 1260 
-
-
-
10 mg 
1.1 mg 
3.3 mg 
10 mg 
10 mg 
10 mg 
-
-
" The first dose was a loading dose which was five times higher than the maintenance doses indicated 
here 
For the animal experiment, the 0-1 ortho and the 1-2 ortho PCB fractions were 
combined into one fraction. Although this combined fraction contained approximately 5% of 
the total di-ortho PCB mass in Aroclor 1260, it will be further referred to as 0-1 ortho 
fraction. This was done in order to make a clear distinction between the fraction containing all 
PCB congeners with a dioxin-like activity on the one hand and the fraction strictly containing 
non-dioxin-like congeners on the other hand. 
The 0-1 ortho and the 2-4 ortho fractions were studied separately as well as a 
reconstituted mixture, the 0-4 ortho fraction. The combination of the 0-1 ortho and the 2-4 
ortho fractions was based on the relative concentrations of these congeners in Aroclor 1260 
(Table 5.1). A small amount of the fractions was dissolved in DMSO to test the total dioxin 
like potency of the fractions in the Ah receptor-dependent H4IIE-Luc reporter gene assay 
(DR-CALUX). For animal exposure, all fractions were dissolved in corn oil and the following 
exposure groups were included: corn oil as a negative control; TCDD as a positive control (1 
Hg/ml); a 2-4 ortho PCB fraction of Aroclor 1260 (1, 3 and 9 mg/ml); a 0-1 ortho PCB 
fraction of Aroclor 1260 (1 mg/ml); a reconstituted 0-4 ortho fraction (10 mg/ml); Aroclor 
1260 (10 mg/ml); and, PCB 153 (1 and 9 mg/ml) (Table 5.1). 
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GC-ECD and GC-MS analysis 
The PCB congener composition and the concentrations of 16 selected chlorobiphenyls in 
corn oil samples of Aroclor 1260, the Aroclor 1260 fractions, as well as rat liver samples of 
groups treated with the 0- 1 ortho (n=3), the 0-4 ortho (n=3) and the highest dose of the 2-4 
ortho fraction (n=3) were analysed by the Netherlands Institute for Fisheries Research 
(RTVO). 
Extraction and clean-up prior to the GC determination of the PCBs were similar for 
ortho and non-ortho PCBs (De Boer, 1988), but an additional HPLC step was added to 
separate the non-ortho PCBs from the other PCBs. About 1 g of corn oil and 1 g of rat liver 
was homogenised, mixed with Na2S04 and after ca. 3 hours drying time Soxhlet extracted for 
6 hours with dichloro methane/pentane (1:1, v/v). A spike of 13C labelled PCBs 77, 126 and 
169 was added prior to extraction. After extraction, iso-octane was added as a keeper and the 
dichloro methane was removed by means of a rotary evaporator. Pentane was added to a 
volume of 50 ml. A gravimetric extractable lipid determination was carried out on this 
residue. The extracts were eluted with n-pentane over 15 g alumina columns (80% H20) with 
a capacity of 250 mg lipid. On average ca. 40-120 mg of lipid per rat liver was transferred to 
the alumina columns. Subsequently, the extracts were concentrated to 2 ml and eluted over 
1.6 g silica columns (2% H20). The first fraction of 11 ml contained all PCBs. The mono- and 
di-ortho PCBs 101 (2,2',4,5,5'-PeCB), 105 (2,3,3',4,4'-PeCB), 118 (2,3',4,4',5-PeCB), 128 
(2,2',3,3',4,4'-HxCB), 138 (2,2',3,4,4',5'-HxCB), 153 (2,2',4,4',5,5'-HxCB), 156 (2,3,3',4,4',5-
HxCB), 180(2,2',3,4,4',5,5'-HeCB), 187 (2,2',3,4',5,5',6-HeCB), 189 (2,3,3',4,4',5,5'-HeCB), 
195 (2,2',3,3',4,4',5,6-OcCB) and 206 (2,2',3,3',4,4',5,5',6-NoCB) were analysed by GC-ECD 
according to a method of De Boer (1988). PCB 112 was used as an internal standard. An 
internal reference material, cod liver, a blank and a recovery standard were analysed in 
parallel. Two GC columns were used under conditions described in table 5.2. 
The elution order and retention times of the PCBs mentioned above were all carefully 
checked as well as possible co-elution with other PCBs. This was done by injecting three 
standard solutions containing in total 94 PCBs on both columns and comparing the 
chromatograms with available information on retention times of ca. 50 PCBs previously 
individually injected on the same columns and with literature data (Larsen et ah, 1992, 
Larsen, 1995). Another part of this fraction was concentrated and transferred to an HPLC 
column. The non-ortho PCBs 77 (3,3',4,4'-TeCB), 81 (3,4,4',5-TeCB), 126 (3,3',4,4',5-PeCB) 
and 169 (3,3',4,4',5,5'-HxCB) were separated from the ortho PCBs by HPLC using a 
graphitised (Hypercarb) carbon column according to a method of De Boer et al. (1992). The 
non-ortho PCB fraction was concentrated under nitrogen to 0.2 ml in toluene, after addition of 
a recovery standard (PCB 101). Eel was analysed in parallel as an internal reference. The 
extracts were analysed by GCMS, under conditions as described in table 5.2 according to De 
Boer et al. (1992). 
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Table 5.2 Analytical conditions used for GC/ECD and GC/MS 
Parameter 
Instrument 
Column 
Carrier gas 
Ionisation method 
Oven temp. 
Reagent gas 
Source temp. 
Analyser temp. 
Detector temp. 
Injector temp. 
Interface temp. 
Injection 
Injection volume 
GC/ECD 
HP 6890 
CPSill9,50m,0.15 
mm, 0.2 um 
Hydrogen, 200kPa 
3 min 90 °C, 30 
°C/minto215°C, 40 
min 215 °C, 5 °C/min 
to 270 °C, 20 min 270 
°C 
300 °C 
250 °C 
Splitless (2 min) 
1 ul 
GC/ECD 
PE Autosystem 
HT-8, 50 m, 0.20 mm, 
0.2 um 
Hydrogen, 180 kPa 
2 min 90 °C, 30 
°C/mintol70°C, 3 
°C/minto215°C, 15 
min215°C,2°C/min 
to 280 °C 
375 °C 
270 °C 
Splitless (1 min) 
0.5 ul 
GC/MS 
HP 5890 (GC) 
HP 5988A (MS) 
DB-5, 20 m, 0.25 mm, 
0.25 um 
Helium, 100 kPa 
NCI, 150 eV 
3 min 90 °C, 30 
°C/mintol80°C, 10 
°C/minto280°C,45 
min 280 °C 
methane, 0.65 torr 
175 °C 
100 °C (front) 
75 °C (back) 
290 °C 
285 °C 
Splitless (2 min) 
2ul 
The detection limit (ng/kg) of the congeners was calculated as: 
lowest calibration concentration (ng/ml) x volume (ml) x 1000 
sample amount (g) 
The lowest concentration of the calibration curve was chosen at a signal-to-noise ratio of ca. 
5. The relative standard deviations of the analysed PCB congeners were as follows: PCB 77 
2.6%; PCB 126 3.4%; PCB 169 16%; PCB 28 16%; PCB 52 9.4%; PCB 101 7.5%; PCB 105 
8.5%; PCB 118 7.7%; PCB 138 7.5%; PCB 153 6.9%; PCB 156 10%; and, PCB 180 7.0%. 
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Ah receptor-dependent H4IIE-Luc reporter gene assay (DR-CALUX) 
The DR-CALUX assay was performed to test the dioxin-like potency of the PHAH 
mixtures according to Aarts et al. (1995) adapted for a 96-wells plate as described by Murk et 
al. (1998). Rat H4IIE.pGudlucl.l cells were prepared as previously described (Aarts et al, 
1995; Garrison et al, 1996). Cells were seeded in 96-wells plates and grown in minimal 
essential medium (alfa-MEM) with 10% heat inactivated foetal calf serum. After culturing for 
24 hours under standard conditions (37 °C, 5% C02) the cells were exposed to the test 
compounds for another 24 hours. Then the medium was removed from the cells, the cells 
were rinsed with 0.5><PBS buffer, lysed with lysis buffer (10 mM Tris, 2 mM dithiolthreitol 
and 2 mM l,2-diaminocyclohexane-N,N,N',N'-tetra-acetic acid, pH 7.8) and after adding the 
luciferin assay mix the signal was measured with a Luminometer plate reader (Luminometer, 
Labsystem). Each concentration of a sample was tested in triplicate. Dose-response curves of 
the samples were interpolated on a standard curve of TCDD to obtain a relative toxic potency 
(REPCALUX) for the sample. 
Rat liver tumour promotion experiment 
The animal experimental protocols were approved by the Animal Welfare Committee 
before starting the experiments. Young female Sprague Dawley rats (Mollegaard Breeding 
Centre Ltd., Denmark), about three weeks old at the day of arrival, were kept in wire bottom, 
stainless steel cages in groups of three or four animals under standard conditions (12 hr 
light/dark cycle, temperature 22 °C, humidity 55%) and fed ad libitum (Hope Farms Woerden, 
The Netherlands). After three weeks of acclimatisation, the initiation treatment was started by 
removing two thirds of the liver (partial hepatectomy; PH) under ether anaesthesia followed 
by an i.p. injection with NDEA (30 mg/kg) 24 hours after PH. Five weeks after PH the 
animals were divided in treatment groups; a vehicle control group (n= 18), a TCDD exposed 
positive control group (n= 10) and eight experimental groups (n=10). One group of animals 
did not receive a promotion treatment at all. The promotion treatment was started six weeks 
after the initiation procedure and consisted of a weekly s.c. injection with the test compound 
in corn oil (1 ml/kg body weight per week) for twenty weeks. Exposure concentrations were 
as indicated in table 5.1. The first dose was a loading dose, which was five times higher than 
the maintenance dose in order to achieve steady state conditions within a shorter period of 
time (Flodstrom and Ahlborg, 1989; Krowke et al, 1989). Body weight, food and water 
consumption were recorded weekly. 
One week after the last exposure the animals were sacrificed under ether anaesthesia by 
orbita puncture for blood collection (heparinised), followed by decapitation. The liver was 
sampled and a part of the lateral and caudal liver lobe was fixed in ice-cold acetone (4 °C), 
and embedded in paraffin 24 hours after fixation. A part of the lateral liver lobe was stored at 
-80 °C for gas chromatographic and mass spectrometric (GC-MS) analyses whereas the rest of 
the liver was homogenised on ice in a Potter tube with 0.01 M Tris-HCl-buffer and 0.25 M 
sucrose (pH 7.4). The homogenate was stored at -80 °C until preparation of microsomes. 
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Thymus, spleen, lung, heart, brain, kidneys and some adipose tissue were collected, 
weighed and stored at -80 °C for possible future studies. 
General histopathology of liver samples 
General histopathology was performed on liver tissue of the groups treated with corn oil, 
TCDD, Aroclor 1260, 0-1 ortho fraction, 9 mg/kg bw/week 2-4 ortho fraction and the 0-4 
ortho fraction. Sections (5 urn) of formalin fixed tissue (n=5) were processed routinely for 
paraffin embedding, stained with haematoxylin and eosin (H&E) and examined by light 
microscopy. 
Staining and analysis of altered hepatic foci 
Sections (4 urn) of acetone fixed tissue were stained for GST-p positive foci as 
described by Haag-Gronlund et al. (1997a). Sections were deparaffinised in xylene and air 
dried. The endogenous peroxidase activity was blocked with a fresh solution of 0.5% H202 in 
methanol (10 min). Aspecific binding sites were then blocked with a 2.5% BSA solution in 
PBS (30 min). Sections were incubated overnight at room temperature with the GST-p 
primary antibody (dilution 1:2000) followed by incubation with peroxidase conjugated 
secondary antibody (dilution 1:100) for 2'/2 hours. GST-p positive cells were stained for 5 
minutes with diaminobenzidine tetra hydrochloride. Foci were analysed in the right lateral 
lobe of the liver using a Leica Aristoplan microscope connected to a Quantimet 570 Image 
Processing and Analysis system (Leica Cambridge Ltd. England). The methods used for 
stereological evaluation of altered hepatic foci have been reported previously (Flodstrom et 
al, 1988). A total sectional area of approximately 3 cm2 was analysed whereby the smallest 
group of GST-p positive cells scored as a focus had a radius of 35 urn (cut off limit). 
Preparation of microsomes 
Microsomes were prepared by differential centrifugation of liver homogenates at 9000 g 
for 30 minutes, the resulting supernatant was centrifuged at 105,000 g for 90 minutes, and the 
pellet was resuspended in a 0.01 M Tris-HCl buffer, pH 7.4. Microsomes were stored at -80 
°C until further analysis. 
Cytochrome P450 and other liver enzyme activity and protein measurements 
The protein concentration in the liver microsomes was measured using the commercial 
available Bradford Protein Assay reagent with crystalline BSA as a standard. 
The total cytochrome P450 content in liver microsomes was analysed according to the 
method of Omura and Sato (1964) with modifications of Rutten et al, (1987). The difference 
spectrum was measured of microsome samples (protein concentration ±1 mg/ml) saturated 
with CO (60 seconds) followed by dithionite reduction of P450. 
Ethoxyresorufin-O-deethylase (EROD) and penthoxyresorufin-O-deethylase (PROD) 
activity were measured in liver microsomes according to Burke et al, (1977), adapted for use 
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with 96-well plates and a fluoro spectrophotometric plate reader (CytoFluor 2530, Millipore) 
as described by Morse et ah, (1996b). A pre-incubated mixture of microsomes (protein 
concentrations 100-400 ug/ml), BSA (4 mg/ml) and ethoxy- or penthoxyresorufin (8 uM) was 
incubated for 5 minutes at 37 °C after adding of 0.4 mM NADPH. Resorufin concentrations 
were measured after the reaction was stopped with 1 M NaOH. 
Alanine-aminotransferase (ALT) and aspartate-aminotransferase (AST) were measured 
using a commercially available kit (Boehringer Mannheim, Germany), adapted for 96-wells 
plates. 200 ul Buffer (37 °C) was incubated for several minutes at 37 °C with 20 ul plasma 
where after 20 fo.1 substrate was added. The absorbency change was measured at 365 nm with 
a spectrophotometer (Spectramax 340, Molecular Devices) during 5 minutes with intervals of 
11 seconds. 
Statistical analysis 
Data were analysed with the statistical package SPSS-PC 7.5. Foci and total P450 data were 
log transformed in order to obtain a homogeneous variance between the groups. A Tukey's 
Honestly Significant Difference (HSD) test was used to perform a multiple comparison on 
statistical differences between groups. 
Results 
CALUXactivity oftheAroclor 1260fractions 
The Ah receptor-mediated induction of luciferase (DR-CALUX) activity of the Aroclor 
1260 fractions was measured in order to determine the dioxin-like activity in these fractions. 
The 0-1 ortho fraction showed CALUX activity up to 25 % of the maximum effect induced by 
TCDD (Figure 5.1). However, the 0-4 ortho fraction showed a maximum CALUX activity of 
only 3% and cytotoxicity at the highest dose level tested. The 2-4 ortho fraction did not 
demonstrate any CALUX activity at all indicating the absence of Ah receptor agonists. Using 
the CALUX, the dioxin-like activity for the different mixtures could be deduced (Table 5.1). 
The low maximum activity of the 0-4 ortho fraction is possibly a consequence of antagonistic 
interactions between the 2-4 ortho substituted PCBs and the planar congeners, as was 
observed by Aarts et ah (1995) and Van der Plas et ah (1998a Chapter 2). Because no reliable 
dioxin-like potency could be calculated from the 0-4 ortho curve, the curve of the 0-1 ortho 
fraction was used for this purpose. 
GC-ECD and GC-MS analysis of the Aroclor 1260 fractions 
Qualitative GC-ECD analysis of the Aroclor 1260 sub-fractions was performed prior to 
the final fraction preparation, to ensure that the 2-4 ortho fraction contained no 0- and l-ortho 
PCB congeners. The 0-ortho PCB concentrations were below detection level and therefore the 
analysis was focussed on the l-ortho PCBs, i.e. when l-ortho PCBs are absent consequently 
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Figure 5.1 CALUX activity of 2,3,7,8-TCDD (concentration in ug/ml* 10") and the 
Aroclor 1260 fractions, expressed as % of the maximum induction by 2,3,7,8-TCDD 
the 0-ortho PCBs are absent as well. No traces of \-ortho congeners were found in the 2-4 
ortho sub-fractions whereas seven \-ortho PCBs were found in the 0-1 ortho sub-fractions. 
The following I-ortho PCBs could be measured: PCB 105 (2,3,3',4,4'), 118 (2,3',4,4',5), 122 
(2',3,3',4,5), 156 (2,3,3',4,4',5), 157 (2,3,3',4,4',5'), 167 (2,3',4,4',5,5') and 189 (2,3,3',4,4',5,5'). 
Concentrations of sixteen PCB congeners were quantitatively measured in Aroclor 1260 
and the final Aroclor 1260 fractions (Table 5.3). No 0- and l-ortho PCBs could be detected in 
the 2-4 or//?o-substituted fraction, which is in accordance with the results obtained from the 
GC-ECD analysis of the sub-fractions. However, subtraction of the measured levels in the 
reconstituted 0-4 ortho and the 0-1 ortho fraction suggests relatively low levels of PCB 118, 
PCB 156 and PCB 189 in the 2-4 ortho fraction compared to the 0-1 ortho fraction. In the 0-1 
ortho fraction low levels of several di-ortho PCBs were found (Table 5.3). The sum of PCB 
congener concentrations in the 0-1 and the 2-4 ortho fraction corresponds quite well to the 
PCB levels measured in the reconstituted mixture 0-4 ortho fraction. PCB levels in the 0-4 
ortho fraction are slightly lower compared to PCB levels found in Aroclor 1260. 
GC-MS analysis of rat liver tissue 
Large differences between PCB concentrations per kg liver tissue (ww) were observed 
(Table 5.4) which is largely in accordance with concentration differences as found in the given 
PCB mixtures (Table 5.3). With the exception of PCB 126 in the livers of 0-1 ortho exposed 
animals, no planar compounds could be detected in either of the liver samples. Low levels of 
both 1- and 2-ortho PCBs could be detected. Liver retention of the PCB congeners was below 
1% of the given dose for most congeners (Table 5.4). For PCB 126, a retention of 6% was 
observed in the 0-4 ortho group but this was only a single and possibly extreme observation. 
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Table 5.3 PCB congener concentrations in Aroclor 1260 and Aroclor fractions 
IUPAC 
nr. 
77 
81 
101 
105 
118 
126 
128 
138 
153 
156 
169 
180 
187 
189 
195 
206 
CI substitution 
3,3',4,4' 
3,4,4',5 
2,2',4,5;5' 
2,3,3',4,4' 
2,3',4,4',5 
3,3',4,4',5 
2,2',3,3',4,4' 
2,2',3,4,4',5' 
2,2',4,4',5,5' 
2,3,3',4,4',5 
3,3',4,4',5,5' 
2,2,,3,4,4',5,5' 
2,2',3,4',5,5',6 
2,3,3',4,4',5,5' 
2,2',3,3',4,4',5,6 
2,2',3,3',4,4',5,5',6 
Aroclor 
ug/ml corn oil 
0.02 
0.003 
363 
<9 
53 
0.02 
43 
594 
914 
41 
<0.01 
1013 
625 
13 
96 
64 
0-1 ortho 
ug/ml corn oil 
0.07 
0.004 
26 
2.1 
31 
0.023 
12 
62 
40 
28 
0.004 
41 
3.2 
9 
<2 
<1 
2-4 ortho 
Ug/ml corn oil 
O.0001 
O.00008 
243 
<6 
<18 
<0.00005 
23 
396 
729 
<7 
O.00007 
801 
531 
<2 
78 
55 
0-4 ortho 
ul/ml corn oil 
0.05 
0.002 
288 
<7 
39 
0.014 
34 
477 
756 
32 
<0.003 
810 
522 
10 
81 
53 
Animals received 1 ml corn oil/kg body weight/week for 20 weeks. The first dose was a loading dose, 
which was 5 times the PCB concentration of the maintaining dose. The total dose given to the animals 
is therefore equivalent to 24 ml corn oil/kg body weight -21.6 gram corn oil/kg body weight. 0-1 
ortho= 0-1 ortho substituted PCB fraction of Aroclor 1260 with a trace of 2 ortho substituted PCBs; 
2-4 ortho= 2-4 ortho substituted PCB fraction of Aroclor 1260; 0-4 ortho= the reconstituted mixture 
of the 2-4 and the 0-1 ortho fraction. Absolute lowest reliable detection limits for the planar PCBs 
were 0.16 pg for PCB 77, 0.08 pg for 126, 0.12 pg for PCB 169 and 0.14 pg for PCB 81. 
PCB 126 levels in the other analysed liver samples of the 0-4 ortho group were below the 
detection limit. 
Clinical observations 
No obvious treatment related signs of toxicity were observed throughout the study. 
Three animals were sacrificed during the promotion treatment period because of a poor 
condition: one animal of the TCDD treatment group (week 4); one in the group treated with 
the 0-1 ortho fraction (week 19); and, one animal in the group treated with the highest dose of 
the 2-4 ortho fraction (week 19). None of them was considered to be related to the treatment. 
No changes were observed in body weight and body weight gain in the treatment groups 
(Table 5.5). The relative thymus weight in the TCDD treated group was slightly but not 
statistically significant reduced compared to the corn oil treated control group. The relative 
liver weights were significantly increased in the TCDD group, the group treated with 9 mg/kg 
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Figure 5.2 A-B Liver tissue (HE stained) of female Sprague Dawley rats after 20 weeks of promotion 
treatment (magnifiction lOx). A Corn oil control; no evident changes in the morphology but some 
hepatocellular heterogeneity and clear cell foci were present. B TCDD; multinucleate cells, diffuse 
(non-zonal) lipid-laden cells (arrowhead) and an increased number of clear cell foci (arrow) were 
observed. 
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Figure 5.2C-D Liver tissue (HE stained) of female Sprague Dawley rats after 20 weeks of promotion 
treatment (magnifiction lOx). C 2-4 ortho fraction; changes were mainly centrilobular and consisted 
of prominent hepatocellular hypertrophy with morphological evidence for SER proliferation and fatty 
vacuolated cells. D 0-4 ortho fraction; pathology was similar to the 2-4 ortho fraction group 
(C=central vein, indicating centrilobular area; P=portal area). In none of the groups clear signs of 
liver necroses were found. 
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bw/week PCB 153, the 0-4 ortho fraction and Aroclor 1260 as compared to the corn oil group. 
A slight dose dependent increase of the relative liver weights was observed in the 2-4 ortho 
treated animals, this was however not statistically significant. No changes were found in the 
weights of the other organs examined (data not shown). 
Liver toxicity parameters 
Aspartate transaminase (AST) and alanine transaminase (ALT) activities were measured 
in the plasma as indicators for liver toxicity and are presented in table 5.5. No significant 
changes were observed in AST and ALT levels, indicating no overt liver damage in the 
various treatment groups. 
Histopathology of the liver 
In the corn oil control animals, some hepatocellular heterogeneity and clear cell foci 
were present but no evident changes in the morphology were observed (Figure 5.2A). Similar 
histology was observed in the group treated with the 0-1 ortho fraction (not shown), with the 
exception of a small increase in lipid-laden cells. In the other PHAH treatment groups, a more 
obvious change in morphology was observed in the liver tissue compared to the corn oil 
control group. In the TCDD treatment group, multinucleate cells, diffuse (non-zonal) lipid-
laden cells and an increased number of clear cell foci were observed (Figure 5.2B). However, 
the observed changes in the 2-4 ortho (Figure 5.2C), the 0-4 ortho (Figure 5.2D) and the 
Aroclor 1260 (not shown) group were different from the TCDD treatment group. The most 
remarkable difference was that the changes seen in the 2-4 ortho, the 0-4 ortho and the 
Aroclor 1260 group were mainly centrilobular; these changes consisted of prominent 
hepatocellular hypertrophy with morphological evidence for SER proliferation and fatty 
vacuolated cells. No clear differences between the 2-4 ortho, the 0-4 ortho and the Aroclor 
1260 group could be seen (not shown). No clear signs of liver necroses were found in any of 
the treatment groups. 
Liver Cyp450 enzyme induction 
The total cytochrome P450 content (Table 5.6) was significantly increased compared to 
the corn oil group in all PHAH treated groups except in the 0-1 ortho PCB group and the 1 
and 3 mg/kg bw/week 2-4 ortho PCB treated groups. A dose dependent increase in the total 
P450 content was found for both the 2-4 ortho PCB and the PCB 153 treated groups. 
The EROD activity was increased by 146 fold in the TCDD treated group compared to 
the corn oil and the untreated group (Table 5.6). None of the PCB treated groups reached 
similar activity levels. The EROD activity in the groups treated with Aroclor 1260 was 
significantly increased (8 fold) compared to the corn oil group and was slightly, but not 
significantly, higher than the group treated with the 0-4 ortho reconstituted PCB fraction. 
However, a 3-fold difference in EROD activity between the 0-1 ortho and the 0-4 ortho 
fraction was found, although both PCB fractions contained the same amount of dioxin-like 
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congeners. The groups treated with the 2-4 ortho fraction showed a slight, dose dependent 
increase of EROD activity which was only significantly different from the control group for 
the highest treatment dose. 
The PROD activity was significantly increased in all exposure groups compared to the 
corn oil and the untreated control group, except in the groups treated with the 0-1 ortho 
fraction and the lowest dose of the 2-4 ortho fraction (Table 5.6). An increased PROD activity 
of 4 times the control level was also measured for TCDD, which is normally not considered to 
induce CYP2B. 
Hepatic foci induction 
Altered hepatic foci (AHF) development (Table 5.6) was expressed as the number of 
foci per cm3 exceeding a cut off limit of 35 um, the mean foci volume and the volume fraction 
of the liver occupied by foci. 
All groups showed large numbers (5000-8000 foci/cm3) of GST-p positive foci in the 
liver with a significant increase in the TCDD and the 0-4 ortho PCB exposed group compared 
to the corn oil control. The number of foci in the untreated control group represents the foci 
that are found after initiation treatment only (partial hepatectomy followed by a NDEA 
injection) without further promotion treatment and therefore represents a control for the 
initiation event. 
The mean foci volume was significantly increased compared to the corn oil group in the 
groups treated with TCDD, 9 mg/kg bw/week of 2-4 ortho fraction and 9 mg/kg bw/week of 
PCB 153, the 0-4 ortho fraction and Aroclor 1260. A slight but non-significant increase was 
found in the groups treated with the lowest and the middle dose of the 2-4 ortho PCBs and 
PCB 153. No effect was found in the group treated with the 0-1 ortho fraction. The group 
treated with the reconstituted 0-4 ortho fraction showed a slight but non-significant lower 
mean foci volume compared to Aroclor 1260 treated group. 
The volume fraction of the liver occupied by GST-p positive foci (VF) is considered the 
best parameter reflecting the promoting potential of a compound (Pitot et al, 1980, 1987). 
The VF was significantly increased in most treated groups compared to the corn oil control 
and the untreated group but not in the groups treated with the lowest dose of PCB 153 and the 
0-1 ortho PCB fraction. No clear dose-response of the 2-4 ortho fraction was observed on the 
VF. However it was striking that 1 mg/kg bw/week 2-4 ortho fraction showed a statistically 
significant effect on the VF while the same concentration 0-1 ortho fraction did not. The 
highest dose of the 2-4 ortho fraction and the reconstituted 0-4 ortho fraction caused a 2.6 and 
a 3.1 fold induction respectively of the VF, whereas the concentration equivalent 0-1 ortho 
fraction caused a mere 1.3 fold induction. Again, the induction in the group treated with 
Aroclor 1260 was slightly higher compared to the 0-4 ortho fraction. PCB 153 had a similar 
effect on both the mean foci volume and the VF compared to the 2-4 ortho fraction. 
The sum of the individual effects of the 0-1 and the 2-4 ortho fraction on the mean foci 
volume and the VF was found to be equal to the effect of the 0-4 ortho fraction (Figure 5.3), 
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Aroclor 1260 
Figure 5.3 The volume fraction of the liver occupied by foci as: the sum of the individual 
0-1 ortho (upper part) and the 2-4 ortho fraction (lower part), induced by the reconstituted 
0-4 ortho fraction and induced by Aroclor 1260. 
suggesting that possibly no interactive effects occurred between the 0-1 and the 2-4 ortho 
fraction. Interestingly, the 2-4 ortho fraction contributed approximately 80% to the effect on 
the VF by the reconstituted 0-4 ortho fraction (Figure 5.3). 
Discussion 
Most studies on tumour promotion by PCBs have investigated the potency of planar, 
dioxin-like congeners, with the presumption that the Ah-receptor pathway is also involved in 
mediating the tumour promoting effects of PHAHs. In addition, in most experiments the 
tumour promotion potential of individual compounds was studied (Flodstrom and Ahlborg, 
1989; Warn et al., 1991; Hemming et al., 1993; Haag-Gronlund et al, 1997a,b) or at most 
combinations of two or three congeners (Sargent et al., 1991; Bager et al, 1995; Haag-
Gronlund et al., 1998). In this study, we have focused on complex mixtures of PCBs more 
closely resembling the mixtures present in the human diet. In a previous experiment it was 
shown that the TEF approach predicted the tumour promotion potency for a complex, dioxin-
like PHAH mixture quite well, e.g. within a factor of two (Van der Plas, et al., 1999 Chapter 
4). The major aim of this study was to determine the contribution, if any, of the 2-4 ortho 
substituted PCBs as compared to the dioxin-like, 0-1 ortho PCBs. A secondary goal was to 
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evaluate the predictability of the TEF concept for the tumour promoting potency of complex 
PHAH mixtures as surrogates for the actual mixtures present in the human diet. Separate 
fractions of 2-4 and 0-1 ortho substituted PCB mixtures were obtained by sub-fraction of the 
technical PCB mixture Aroclor 1260. 
The 2-4 ortho substituted PCB fraction induced the formation of altered hepatic foci 
(AHF) to the same extent as the reconstituted 0-4 ortho fraction and Aroclor 1260 (Table 5.6). 
Surprisingly, approximately 80% of the total tumour promoting capacity of the reconstituted 
0-4 ortho fraction, was explained by the effects induced by the 2-4 ortho PCB fraction. The 
contribution of the 0-1 ortho PCB fraction had a negligible effect on the induction of AHF. At 
the dose levels used, reconstitution of the 0-1 and the 2-4 ortho fraction into the 0-4 ortho 
mix, resulted in additive rather than interactive effects on AHF formation. This is an 
astonishing and important result, particularly because the toxicity of 2-4 ortho substituted 
PCBs is not taken into account in any kind of risk analysis of complex environmental PHAH 
mixtures. 
To analyse the tumour promoting capacity of the tested PCB mixtures, the development 
of enzyme altered, glutathione-S-transferase-p positive foci was used. Foci are commonly 
seen as an early predictor of tumour promotion. Because selective proliferation of initiated 
cells may indirectly be stimulated by cytotoxic events, it is important to consider cytotoxic 
properties of promotive substances (Butterworth et ai, 1992). In this study, no biochemical 
signs of severe liver cytotoxicity were observed in any of the exposure groups. Histopathology 
of the liver slices showed no clear signs of necrosis. Therefore, we are confident that the 
observed foci induction is due to specific interaction of the test compounds and not a result of 
an aspecific toxicological response. Furthermore, a similar histological appearance was 
observed in the 2-4 ortho treatment group as in the groups treated with Aroclor 1260 and the 
0-4 ortho fraction. The pathological changes observed in the liver tissue of the group treated 
with the 2-4 ortho fraction, were different from the changes observed in the TCDD treated 
group and resembled the morphology seen after phenobarbital treatment i.e. centrilobular 
hypertrophy and SER proliferation (Buchmann et al, 1991; Popp and Cattley, 1991). This 
supports the observation that the liver effects are mainly caused by the 2-4 ortho substituted 
PCBs in the commercial mixture. 
To be certain that the observed effect on tumour promotion of the 2-4 ortho fraction was 
really an effect of the non dioxin-like PCBs and not a result of contamination with planar 
compounds, several analyses were performed. After fractionation of Aroclor 1260 a 
qualitative GC analysis was done. On the basis of the GC chromatograms it was concluded 
that it was highly unlikely that planar compounds were present in the 2-4 ortho fraction. A 
GC-MS analysis of the Aroclor fractions was performed to quantify a selection of PCB 
congeners. No planar PCBs could be detected in the 2-4 ortho fraction. In addition to the GC-
MS analysis, the DR-CALUX assay was used to test the total dioxin-like potency of the 
Aroclor fractions. No CALUX activity was observed in the 2-4 ortho fraction, indicating the 
absence of dioxin-like compounds. Another indicator for the presence of dioxin-like 
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compounds is the EROD activity in the liver of treated animals. Although there was a 
tendency towards a dose dependent increase of EROD activity induced by the 2-4 ortho 
fraction, EROD activity levels were still below the observed activity after exposure to the 0-1 
ortho fraction. Based on the combined results of the GC and GC-MS analysis, the DR-
CALUX and EROD assay, it can be concluded that the observed effects on tumour promotion 
by the 2-4 ortho fraction can be truly attributed to the non-dioxin-like PCBs. Consequently, 
the 2-4 ortho PCBs present in the reconstituted 0-4 ortho fraction were mainly responsible for 
the effects observed. Furthermore, GC-MS analysis showed that, with the exception of PCB 
126, no planar congeners were detected in liver tissue of animals exposed to Aroclor 1260, the 
0-1 or the 0-4 ortho fraction, which also suggests a minor role for the planar PCBs on the 
induction of AHF. 
The hepatic retention (% of the given dose) was calculated based on the measured PCB 
concentrations in the Aroclor fractions and liver samples of the exposed animals. The hepatic 
retention tended to be quite low for e.g. PCB 156 (2-4 fold) but especially for PCB 126 (3-18 
fold) as compared to retention levels seen in earlier experiments reported by Hemming et al. 
(1995) and Van der Plas et al. (1998b Chapter 3). Abraham et al. (1988) described a dose-
dependent hepatic retention of TCDD, which did not change significantly between 1 and 10 
ng TCDD/kg body weight but rised sharply between doses of 10 and 300 ng TCDD/kg body 
weight. In addition a linear relationship between the TCDD liver concentration and the EROD 
induction was observed (Abraham et al, 1988). Deposition of PHAHs in the liver depends on 
the solubility of the congeners in liver fat and the induction of and/or binding to hepatic 
binding proteins (Leung et al. 1988) of which CYP1A2 is assumed to be an important 
inducible binding site in the liver for TCDD and related compounds (Kedderis et al, 1993; 
Andersen et al., 1993; DeVito et al., 1998; Diliberto et al, 1999). From the observed EROD 
induction and the GC-MS analysis of both Aroclor fractions and liver tissue it is evident that 
the animals in our study were exposed to low levels of dioxin-like PCBs. Low induction of 
hepatic binding proteins due to low exposure levels of dioxin-like PCBs might therefore 
explain the low hepatic retention of some of the PCB congeners observed in this study. 
The EROD activity in the reconstituted 0-4 ortho group was approximately twice the 
sum of the activity observed after exposure to the separate 0-1 ortho and 2-4 ortho fractions. 
This observed non-additivity might be explained by the low EROD activity induced by the 
individual 0-1 ortho and 2-4 ortho fraction, below the steep part of the dose response curve. A 
low, statistically significant EROD induction was observed in the 9 mg/kg bw/week dose of 
the 2-4 ortho fraction. However, no Ah-receptor activity in the 2-4 ortho fraction was found 
with the in vitro CALUX assay. 
An increased PROD activity was observed in the groups exposed to PCB 153, the 2-4 
ortho fraction, the reconstituted 0-4 ortho fraction and Aroclor 1260. An increase of 4 times 
the control level was also measured for TCDD, which is normally not considered to induce 
CYP2B. An increased PROD activity induced by TCDD, or PCB 126 has been reported 
before and was shown not to correspond with increased enzyme P4502B1/2 protein or mRNA 
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levels (Van Birgelen et al, 1996b; Van der Plas et al, 1999 Chapter 4; Schuur et al, 1998). 
This TCDD and PCB 126 induced PROD activity possibly reflects induction of CYP1A as 
penthoxyresorufin is also moderately metabolised by CYP1A (Burke et al, 1994). 
From these results it is clear that the 2-4 ortho substituted PCBs play an important role 
in tumour promotion by the commercial PCB mixture Aroclor 1260. This challenges the 
hypothesis that the Ah receptor route is the only mechanism involved in tumour promotion by 
PHAHs. Other mechanisms, different from the Ah receptor route may play an important role 
in the tumour promotive effects of PCBs. There are only very limited studies that focus on 
mixtures of di-tetra ortho substituted PCBs. Kihlstrom et al. (1992) studied the reproductive 
effects of Clophen A50, Aroclor 1254 and fractions of these mixtures in mink. From this 
study it was concluded that the 2-4 ortho PCBs increased the toxicity of the other fractions but 
did not show a significant activity on its own. Furthermore they suggest that from this 2-4 
ortho fraction the major methyl-sulfonyl-substituted PCBs are formed which can be very 
persistent in some wildlife animals (Bergman et al., 1992; Kihlstrom et al., 1992). 
Interestingly, some of the methyl-sulfonyl-substituted PCBs were found to inhibit the 
intercellular communication in vitro (Kato et al., 1998), which is seen as an important 
parameter for tumour promotion. Mayes et al. (1998) recently published an extensive chronic 
study on the comparative carcinogenicity of the commercial mixtures Aroclor 1016, 1242, 
1254 and 1260. They concluded that the tumour incidence differed between Aroclor mixtures 
in a manner that paralleled the differences between Aroclors in TEQs (Mayes et al,. 1998). 
Our study however suggests that the group of non-Ah-receptor agonists may contribute 
considerably to the total tumour promotion potential of PCB mixtures. Another factor of 
importance in the tumour promotion capacity of complex mixtures may be the presence of 
readily metabolising PCBs like 2,3',4,4',5,-pentachlorobiphenyl (PCB 118). However, in an 
earlier study performed by Haag-Gronlund et al. (1997a) it was shown that the highly 
metabolised PCB 118 is a very weak tumour promoter. Not much is known yet about the 
carcinogenic potency of hydroxy PCB metabolites in vivo. However, it was shown in vitro 
that several hydroxy PCB metabolites inhibit intercellular communication (De Haan et al, 
1994a). 
PCB 153 showed tumour promotion activity comparable to the 2-4 ortho fraction, 
suggesting that this congener may act as a model compound for tumour promotion of non-
dioxin-like PCBs. However, nothing is known yet about the mode of action as well as the 
similarity between the tumour promotion potential of PCB 153 and complex 2-4 ortho PCB 
mixtures with a different composition. This information may be valuable because several 
studies have been performed, using PCB 153 as a model compound for the group of non-
dioxin-like PCBs (Buchmann et al, 1986; Hemming et al., 1993; Bager et al., 1995). 
The lowest dose of the 2-4 ortho PCB fraction (1 mg/kg bw/week) used in this experiment 
showed a significant effect on the AHF development after sub-chronic exposure. In risk 
management little or no attention is paid to this category of PCBs. From GC-MS analysis of 
environmental PCB mixtures it is known that over 90% consist of 2-4 ortho substituted 
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congeners (De Boer et ai, 1992). This means that an intake of 160 ug PCBs/kg bw/day, of 
which 90% is 2-4 ortho substituted, corresponds with an intake level of 2-4 ortho PCBs found 
to be carcinogenic in this study. This is approximately 50 times the Acceptable Daily Intake 
(ADI) of 3 ug PCBs/kg bw/day. 
In conclusion, the 2-4 ortho PCBs were shown to be potent tumour promoters and were 
responsible for approximately 80% of the observed effect on foci development by the 0-4 
ortho PCBs present in Aroclor 1260. No interactive effect on tumour promotion between the 
0-1 and 2-4 ortho PCBs was observed. This study indicates that the tumour promotion 
potential of 2-4 ortho substituted PCBs is more important in the total toxicity of a complex 
PCB mixture than dioxin-like PCB congeners. This should seriously be taken into account in 
risk estimation of the tumour promotion potential of environmental mixtures of PHAHs. 
There is, however, at this moment no risk management tool (e.g. like the TEF concept for 
dioxin-like PCBs) available for these non-dioxin-like PCBs. In this study PCB 153 was 
shown to possess a similar tumour promotion activity as the 2-4 ortho fraction of Aroclor 
1260 and thus may serve as a model compound for this group of congeners. 
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Effects of sub-chronic exposure to complex mixtures of dioxin-like 
and non-dioxin-like polyhalogenated aromatic compounds on thyroid 
hormone and vitamin A levels in female Sprague-Dawley rats 
Abstract 
The aim of this study was to determine the effects of sub-chronic exposure to complex 
mixtures of polyhalogenated aromatic hydrocarbons (PHAHs) on the thyroid hormone and 
retinoid status in female Sprague-Dawley rats and to investigate the predictability of these 
effects by the toxic equivalency factor (TEF) concept. In the first experiment the focus was on 
a complex dioxin-like PHAH mixture, which covered > 90% of the total toxic equivalents 
(TEQ) present in Baltic herring. In the second experiment the contribution of non-dioxin-like 
polychlorinated biphenyls (PCBs) was investigated by testing the commercial PCB mixture 
Aroclor 1260, its 0-1 ortho and 2-4 ortho fractions and the reconstituted 0-4 ortho fraction. 
Hepatic retinoid levels were severely decreased (-70%) after treatment with the dioxin-like 
PHAH mixture, similar to the effect of a TEQ equivalent dose of 1 ug 2,3,7,8-TCDD/kg 
bw/week. However, the TEF concept failed to predict the effect on plasma retinol since a 
decrease (21%) was observed after treatment with the PHAH mixture, while an increase 
(21%) was found after treatment with TCDD. A more severe decrease of total thyroid 
hormone in plasma was observed after exposure to the PHAH mixture compared to treatment 
with TCDD (-60% vs. 38%). The discrepancy found between the predicted and observed 
effects on plasma retinol and thyroid hormone is possibly due to an additional effect of 
hydroxylated PCBs, formed from metabolisable PCBs present in the PHAH mixture. Aroclor 
1260 and its fractions did not significantly alter the retinoid and thyroid hormone status at the 
dose levels tested, indicating that in case of exposure to complex PCB mixtures at 
environmental levels, no or at best only marginal effects can be expected on the retinoid and 
thyroid hormone status. 
Based on: Van der Plas, S.A., Lutkeschipholt, I., Spenkelink, B., and Brouwer, A. (2000). Effects of 
sub-chronic exposure to complex mixtures of dioxin-like and non-dioxin-like polyhalogenated 
aromatic compounds on thyroid hormone and vitamin A levels in female Sprague-Dawley rats. 
Toxicological Sciences In press. 
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Introduction 
Polychlorinated biphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs), poly-
chlorinated dibenzofurans (PCDFs) and other polyhalogenated aromatic hydrocarbons 
(PHAHs) elicit a broad spectrum of toxic effects and biochemical changes, e.g. body weight 
loss, thymic atrophy, hepatotoxicity, carcinogenicity, induction of hepatic cytochrome P450 
isoenzymes and alterations of the retinoid status and thyroid hormone metabolism (Safe, 
1990, 1994). 
Most if not all of the toxic responses of PHAHs are suggested to be mediated by the aryl 
hydrocarbon (Ah) receptor (Ahlborg et al, 1994; Safe, 1994). The most toxic PHAH 
compounds exhibit a planar molecular conformation with lateral chlorine substitution thereby 
expressing a so-called dioxin-like toxicity. Di-ortho substituted PCBs are in general less toxic 
and due to their non-planar conformation they do not exhibit Ah-receptor agonistic activity 
but have been shown to possess a phenobarbital-like toxicity (Safe, 1994). 
In environmental matrices and biota PCBs, PCDDs and PCDFs are always present as 
complex mixtures. The toxic equivalency factor (TEF) concept has been developed to aid the 
risk assessment of complex mixtures of PHAHs. Based on in vivo and in vitro studies the 
relative toxic potencies of individual PHAHs have been determined relative to 2,3,7,8-TCDD, 
as being the most toxic congener. The TEF concept is based on the assumptions that all non-
ortho and mono-ortho chlorine substituted PCB congeners and related dibenzo-p-dioxins and 
dibenzofurans act through the Ah receptor-based mechanism of action and that the effects of 
the individual compounds in a mixture, expressed as toxic equivalencies (TEQs), are additive 
(Safe, 1990, 1994; Ahlborg et al., 1994). However, interactive effects have been observed 
between PHAHs and some non-planar di-ortho PCB congeners, or PCB mixtures (Aarts et al, 
1995; Bager et al., 1995; Biegel et al, 1989; Davis and Safe, 1989; Haag-Gronlund et al., 
1998; Sargent et al., 1991; Yao and Safe, 1989; Zhao et al, 1994). In addition, several di-
oriho PCBs have been shown to possess toxic properties both in vivo and in vitro, e.g. 
disturbance of the vitamin A and thyroid hormone status, development of altered hepatic foci 
and inhibition of intercellular communication (Van Birgelen et al, 1992; Bager et al., 1997; 
DeHaan et al, 1996). 
Several toxicity studies have been performed with complex PCB mixtures (Kimbrough 
et al., 1975; Ward 1985; Ahlborg et al., 1987; Abraham et al, 1989; Kihlstrom et al, 1992; 
Morse et al, 1996a). However, in most studies the focus was on individual PHAH congeners, 
or combinations of two or three congeners (Bager et al, 1995; Van Birgelen et al, 1994a,b; 
Haag-Gronlund et al, 1998; Sargent et al, 1991). Our major aim of this project was to 
evaluate the applicability of the TEF concept for the tumour promotion potential of complex 
environmentally relevant PHAH mixtures (Van der Plas et al. 1999 Chapter 4, 2000a Chapter 
5). In addition, the effect of sub-chronic exposure to these PHAH mixtures was determined on 
endocrine parameters, in particular on the vitamin A and thyroid hormone system. Vitamin A 
and thyroid hormone are both essential for normal tissue growth, differentiation and foetal 
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development and are possibly involved in carcinogenesis (Blomhoff, 1994; Dunn, 1989; 
Guernsey, 1993). 
Alterations in both vitamin A and thyroid hormone levels are a well known effect of 
PHAHs in rodents, following single dose, or sub-chronic treatment (Brouwer et al, 1988b; 
Chen et al, 1992; Van Birgelen et al, 1992, 1994a,b, 1995). In short, retinol and thyroxin 
(T4) were both reduced in rat plasma following exposure to metabolizable planar (PCB 77), 
mono- and di-ortho PCBs (Brouwer et al. 1988a; Morse et al 1996a). However, TCDD and 
relatively stable PCBs (PCB 126, 169, 156) were found to increase plasma retinol, while T4 
was still reduced (Van Birgelen 1994a,b, 1995). The reasons for the effects of PHAHs on 
plasma levels of retinol and T4 are partly due to a) direct effects of hydroxylated PHAH 
metabolites on the plasma transport protein complex of T4 and retinol (Brouwer and Van den 
Berg, 1986; Brouwer et al, 1988a,b) b) effects on hepatic metabolism of T4 and retinol by 
parent compounds, i.e. mainly increased T4 glucuronidation and reduced formation of retinyl 
esters and retinol metabolism (Zile, 1992; Brouwer et al, 1998b). 
In this manuscript the effects on vitamin A and thyroid hormone status in female 
Sprague Dawley rats was studied after sub-chronic exposure to complex PHAH mixtures. The 
possible interactive effects between congeners and the involvement of different mechanisms 
are discussed. Data were obtained from two independent experiments. In the first experiment 
the focus was on a complex synthetic mixture of dioxin-like, planar compounds and possible 
interactive effects with the non-dioxin-like PCB 153 (2,2',4,4',5,5'-HxCB). The composition 
of this mixture was based on the presence and relative ratio's of PHAH in fish, as being one 
of the main contributors of PHAHs to the human diet. In the second experiment the main 
focus was on complex mixtures containing only di-ortho PCBs, or planar (non- and mono-
ortho) PCBs. These mixtures were obtained by fractionation of the commercial PCB mixture 
Aroclor 1260. The planar and di-ortho PCBs were individually tested and after reconstitution. 
Materials and methods 
Chemicals 
N-nitrosodiethylamine (NDEA) was obtained from Fluka (Fluka Chemie, Buchs, 
Switzerland). 
3,3',4,4',5-Pentachlorobiphenyl (PCB 126), 2,3',4,4',5-pentachlorobiphenyl (PCB 118), 
2,3,3',4,4',5-hexachlorobiphenyl (PCB 156) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) 
were kindly provided by Prof. A. Bergman (Department of Environmental Chemistry, 
Stockholm University, Sweden). 1,2,3,7,8-Pentachlorodibenzo-jP-dioxin (PeCDD) was 
obtained from Wellington Laboratories (Canada), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) 
was a gift from Prof. S.H. Safe (College of Veterinary Physiology and Pharmacology, Texas, 
A&M University, USA) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased 
from RADIAN CIL, inc.(U.S.A.). All compounds had a purity > 99%. Aroclor 1254 and 1260 
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were kindly provided by Dr. M. Van den Berg (Research Institute of Toxicology, University 
of Utrecht, The Netherlands). 
Retinoid standards (retinol, retinyl palmitate and retinyl acetate) were all obtained from 
Fluka Chemie (Sigma-Aldrich Chemie BV, Zwijndrecht, the Netherlands). Amerlite 
chemiluminescence assay kits for thyroid hormone analysis were obtained from Ortho-clinical 
Diagnostics (Amersham, UK). 
All other compounds were of analytical grade. 
Animal experiments 
Two sub-chronic animal experiments were performed, both approved by the animal 
welfare committee before starting the experiments. The treatment protocol used for these 
experiments was based on the altered hepatic foci (AHF) tumour promotion protocol 
introduced by Pitot et al. (1978) and described in detail by Van der Plas et al. (1999 Chapter 
4, 2000a Chapter 5). In short, an initiation step, consisting of a diethylnitrosamine injection 
(i.p. 30 mg/kg body weight) 24 hours after a partial 2/3 hepatectomy, is followed by a 
promotion treatment of 20 weeks starting six weeks after the hepatectomy. 
For these experiments, juvenile female Sprague-Dawley rats (Mollegaard Breeding 
Center Ltd., Denmark) of about six weeks old at the start of the experiment were used. The 
rats were kept in wire bottom, stainless steel cages in groups of four animals under standard 
conditions (12 hr light/dark cycle, temperature 22 °C, humidity 55%) and fed ad libitum 
(pellets, Hope Farms Woerden). Test compounds were administered once a week by 
subcutaneous injections for 20 weeks in concentrations as indicated in table 6.2. A corn oil 
group (1 ml/kg body weight/week) as a negative vehicle control and a TCDD group (1 ug/kg 
body weight/week) as a positive control were incorporated in both experiments. The first dose 
was a loading dose, which was 5 times the concentration of the maintenance dose given for 
the following 19 weeks. 
One week after the last injection the animals were sacrificed under ether anaesthesia, 
using orbital puncture for blood collection (heparinised), followed by decapitation. The liver 
was collected, of which a part was stored at -80 °C for gas chromatography and mass 
spectrometry (GC-MS) analysis, a part was placed in formaldehyde and acetone fixative for 
immunohistochemistry purposes whereas the rest of the liver was homogenised on ice in a 
Potter tube with 0.01 M Tris-HCl-buffer and 0.25 M sucrose (pH 7.4). Plasma was collected 
by centrifugation of the blood at 500 g for 10 minutes. 
PHAH exposure mixtures 
Two different environmentally relevant PHAH mixtures were tested in separate sub-
chronic animal experiments in groups and concentrations as presented in table 6.1. 
The composition of the PHAH mixtures tested in experiment 1 was based on PHAH 
contamination found in Baltic herring and covered over 90% of the TEQs present in these 
fish. The PHAH mixture contained the following congeners: 2,3,7,8-TCDD, 1,2,3,7,8-
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Table 6.1 Dose levels of the PHAH mixtures and Aroclor 1260 fractions used in the animal 
studies 
Mixture 
(experiment) 
Corn oil (1&2) 
2,3,7,8-TCDD (1&2) 
PHAH+ (1) 
PHAH- (1) 
0-1 ortho fraction (2) 
2-4 ortho fraction (2) 
0-4 ortho fraction (2) 
Aroclor 1254 (1) 
Aroclor 1260 (2) 
Group size 
n 
18 
12&10 
12 
12 
10 
10 
10 
12 
10 
Dose 
/kg bw/week 
1ml 
1 "g 
1.1 mg 
2.3 mg 
4.5 mg 
1.0 mg 
1 mg 
lmg 
3mg 
9mg 
10 mg 
7.5 mg 
10 mg 
Equivalent to 
Aroclor 1260 
amount (mg) 
-
-
-
-
-
-
10 
1.1 
3.3 
10 
10 
-
10 
TEQ 
/kg bw/week 
no activity 
1 Hg 
0.5 ug" 
lug" 
2ug" 
lug" 
0.8 ng* 
no activity* 
no activity* 
no activity* 
0.8 ng* 
0.2 ngc 
1.7 ng* 
" TEQ values based on literature data (see Van der Plas et al 1999 Chapter 4).b TEQ values 
determined using the DR-CALUX assay (Van der Plas et al, 2000a Chapter 5, Chapter 2). 'TEQ 
value based on WHO TEF values (Van den Berg et al, 1998) and PCB concentrations in Aroclor 
1254 (Leonards et al, 1995). 
PeCDD, 2,3,4,7,8- PeCDF, PCB 126, PCB 118, PCB 156 and PCB 153, in relative ratios as 
indicated in table 6.2. In order to investigate possible interactive effects between planar and 
non-planar congeners, the mixture was also tested without the non-dioxin-like PCB 153. The 
PHAH mixture containing solely dioxin-like PHAHs is referred to as PHAH-, the mixture 
including PCB 153 is referred to as PHAH+. A more detailed description of the mixture 
preparation and the experimental set up is given in Van der Plas et al. (1999 Chapter 4). In 
addition to the PHAH mixtures, the commercial PCB mixture Aroclor 1254 was tested. 
Calculation of the TEQs of the PHAH mixtures was based on TEF values as proposed by the 
WHO (Ahlborg et al, 1994) and relative potency (REP) values obtained from tumour 
promotion studies (Waern et al, 1991; Hemming et al, 1993, 1995). 
In experiment 2. the focus was on the non-dioxin-like di- to tetm-ortho substituted 
PCBs. For that purpose the commercial PCB mixture Aroclor 1260 was chosen as the 
experimental mixture, since approximately 90% of Aroclor 1260 consists of non-dioxin-like 
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Table 6.2 Congener composition of the PHAH mixtures of experiment 1 
Congener 
2,3,7,8-TCDD 
1,2,3,7,8-PeCDD 
2,3,4,7,8-PeCDF 
PCB 126 
PCB118 
PCB 156 
PCB 153 
Relative level (weight base); 
PHAH- mixture 
-PCB 153 
1 
3.3 
17 
61 
12800 
1888 
-
PHAH+ mixture 
+ PCB 153 
1 
3.3 
17 
61 
12800 
1888 
20000 
The composition of the mixtures is based on Swedish herring oil and covers over 90% of the TEQs in 
Swedish herring. 
congeners. Aroclor 1260 was fractionated into a 0-1 ortho dioxin-like fraction (-9.7 % of the 
total mass) containing mainly 0 and l-ortho substituted PCBs and a trace ofl-ortho PCBs, 
and a 2-4 ortho non-dioxin-like fraction (-90% of the total mass). This was done according to 
a method described by Athanasiadou et al. (1991) with slight modifications described in more 
detail by Van der Plas et al. (2000a Chapter 5). The 0-1 ortho fraction and the 2-4 ortho 
fraction were tested separately and as a reconstituted 0-4 ortho mixture. Aroclor 1260 and 
PCB 153 were incorporated as an extra positive control and a model compound for the di-
ortho PCBs respectively. The composition of PCB congeners in the various fractions was 
tested by GC-MS analysis and confirmed that no 2-4 ortho PCBs were present in the 0-1 
ortho fraction (Van der Plas et al., 2000a Chapter 5). The TEQs of the Aroclor 1260 fractions 
were determined using the DR-CALUX bio-assay (Van der Plas et al., 2000a Chapter 5). 
Vitamin A analysis 
Retinol levels were measured in plasma and retinol and retinyl palmitate levels in liver 
homogenates according to Brouwer et al. (1989) with some modifications. Plasma, or liver 
homogenate (50 ui) was extracted with methanol containing a 0.1% BHT as an anti oxidant 
and an internal standard (0.5 ug retinyl acetate/ml for plasma, 1 u.g retinyl acetate/ml for liver 
homogenate), and diisopropyl ether in a 1:1:2 concentration. Samples were vortexed for 30 
sec, kept overnight at -20 °C, vortexed again and centrifuged for 10 minutes at 5000 rpm in 
an eppendorf centrifuge. The diisopropyl-ether phase was collected and filtered over a 0.45 
um filter (Millipore, Etten Leur, The Netherlands) evaporated under N2 and resuspended in 50 
ul methanol (plasma extracts) or 200 ul 1:3 ethylacetate/methanol (liver extracts) with 0.1% 
BHT. Extractions were carried out in duplicate. Extraction efficiencies were routinely above 
80%. Twenty ul aliquots of resuspended extracts were analysed with HPLC using a C18 
analytical reversed phase column (Pecosphere, 3 um particle size, 3.3 cm length and 4.6 mm 
104 
Effects of exposure to complex PHAH mixtures on thyroid hormone and vitamin A levels 
internal diameter, Perkin Elmer) and a wavelength of 326 nm for detection of retinoids. A 
Merck-Hitachi HPLC system was used consisting a L-6200 Intelligent pump, L-4200 UV-VIS 
detector, AS-2000 Autosampler and a D-2500 Chromato Integrator. Plasma extracts were 
analysed isocratically with 86% methanol and 14% water with a flow rate of 1 ml/min and 
data collection for 10 minutes. Hepatic retinoids were analysed by 86% methanol and 14% 
water for 1.5 minutes, followed by a gradient to 100% methanol for 2.5 minutes, and 
subsequent elution of the retinyl esters for 12 minutes. The column was then re-equilibrated at 
86% methanol and 14% water for 6 minutes. 
Plasma thyroid hormone analysis 
Total thyroxin (TT4), total triiodothyronine (T3) and free thyroxin (FT4) levels were 
determined in plasma using commercially available chemiluminescence kits, according to the 
protocol of the supplier with the following modifications: the T4 assay buffer was diluted 5 
times in demineralised water. The standard curve for TT4 ranged from 0-120 nmol/liter, for 
T3 from 0-6 nmol/liter and for FT4 from 0-106 pmol/liter. Thyroid hormone levels were 
calculated from the luminescence data with the Elia-Securia II software program of Canberra 
Packerd. 
Statistical analysis 
Data were analysed with the statistical package SPSS-PC 7.5. A Tukey's Honestly 
Significant Difference test was used to perform a multiple comparison on statistical 
differences between groups. 
Results 
Vitamin A levels 
Experiment 1 (Table 6.3): Plasma retinol levels were significantly increased by 21% in 
the TCDD treatment group compared to the corn oil group. In contrast, significantly decreased 
plasma retinol levels were observed for all dioxin-like PHAH mixture groups as well as for 
Aroclor 1254. A dose dependent decrease up to 32% reduction was observed in the groups 
treated with the PHAH+ mixture. The largest decrease in plasma retinol was found after 
treatment with Aroclor 1254 (38%), which is interesting since in this group no significant 
effects were observed on the hepatic retinyl palmitate levels. In all other treatment groups, 
hepatic retinyl palmitate levels were strongly decreased (60 to 80%) as compared to the corn 
oil control group. The lowest dose of the PHAH+ mixture, 0.5 |ig TEQ/kg/week, still gave 
rise to significant plasma retinol and in particular hepatic retinyl palmitate reductions, 
indicating that this is a very sensitive response of the PHAH mixture. 
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Table 6.3 Retinoid levels in plasma and liver tissue of female Sprague-Dawley rats following 
sub-chronic exposure to dioxin-like PHAHs (Experiment 1) 
Treatment 
dose/kg bw/week 
Corn oil 
TCDD 
1ml 
1 Hg 
Aroclor 1254 7.5 mg 
PHAH-
PHAH+ 
PHAH+ 
PHAH+ 
lugTEQ 
0.5 ug TEQ 
1 Ug TEQ 
2ugTEQ 
Retinol 
in plasma 
(ng/ml) 
172.3 ±6.8* 
208.3 ± 12.4" 
106.8 ± 5.5"-6 
124.3 ± 6.5ab 
155.9 ±8.1* 
136.6 ± 11.2a-b 
117.1 ±9.2° 
Retinol 
in liver tissue 
(ug/g liver) 
4.75 ± 0.33 
3.63 ± 0.44 
5.67 ±0.55 
3.37 ±0.32 
4.06 ± 0.43 
4.04 ± 0.87 
3.50 ±0.40 
Retinyl 
palmitate 
in liver tissue 
(ug/g liver) 
1402.8 ±43.6* 
357.4 ±17.7" 
1258.4 ±51.7* 
471.6 ±20.8"'' 
569.9 ± 37.4° 
436.9 ±16.1a6 
303.4 ±16.2°'' 
Retinol/Retinyl 
Palmitate 
(ug/mg) 
3.5 ±0.3 
10.4 ±1.4 
4.8 ±0.5 
7.3 ± 0.7 
7.4 ± 0.9 
9.1 ±1.8 
11.5 ± 1.0 
Data are given as arithmetic mean ± the standard error. Doses are given per kg bodyweight per week. 
" Significantly different from the corn oil group (p<0.05 Tukey HSD test).b Significantly different 
from the TCDD group (p<0.05 Tukey HSD test). 
Table 6.5 Thyroid hormone levels in plasma of female Sprague-Dawley rats following sub-
chronic exposure to dioxin-like PHAHs (Experiment 1) 
Treatment 
dose/kg bw/week 
Corn oil 
TCDD 
1ml 
1 Ug 
Aroclor 1254 7.5 mg 
PHAH-
PHAH+ 
PHAH+ 
PHAH+ 
lugTEQ 
0.5 ug TEQ 
1 Ug TEQ 
2 ug TEQ 
Total T3 
in plasma 
(nmol/1) 
1.56 ±0.07 
1.46 ±0.09 
1.37 ±0.09 
1.40 ±0.07 
1.22 ±0.09 
1.32± 0.11 
1.18 ± 0.11 
Total T4 
in plasma 
(nmol/1) 
34.39 ±1.52' 
21.46 ±1.34° 
19.96 ±1.75" 
15.71 ±1.22" 
15.50 ±1.67" 
11.73 ±1.32"'* 
8.28±0.81a* 
Free T4 
in plasma 
(pmol/1) 
13.75 ±0.89* 
8.80 ± 0.60" 
12.33 ±1.07 
10.24 ±0.76 
8.31 ±0.93" 
8.14 ±0.91° 
7.34 ± 0.64" 
Total T4 
/Free T4 
(nmol/pmol) 
2.6 ±0.11 
2.5 ±0.15 
1.6 ±0.05"* 
1.5±0.06"-4 
1.9 ± 0.10"* 
1.5±0.06ai 
1.1 ± 0.08"4 
Data are given as arithmetic mean ± the standard error. Doses are given per kg bodyweight per week. 
" Significantly different from the corn oil group (p<0.05 Tukey HSD test). ' Significantly different 
from the TCDD group (p<0.05 Tukey HSD test). 
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Table 6.4 Retinoid levels in plasma and liver tissue of female Sprague-Dawley rats following 
sub-chronic exposure to non-dioxin and dioxin-like fractions of Aroclor 1260 (Experiment 2) 
Treatment 
dose/kg bw/week 
Untreated 
Corn oil 
TCDD 
Aroclor 1260 
0-4 ortho 
0-1 ortho 
2-4 ortho 
2-4 ortho 
2-4 ortho 
PCB 153 
PCB 153 
-
1ml 
1 fig 
10 mg 
10 mg 
1 mg 
lmg 
3mg 
9mg 
1 mg 
9mg 
Retinol 
in plasma 
(ng/ml) 
176.6 ±6.9 
171.7 ±6.6 
223.1 ±16.0" 
162.1 ±6.6 
167.0 ±6.3 
143.4 ±9.9 
177.3 ±11.8 
168.3 ±12.7 
174.0 ±11.0 
168.4 ±8.6 
184.6 ±12.6 
Retinol 
in liver tissue 
(ug/g liver) 
8.22 ± 0.86 
7.37 ±0.73 
4.05 ± 0.39a 
4.65 ±0.31 
5.73 ± 0.68 
6.72 ± 0.76 
5.58 ±0.72 
4.59 ± 0.43 
5.14 ±0.58 
6.04 ± 0.85 
4.56 ±0.71 
Retinyl 
palmitate 
in liver tissue 
(ug/g liver) 
2052.3 ±111.3 
1733.1 ±70.4 
474.5 ± 32.0" 
1280.8 ± 46.3° 
1400.0 ±62.3 
1731.5 ±175.7 
1688.6 ±71.9 
1529.2 ±64.3 
1476.1 ±66.9 
1770.4 ±89.8 
1233.9 ± 77.0" 
Retinol/Retinyl 
Palmitate 
(lig/nig) 
4.0 ±0.3 
4.2 ±0.4 
9.1 ±1.3" 
3.7 ±0.3 
4.1 ±0.5 
4.1 ±0.6 
3.3 ±0.4 
3.0 ±0.2 
3.5 ±0.4 
3.4 ±0.4 
3.6 ±0.5 
Data are given as arithmetic mean ± the standard error. Doses are given per kg bodyweight per week. 
2-4 ortho = 2-4 ortho substituted PCB fraction of Aroclor 1260; 0-1 ortho = 0-1 ortho substituted 
PCB fraction of Aroclor 1260 with a trace of 2 ortho substituted PCBs; 0-4 ortho = the reconstituted 
mixture of the 2-4 and the 0-1 ortho fraction." Significantly different from the corn oil group (p<0.05 
Tukey HSD test). 
Retinol levels in the liver were not affected in the PHAH treatment groups compared to the 
corn oil group. As a consequence the retinol/retinyl palmitate ratios were increased in all 
treatment groups as compared to corn oil controls. 
Experiment 2 (Table 6.4): Similar to results from the first experiment, the plasma retinol 
level was significantly increased in the TCDD treatment group, by 30%, compared to the corn 
oil control group. However, no significant changes in plasma retinol levels were observed 
after exposure to any of the PCB fractions, Aroclor 1260 or PCB 153. Hepatic retinoid levels 
in the corn oil group were slightly, but non-significantly lower compared to the untreated 
control group. Analysis of the hepatic ethoxyresorufin-O-deethylase activity (Van der Plas et 
ah, 2000a Chapter 5) and luciferase induction by hepatic microsomes (unpublished results) in 
the AhR-dependent H4IIE-Luc reporter gene (DR-CALUX) assay did not indicate that this 
may be due to a PHAH contamination of the corn oil. Therefore it is concluded that the 
observed difference between the untreated and the corn oil group in hepatic retinoid levels is 
more likely related to the treatment procedure. In the group treated with TCDD the hepatic 
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retinyl palmitate level was significantly decreased to 55% of the corn oil control group. 
Aroclor 1260 and PCB 153, 9 mg/kg bw/week, also significantly decreased the hepatic retinyl 
palmitate levels to 62% of the corn oil group. The Aroclor 1260 fractions and PCB 153, 1 
mg/kg bw/week, did not affect retinyl palmitate levels in the liver significantly, although there 
was a tendency for a dose-dependent reduction in the 2-4 ortho fraction. Retinol levels in the 
liver after PCB exposure were all non-significantly decreased compared to the corn oil 
control. Except for TCDD, none of the PHAH compounds changed the hepatic retinol/retinyl 
palmitate ratio. 
Thyroid hormone levels 
Experiment 1 (Table 6.5): A small statistically non-significant decrease was observed in 
the total plasma T3 levels after PHAH treatment compared to the corn oil control. However, 
plasma total and free T4 levels were decreased in most PHAH treatment groups. A dose 
dependent decrease of the total T4 levels compared to the corn oil group was observed after 
treatment with different doses of the PHAH+ mixture up to 76% reduction in the highest dose 
of 2 ug TEQ/kg bw/week. At the lowest dose of 0.5 ug TEQ/kg bw/week of the PHAH+ 
mixture the plasma total T4 levels was still reduced by >50% as compared to corn oil 
controls. The total T4 level was much less reduced, 38%, after exposure to 1 ug/kg bw/week 
TCDD as compared to the TEQ equivalent dose of the PHAH+ mixture. Free T4 levels were 
decreased in all treatment groups but the ratio of total T4 over free T4 (illustrating the effect 
on the T4 fraction bound to its transport protein TTR) differed between the treatment groups. 
The total T4/free T4 ratio was not changed in the TCDD exposure group compared to the corn 
oil control. However a dose-dependent decrease of the total T4/free T4 ratio was observed for 
the PHAH mixture groups. Although the PHAH- and PHAH+ groups at 1 ug TEQ/kg 
bw/week are equipotent in theory, the effects on T3 and T4 levels were stronger in the latter. 
Experiment 2 (data not shown): No changes were found in thyroid hormone levels after 
exposure to Aroclor 1260, any of its fractions or PCB 153. A slight, non-significant decrease 
in total T4 was observed after treatment with TCDD. The total T4/free T4 ratio was 
significantly decreased (24%) after treatment with the 0-4 ortho fraction. 
Discussion 
The effects on endocrine parameters, i.e. thyroid hormone and retinoid status, by 
complex mixtures of PHAHs are part of a larger study aimed at investigating the predictability 
of sub-chronic effects, as tumour promotion and biochemical effects, by the toxic equivalency 
factor (TEF) concept. The focus in this paper is on the impact of dioxin-like and non-dioxin-
like PHAH mixtures on thyroid hormone and retinoid levels in plasma and liver. Both 
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parameters have been suggested to be implicated in the expression of sub-chronic effects, 
such as tumor promotion and, reproductive and developmental effects. Till now, much 
research has been performed on studying mainly short-term effects of individual congeners of 
PCBs and dioxins on vitamin A and thyroid hormone metabolism. Here, the impact of 
complex PHAH mixtures following sub-chronic exposure is discussed and attention is given 
to the contribution of strictly dioxin-like and non-dioxin-like PCB congeners, the involvement 
of different mechanisms and the predictive value of the TEF concept. 
Effects on hepatic retinoids 
A statistically significant decrease of the retinyl palmitate but not of the hepatic retinol 
levels was observed after treatment with TCDD (experiment 1), the PHAH+ and the PHAH-
mixture, PCB 153 and the commercial PCB mixture Aroclor 1260. In experiment 2, TCDD 
decreased both hepatic retinol and retinyl palmitate. The effects of TCDD on vitamin A status 
have been extensively studied in many species and have been shown to alter the vitamin A 
status in all species examined so far (Zile, 1992). A severe decrease of the hepatic vitamin A 
levels was also observed after exposure to e.g. PCB 77 (Brouwer and Van den Berg, 1986; 
Chen et al, 1992), PCB 126 (Chen et al, 1992; Van Birgelen et al, 1994b), PCB 156 (Van 
Birgelen et al, 1994a), and to a lesser extent after treatment with e.g. PCB 153 (Van Birgelen 
et al, 1992) and Aroclor 1254 (Morse and Brouwer, 1995). The decrease of hepatic retinyl 
ester levels induced by TCDD and related PHAHs, may be due to a combination of increased 
mobilisation of hepatic stores of vitamin A and inhibition of the storage of newly ingested 
vitamin A in the liver (Hakansson and Ahlborg, 1985; Hakansson et al, 1988; Zile, 1992; 
Kelley et al, 1998). TCDD was found to severely decrease the lecithin:retinol acyltransferase 
(LRAT) activity in the hepatic stellate cells (Nilsson et al, 1996), an enzyme involved in the 
conversion of retinol into retinyl esters. Increased mobilisation of hepatic retinyl esters could 
be the result of a direct effect of TCDD on hepatic enzyme activities or by an up regulation of 
a signal controlling release of vitamin A stores into circulation (Zile, 1992; Kelley et al, 
1998). 
The decrease of the hepatic retinyl palmitate concentration appeared to be a rather 
sensitive effect of PHAH exposure. Even at the lowest dose of 0.5 ug TEQ/kg bw/week of the 
PHAH+ mixture, equivalent to -70 ng TEQ/kg bw/day, a reduction of 60% of the hepatic 
retinyl palmitate level was found. In addition, the effect of the dioxin-like PHAH mixtures 
appeared to be quite well predicted by the TEF concept, i.e. an almost equal decrease of 
hepatic retinyl palmitate levels was observed after treatment with TEQ equivalent doses of 
PHAH mixture and TCDD (68% vs. 75%). The effect of the PHAH+ mixture on the hepatic 
retinoid level is within the same range as observed for the TEQ equivalent dose of the PHAH-
mixture, whereas both mixtures have a slightly, but significant, smaller effect on the hepatic 
retinoid level as compared to the equipotent TCDD group. The Lowest Observed Adverse 
Effect Level (LOAEL) for the PHAH mixtures from this study is close to the Lowest 
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Observed Adverse Effect Level (LOAEL) of 14 ng TEQ/kg bw/day of TCDD reported by Van 
Birgelen et al. (1995). In contrast to the PHAH mixtures, Aroclor 1254 (estimated dose 0.2 ug 
TEQ/kg bw/week) induced only a slight decrease of the hepatic retinyl palmitate level as 
compared to the corn oil group. A possible explanation might be that PCB 118 and PCB 156 
are the main contributors (-60%) to the TEQ value of Aroclor 1254 (Leonards et al, 1995), 
while for the TEQ of the PHAH mixtures these congeners are only of minor importance 
(14%). Hakansson et al. (1994) reported that PCB 118 had no effect on the hepatic vitamin A 
content at dietary levels up to 2000 ug/kg. Also for exposure to PCB 156 the loss of hepatic 
retinoids was shown to be a less sensitive parameter than for instance reduction of plasma T4 
or CYP1A2 induction (Van Birgelen et al, 1994a). 
Aroclor 1260 reduced the hepatic retinyl palmitate concentration by 30% compared to 
the corn oil control, while its 0-4 ortho PCB fraction decreased the retinyl palmitate levels, 
non-significantly, by 20%. The most likely explanation for this difference in effect is the loss 
of impurities, i.e. PCDFs, during the fractionation of Aroclor 1260 (Athanasiadou et al, 
1991). In fact, a slightly lower ethoxyresorufin-O-deethylase (EROD) activity was observed 
after exposure to the 0-4 ortho PCB fraction as compared to Aroclor 1260 (Van der Plas et al 
2000a Chapter 5), which underscores the former explanation. 
The effect of the 2-4 ortho PCB fraction on the hepatic retinoid concentration was 
somewhat lower but close to the effect of the di-ortho PCB 153. PCB 153 is one of the 
dominant di-ortho congeners in environmental PHAH mixtures and is often used as a 
representative for the group of 2-4 ortho PCBs. In this study a statistically significant effect of 
PCB 153 on the retinoid levels in the liver was observed at the highest dose of 9 mg/kg 
bw/week (-1.2 mg/kg bw/day). This is in agreement with the results of a 13 week feeding 
study in female rat, in which PCB 153 was shown to decrease the hepatic retinoid level from 
10 ppm (-0.72 mg/kg bw/day) onwards (Van Birgelen et al, 1992). Since the toxicity of di-
ortho PCBs is not mediated by the Ah receptor, no TEF values are available and consequently 
risk assessment is not possible for this category of PCBs. However, the observed effects on 
the hepatic retinoid level occurred at very high doses and it is not likely that the non-dioxin-
like PCBs will effect retinoid status at environmental exposure levels. 
Effects on plasma retinol 
The plasma retinol level was increased after TCDD exposure in both experiments, 
compared to the corn oil control. In rat, an increase of plasma retinol after TCDD treatment 
has been reported before (Hakansson et al, 1988; Van Birgelen et al, 1992, 1994a,b, 1995; 
Kelley et al. 1998) and a similar effect was seen after exposure to 3,3',4,4',5,5'-
hexachlorobiphenyl (PCB 169) or 2,3,3',4,4',5-hexachlorobiphenyl (PCB 156) (Chen et al, 
1992; Van Birgelen et al, 1994). An increase of the plasma retinol level after PHAH exposure 
may be the result of an enhanced mobilisation of hepatic vitamin A (Zile, 1992). However, the 
mechanism by which hepatic mobilisation of retinol is increased is still unknown, as TCDD 
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and related compounds either inhibit or have no effect on the activity of hepatic retinyl ester 
hydrolase (REH) (Chen et al, 1992). 
In contrast to the TCDD treatment groups, a decrease of the plasma retinol levels was 
observed in the animals treated with the PHAH mixtures and Aroclor 1254. A decrease of 
plasma retinol levels was also reported after exposure to e.g. 3,3',4,4'-TCB (PCB 77), 
2',3,3',4,5-PeCB (PCB 122), 3,3',4,4',5-PeCB (PCB 126), 2,2',3,3',5,5'-HxCB (PCB 133) and 
the commercial PCB mixture Aroclor 1254 (Brouwer and Van den Berg, 1986; Chen et al, 
1992; Morse et al, 1996a). It has been suggested that a decrease in plasma retinol levels, as 
seen after exposure to the PHAH mixtures, may be caused by a decrease of hepatic REH 
activity, involved in the mobilisation of hepatic vitamin A stores (Zile, 1992). However, such 
a decrease of the REH activity by PHAHs has not been observed before. 
Another mechanistic explanation for a decrease of plasma retinol concentrations by 
PHAHs has been reported by Brouwer et al. (1988a). The 4-hydroxy metabolite of PCB 77 
was found to displace thyroxin (T4) from its transport protein transthyretin (TTR), leading to 
a destabilisation of the RBP-TTR complex and subsequently to a decrease in plasma retinol 
and thyroxin concentrations (Brouwer and Van den Berg, 1986; Brouwer et al., 1988a). A 
number of other hydroxylated PHAHs were found to possess a high binding affinity for TTR 
as well, including hydroxylated PCBs likely to be formed of congeners which are present in 
Aroclor 1254 and/or the PHAH mixtures, i.e., PCB 105 (2,3,3',4,4-PeCB), 118, 126 and 156, 
(Lans et al., 1993, 1995a; Bergman et al. 1994; Brouwer et al, 1998b). Disruption of plasma 
transport of retinol and thyroxin does not play a role in the case of TCDD exposure because 
only low amounts of hydroxy-metabolites are formed from TCDD in vivo (Lans et al, 1995b). 
From the data presented here it became clear that there was no correlation between the 
exposure in TEQs and the effect on plasma retinol. It is therefore concluded that the TEF 
approach is not applicable to the prediction of effects on plasma retinol levels after exposure 
to complex PHAH mixtures. 
Effects on plasma thyroid hormone 
The plasma T3 concentrations were not significantly decreased after PHAH treatment 
compared to the corn oil control. However, severe reductions in both plasma TT4 and FT4 
levels were observed. This phenomenon is in accordance with other reports on effects of 
PHAHs on thyroid hormones (Van Birgelen et al, 1992, 1994a,b; Lans et al. 1995a). 
Interestingly, the decrease of the TT4 levels in the PHAH mixture and the Aroclor 1254 
treatment groups was considerably stronger compared to the effect observed in the TEQ 
equivalent TCDD group, while less or equal effects were observed for free T4. Consequently, 
in the Aroclor 1254 and the PHAH groups the TT4/FT4 ratio was decreased as compared to 
both the TCDD and the corn oil group. This indicates a lower proportion of protein bound T4 
after exposure to Aroclor 1254 or the PHAH mixtures, which is in line with a disturbance of 
the plasma protein transport system of T4 due to T4-TTR binding competition by 
hydroxylated PCB metabolites (Brouwer et al, 1998b). Lans et al. (1995a) demonstrated that 
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in the blood of rats exposed to a single dose of Aroclor 1254, the hydroxylated PCB 
metabolite 4-OH-2,3,3',4'5-PeCB competitively inhibited T4 binding to TTR. It might be 
concluded that the TEF concept failed in its prediction for the effect of PHAH exposure on the 
thyroid hormone status, since the TEF concept does not account for additional toxicity of 
hydroxylated PCBs as possibly observed here. 
In the PHAH+ group the TT4/FT4 ratio was similar to the TEQ equivalent dosed 
PHAH- group, but the absolute decrease of the TT4 and FT4 concentrations was stronger in 
the first. This is probably an indirect effect of the non-dioxin-like PCB 153, which was added 
to the PHAH+ mixture. PCB 153 was shown to increase the hepatic deposition of all dioxin-
like congeners, which resulted in an increased internal exposure (Van der Plas et al, 1998b 
Chapter 3, 1999 Chapter 4) and possibly enhancement of hepatic T4 glucuronidation. A 
direct effect of PCB 153 on hepatic T4 glucuronidation was considered less likely since the 
amount of PCB 153 in the PHAH mixture was below the concentration where effects of PCB 
153 on the thyroid hormone status might be expected (see experiment 2; Van Birgelen et al, 
1992). 
In the second experiment no statistically significant effects on the thyroid hormone 
levels were observed, except for a decrease of the total T4/free T4 ratio after treatment with 
the reconstituted 0-4 ortho PCB fraction and a minor non-significantly, decrease of the total 
T4/free T4 ratio after treatment with Aroclor 1260. Van der Plas et al. (2000a Chapter 5) 
reported a seven to eight fold increase of the EROD induction after treatment with the 0-4 
ortho fraction and Aroclor 1260. Although the EROD activity observed after treatment with 
the 0-4 ortho fraction and Aroclor 1260 is relatively low as compared to the more than 100 
times increase which can be observed after treatment with TCDD, the CYP1A induction 
might be high enough to stimulate formation of hydroxylated PCBs. Based on the exposure in 
TEQs of the 0-4 ortho fraction and Aroclor 1260 (see Table 6.2), no effects were expected 
since a NOEL of TCDD for decreasing plasma TT4 levels was estimated on 26 ng/kg bw/day 
(Van Birgelen et al, 1995). 
On the basis of these studies it was concluded that the effect of complex PHAH 
mixtures on hepatic retinyl palmitate was quite well predictable by the TEF concept. 
However, the TEF concept failed in its prediction for the effects on plasma retinol and 
underestimated the effect on plasma thyroid hormone concentrations, possibly because the 
additional toxicity by hydroxylated PCBs is not taken into account. Treatment with the 0-4 
ortho fraction at a TEQ level more than 100 times below the NOEL for TCDD (estimated by 
Van Birgelen et al, 1995) still induced a significant decrease of the total T4/free T4 ratio. The 
non-dioxin-like PCBs did not significantly alter the retinoid and thyroid hormone status at the 
dose levels tested, indicating that in case of exposure to these PCBs at environmental levels, 
no or at best only marginal effects can be expected on the retinoid and thyroid hormone status. 
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Summary 
The aim of the project described in this thesis consisted of two main objectives, first, to 
examine the tumour promotion potential of complex, environmentally relevant mixtures of 
polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs) and 
polychlorinated dibenzo-p-furans (PCDFs) and secondly, to evaluate the applicability of the 
Toxic Equivalency Factor (TEF) concept for the tumour promotion potential of complex 
mixtures of PCBs, PCDDs and PCDFs. In addition, the effect of sub-chronic exposure to 
these complex mixtures was determined on endocrine parameters, i.e. the vitamin A and 
thyroid hormone status, which play an essential role in normal tissue growth and fetal 
development and are possibly involved in the process of carcinogenesis. 
Carcinogenicity is one of the toxic endpoints in risk assessment of PCBs, PCDDs and 
PCDFs (WHO, 1992). PCBs, PCDDs and PCDFs are considered as tumour promoters rather 
than as initiators of carcinogenicity (Safe, 1989; Silberhorn et al, 1990; Whysner and 
Williams, 1996). So far, most studies on tumour promotion by PCBs have investigated the 
potency of single, mostly planar dioxin-like congeners, based on the presumption that the Ah-
receptor pathway is also involved in mediating the tumour promoting effects of PHAHs (Safe, 
1989; Silberhorn et al, 1990). There is much less information available on the tumour 
promoting effects of complex mixtures of PHAHs after sub-chronic exposure. 
The approach in this thesis was to focus on mixtures of polyhalogenated hydrocarbons 
(PHAHs), both dioxin-like and non-dioxin-like, relevant for the human intake. To reveal 
underlying mechanisms of possible interactions between PHAH congeners and to determine 
the toxic potential of the PHAH mixtures, the ethoxyresorufin-O-deethylase (EROD) and the 
AhR-dependent luciferase reporter gene (DR-CALUX) bio-assays were performed. Both 
assays are indicators for an Ah receptor mediated, dioxin-like toxicity. The tumour promotion 
potential of complex PHAH mixtures in vivo, was studied in female Sprague Dawley rats, 
using the development of altered hepatic foci (AHF) as a parameter in a two-stage 
initiation/promotion bio-assay introduced by Pitot et al. (1978). 
Chapter 2 
In chapter 2, the results of in vitro experiments are described. Interactions between 
individual mono- or di-ortho PCB congeners and 2,3,7,8-TCDD were studied in the EROD 
and the DR-CALUX bio-assay, using mouse and rat hepatoma cell lines. In addition, the 
dioxin-like potential of the PHAH mixtures, designed for the animal experiments, and 
possible interactions between congeners within the mixtures, was determined in the CALUX 
assay. Preliminary data are presented on the inhibition of the gap junctional intercellular 
communication (GJIC), which is seen as an in vitro parameter for tumour promotion, by the 
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PHAH mixtures. 
When individually dosed, the mono-ortho PCBs induced both the EROD and CALUX 
activity but to a lower maximum and at higher concentrations as compared to TCDD. Co-
administration of mono-ortho PCBs and TCDD, decreased the TCDD induced EROD and 
CALUX activity dose-dependently, with increasing concentrations of the partially antagonistic 
mono-ortho PCBs. The residual level of the EROD and CALUX induction in case of co-
administration, was equal to the maximum inducible activity level of the individual mono-
ortho PCB congener. None of the tested di-ortho PCBs was capable of inducing the EROD or 
CALUX activity. However, all di-ortho PCBs antagonised the TCDD-induced EROD and 
CALUX activity in a dose-dependent manner and with different potencies. A couple of 
combined exposures were tested for the inhibition of the GJIC. The results indicated that 
similar non-additive interactions, as observed in the EROD and CALUX assay, were seen 
here. 
The PHAH mixtures designed for the first animal experiment (Chapter 3,4), induced the 
CALUX activity up to the maximum activity level as induced by TCDD. These PHAH 
mixtures were also potent inhibitors of the GJIC. No interactions between individual 
congeners in the PHAH mixture could be observed, neither in the CALUX assay or on the 
inhibiton of the GJIC. Interactive effects were shown in the CALUX assay between the PCB 
fractions designed for the second animal experiment {Chapter 5). The 0- ortho and the 1-
ortho substituted PCB fraction induced the CALUX activity up to 40% and 9% of the 
maximum level induced by TCDD respectively, while the 2-4 ortho fraction did not show any 
induction of the CALUX activity. Co-administration of the fractions inhibited the CALUX 
activity down to 3% of the maximum level induced by TCDD. The GJIC was only slightly 
inhibited by the 2-4 ortho and the reconstituted 0-4 ortho fractions. 
Chapter 3&4 
In the first animal experiment (Chapter 3,4), the development of AHF by a complex 
synthetic mixture of dioxin-like compounds was studied. The composition of this mixture was 
based on the presence of and relative ratio's between the six most relevant PHAHs in Baltic 
herring and covered over 90% of the TEQs present. To study possible interactive effects, PCB 
153 (2,2',4,4',5,5'-HxCB) was added to the mixture as a representative of the non-dioxin-like, 
di-ortho substituted PCBs. 
In chapter 3, the toxicokinetic properties of the PHAH congeners are presented. Gas-
chromatography and mass-spectrometry (GC-MS) analysis of PHAH concentrations in the 
liver showed considerable differences in hepatic retention (as percentage of the given dose) 
between congeners, thereby changing the relative ratios of congeners between external and 
target dose in favor of the planar compounds. Further, it was shown that addition of PCB 153 
to the PHAH mixture increased the hepatic retention of all dioxin-like PHAH congeners in the 
mixture. This observation is explained by the capacity of PCB 153 to induce Ah receptor 
levels in the liver, and consequently increase the hepatic level of CYP1A2, which is known to 
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possess a high binding affinity for planar PHAHs. 
In chapter 4, the AHF data are shown. The promotion of AHF was significantly 
increased after exposure to the PHAH mixtures, but to a lower extent than expected on the 
basis of the TEQs calculated from the TEF values as proposed by the WHO (Ahlborg et al., 
1994). A difference between the WHO TEF values (Ahlborg et al, 1994) used for the 
calculation of the TEQ of the PHAH mixture, and the relative potency (REP) values of the 
individual congeners that are actually based on AHF data, may partly explain the observed 
differences in AHF induction between the rats exposed to the equipotent doses of TCDD and 
the PHAH mixtures. In addition, differences in toxicokinetic properties of the congeners and 
interactive effects on deposition of the congeners (Chapter 3) may have influenced the 
predicted toxic potency of the PHAH mixture as well. No interactive effects of PCB 153 on 
the AHF development or EROD induction could be observed. 
It is concluded that the TEF approach predicted the tumour promotion potency of the 
investigated PHAH mixtures quite well, within a factor of two. An interactive effect between 
PCB 153 and the planar PHAHs occurred at the kinetic level. 
Chapter 5 
Chapter 5 describes the second animal experiment, in which the contribution of non-
dioxin-like as well as dioxin-like PCB congeners to the total induction of AHF by a complex 
PCB mixture was studied. For this purpose the commercial PCB mixture Aroclor 1260 was 
fractionated into a 0-1 ortho and a 2-4 ortho PCB fraction, which were tested separately and 
as a reconstituted 0-4 ortho PCB mixture. 
GC-MS analysis of the Aroclor 1260 fractions confirmed that there were no planar, 
dioxin-like compounds present in the 2-4 ortho PCB fraction. In addition, the 2-4 ortho PCB 
fraction did not show luciferase induction in the in vitro DR-CALUX bio-assay, indicating 
that this fraction had no dioxin-like potential (Chapter 2). A remarkable finding in the rat 
study was that the 2-4 ortho PCB fraction explained approximately 80% of the total observed 
effect on the development of AHF by the 0-4 ortho PCBs present in Aroclor 1260. In contrast 
to what is generally accepted, the dioxin-like PCB congeners did not significantly contribute 
to the effect on AHF development. No interactive effect on AHF development or the 
toxicokinetics was observed for the 0-1 and the 2-4 ortho PCB fraction. PCB 153, 
incorporated as additional treatment, showed a similar potential to induce AHF development 
as the 2-4 ortho PCB fraction in Aroclor 1260. 
It was concluded that the TEF concept largely underestimates the tumour promotion 
effect of complex PCB mixtures, since the tumour promotion potential of the non-dioxin-like 
PCBs is not taken into account. 
Chapter 6 
In chapter 6, the results are shown on the vitamin A and the thyroid hormone status of 
the rats of the first and second tumour promotion experiment (Chapter 4,5). 
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From the first experiment it appeared that hepatic retinyl palmitate is a rather sensitive 
parameter for exposure to dioxin-like PHAHs, as the retinyl palmitate levels were severely 
decreased after treatment with the PHAH mixtures and to a similar extent as compared to 
TCDD treatment. However, an opposite effect was observed on the plasma retinol 
concentration after treatment with the PHAH mixture and TCDD, respectively. In addition, 
the PHAH mixture caused a relatively strong decrease of the thyroid hormone levels in plasma 
and decreased the ratio of total thyroxin and free thyroxine as compared to TCDD. The most 
likely reason for these observations is the formation of hydroxy-metabolites of PCB 118, 
present in the PHAH mixture, which are known to disrupt the transport-protein complex 
(RBP-TTR) of retinol and thyroxine and thereby drastically reducing plasma levels of both 
vitamin A and thyroxine. This situation does not occur in the case of TCDD exposure, which 
effects the vitamin A and thyroid hormone status mainly via interference with liver 
metabolism. 
In the second experiment, the retinoid and thyroid hormone levels were not affected 
significantly. This indicates that in case of exposure to PCBs at environmental levels, no or at 
best only marginal effects can be expected on the retinoid and thyroid hormone status. 
It was concluded on the basis of these observations that the effects on plasma retinol and 
thyroxine by complex mixtures of PHAHs are not well predicted by the TEF concept, due to 
involvement of several different mechanisms and mechanistic interactions depending on the 
composition of the PHAH mixture. 
Concluding remarks 
Applicability of the TEF concept 
The most striking finding of this thesis work is that the non-dioxin-like PCB fraction in 
the commercial mixture Aroclor 1260 explained over 80% of the observed effect on AHF 
development {Chapter 5). On the basis of these results it was concluded that the TEF 
approach was inadequate in its prediction for the tumour promotion potential of a complex 
PCB mixture as used in the second animal experiment. However, the tumour promotion 
potential of the complex dioxin-like PHAH mixture used in the first animal experiment 
{Chapter 4) was quite well predicted by the TEF approach, e.g. within a factor of two. The 
observed kinetic interaction between the congeners {Chapter 3), had apparently no significant 
consequence for the tumour promotion potential of the PHAH mixture. 
Further it was apparent that the TEF concept failed to predict the effect of the dioxin-
like PHAH mixture on plasma retinol and underestimated the effect on the thyroid hormone 
concentrations {Chapter 6). The lack of predictability by the TEF approach for these 
endocrine effects is possibly due to additional toxicity of hydroxylated PCBs, formed of PCB 
congeners present in the dioxin-like PHAH mixture. 
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Interactive effects 
The in vitro experiments {Chapter 2) indicated the possibility of interactive effects 
between dioxin-like PHAHs and mono- and di-ortho PCBs, at the level of Ah receptor 
binding. However, competition between compounds is only likely to occur under conditions 
of Ah receptor saturation and a large concentration difference between the dioxin-like PHAH 
and the mono- and/or di-ortho PCBs. These conditions can be easily reached in vitro but will 
be seldomly observed in vivo. In the animal experiments the major interaction was observed at 
the kinetic level, namely, PCB 153 enhanced the hepatic deposition of the dioxin-like PHAHs 
{Chapter 3), most likely by induction of CYP1A2 which is known to have a high binding 
affinity for dioxin-like PHAHs. No interactive effects, at any level, were observed between 
the dioxin-like and the non-dioxin-like PCB fraction of Aroclor 1260. This may be explained 
by the low hepatic retention of the congeners, possibly due to the low TEQ level of the 
dioxin-like fraction in Aroclor 1260, i.e. no or a marginal induction of hepatic binding 
proteins. At such a low level of hepatic retention interactive effects will not be seen. In terms 
of TEQs the dioxin-like fraction was certainly more close to environmental levels of exposure 
as occurs in wildlife and human, leading to the conclusion that kinetic interactions do not play 
a role at environmental exposure levels. 
Implications for risk assessment 
A remaining question is if, on the basis of these results, it can be concluded whether the 
current approach for risk estimation of complex mixtures of PCDDs, PCDFs and PCBs is 
appropriate or not. On the basis of a chronic carcinogenicity study performed by Kociba et al. 
(1978) for TCDD a no-observed-adverse-effect level (NOAEL) of 1 ng/kg/day was derived. A 
NOAEL for the synthetic dioxin-like PHAH mixture might be close to the NOAEL of TCDD 
{Chapter 3,4), if it is assumed that the dose-response curves for the carcinogenic potential of 
the PHAH mixtures and TCDD have a similar shape. This indicates that the TEF approach 
sufficiently predicts the potential risk of exposure to dioxin-like PHAHs. 
For the non-dioxin-like PCBs it is more complicated, since the TEF concept is not 
applicable for the risk estimation of non-dioxin-like PCBs nor is there another tool available 
for this purpose. In addition, the total PCB intake is not well known since no congener 
specific analysis of the occurrence of PCBs in foodstuff is available as well as any 
information about differences in congener patterns between food items. An extensive survey 
was done in the Netherlands by Li em and Theelen (1997), who reported an intake of 20 
ng/kg/day (sum of 29 PCBs) in 1994, based on a Dutch diet. Given the assumption that a level 
of 20 ng/kg/day in foodstuff covers approximately 20-30% of the total dietary intake, a daily 
intake of PCBs of 60-100 ng/kg/day can be estimated of which >90% consists of 2-4 ortho 
PCBs. In the tumour promotion experiment, a NOAEL for the 2-4 ortho PCBs in Aroclor 
1260 was not achieved; the lowest experimental dose of 1 mg/kg bw/week (~140 |ig/kg 
bw/day, Chapter 5) still enhanced the development of AHF two-fold. Using a factor of 5 for 
extrapolation from the lowest-observed-adverse-effect-level (LOAEL) to NOAEL, a NOAEL 
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Chapter 7 
of approximately 30 |xg/kg/day can be deduced. For the calculation of a Tolerable Daily Intake 
(TDI) for dioxin-like compounds, the WHO uses a safety margin of 100. When the same 
margin is used for the non-dioxin-like compounds a TDI of 300 ng/kg/day can be calculated, 
which is a factor 3-5 above the presumable daily intake. Although there are many 
uncertainties in this calculation, there is probably no reason for immediate concern as large 
safety margins were applied. However, the results of this thesis work demonstrate the 
necessity for risk assessment to look at both the dioxin-like and non-dioxin-like PCBs. 
Overall conclusions 
Overall, the most important conclusion which can be drawn from this thesis work is that 
the majority of the effect on tumour promotion by PCBs is caused by a non-dioxin-like 
mechanism of action. Therefore the TEF approach, although useful to predict effects of 
dioxins and similar compounds, does not predict the tumour promotion potential of complex 
mixtures of PCBs as being present in the environment. This may have important implications 
for the risk assessment of complex mixtures of PHAHs as occur in e.g. foodstuff. 
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Het doel van dit promotie onderzoek was tweeledig; 1. Onderzoek naar de tumor-
promoverende potentie van complexe mengsels van polygehalogeneerde aromatische 
koolwaterstoffen (PHAH's), welke relevant zijn voor het milieu en 2. Evaluatie van de 
toepasbaarheid van het toxisch equivalenten factoren (TEF) concept voor de tumor-
promoverende potentie van die complexe mengsels. Daarnaast is het effect bestudeerd van 
sub-chronische blootstelling aan complexe mengsels van PHAH's op een tweetal endocriene 
parameters, te weten de vitamine A en schildklierhormoonstatus. Zowel vitamine A als het 
schildklierhormoon spelen een vitale rol in de normale weefselgroei en foetale ontwikkeling 
en zijn waarschijnlijk betrokken bij het proces van de carcinogenese. 
Carcinogeniteit is een van de toxische eindpunten in de risicobeoordeling van 
polychloorbiphenylen (PCB's), polychloordibenzo-p-dioxines (PCDD's) en de 
polychloordibenzofuranen (PCDF's) (WHO, 1992). PCB's, PCDD's en PCDF's worden 
beschouwd als tumor promotors en niet zozeer als initiators van de carcinogenese (Safe, 1989; 
Silberhorn et ah, 1990; Whysner and Williams, 1996). Tot nu toe werd de tumor-
promoverende potentie van vooral individuele, dioxine-achtige congeneren onderzocht, 
gebaseerd op de aanname dat de Ah-receptorroute ook betrokken is bij de tumor-
promoverende werking van PHAH's (Safe, 1989; Silberhorn et ah, 1990). Veel minder 
onderzoek is gedaan naar de effecten op tumorpromotie van complexe mengsels van PHAH's 
na subchronische blootstelling. 
Als uitgangspunt voor dit proefschrift is daarom gekozen voor complexe mengsels van 
PCDD's, PCDF's en PCB's, relevant voor de humane inname van deze stoffen. Om 
onderliggende mechanismen van mogelijke interacties tussen PHAH congeneren te 
bestuderen en om de toxische potentie te meten van de gebruikte PHAH mengsels, zijn de 
ethoxyresorufine-O-deethylase (EROD) en de Ah-receptor afhankelijke Luc-reporter-gen 
(DR-CALUX) bio-assay gebruikt. Beide assays worden beschouwd als indicatoren voor een 
Ah-receptor gemedieerde, dioxine-achtige toxiciteit in vitro. De tumor-promoverende potentie 
van de complexe PHAH mengsels, is in vivo bestudeerd in vrouwelijke Sprague Dawley 
ratten, waarbij gebruik gemaakt is van een twee-fasen initiatie/promotie bio-assay 
(gei'ntroduceerd door Pitot et ah, 1978). 
In hoofdstuk 2 zijn de resultaten beschreven van de in vitro experimenten. Interacties 
tussen de individuele mono- of di-ortho PCB congeneren en 2,3,7,8-TCDD zijn bestudeerd in 
de EROD en CALUX assay, in zowel een muizen- als rattenhepatomacellijn. Bovendien zijn 
van complexe PHAH mengsels ontworpen voor de dierexperimenten, de dioxine-achtige 
potentie en het optreden van mogelijke interacties tussen congeneren in die mengsels 
onderzocht in de CALUX assay. Ook worden voorlopige resultaten gepresenteerd met 
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betrekking tot de remming van de intercellulaire communicatie via gap junctions (GJIC), door 
de PHAH mengsels. Remming van de GJIC wordt gezien als een in vitro parameter voor 
tumorpromotie. 
Individueel gedoseerde mono-ortho PCB's induceerden zowel de EROD als de CALUX 
activiteit, maar bereikten een lagere maximum inductie bij hogere concentraties dan het 
2,3,7,8-TCDD. Gelijktijdige toediening van mono-ortho PCB met 2,3,7,8-TCDD, resulteerde 
in een dosis afhankelijke verlaging van de door 2,3,7,8-TCDD gei'nduceerde EROD en 
CALUX activiteit, door de partieel agonistische PCB's. Het uiteindelijke niveau van de 
EROD en CALUX inductie bij gelijktijdige toediening van mono-ortho PCB's met 2,3,7,8-
TCDD, was gelijk aan het maximale inductieniveau van de individuele PCB congeneren. 
Geen van de getestte di-ortho PCB's bezat enige potentie met betrekking tot inductie van de 
EROD of CALUX activiteit. Echter, alle di-ortho PCB's bleken in staat de door 2,3,7,8-
TCDD gei'nduceerde EROD of CALUX activiteit dosis-afhankelijk en met verschillende 
potenties te antagoneren. Een tweetal combinaties is eveneens getest op remming van de 
GJIC. De resultaten suggereren dat in deze assay vergelijkbare, non-additieve interacties 
optreden als in de EROD en CALUX assay. 
De PHAH mengsels ontworpen voor het eerste dierexperiment {Hoofdstuk 3,4), 
induceerden de CALUX activiteit tot hetzelfde maximum niveau als 2,3,7,8-TCDD. Deze 
PHAH mengsels bleken eveneens potente inhibitoren te zijn van de GJIC. Er werden geen 
interacties gevonden tussen de individuele congeneren in het PHAH mengsel in zowel de 
CALUX assay als in de GJIC assay. In tegenstelling hiermee, werden er tussen de PCB 
fracties bedoeld voor het tweede dierexperiment wel interacties gevonden (Hoofdstuk 5). De 
0- ortho en de 1- ortho gesubstitueerde PCB fracties induceerden de CALUX activiteit tot een 
maximum van respectievelijk 40% en 9% ten opzichte van de maximum inductie die 
gevonden wordt na blootstelling aan 2,3,7,8-TCDD. De 2-4 ortho PCB fractie bleek niet in 
staat tot inductie van de CALUX activiteit. Gelijktijdige blootstelling aan alle fracties 
resulteerde in remming van de CALUX activiteit van de 0-1 en de 1-2 ortho PCB fractie, tot 
3% van het maximale inductieniveau van 2,3,7,8-TCDD. GJIC was slechts marginaal 
verlaagd na blootstelling aan de 2-4 ortho en de gereconstitueerde 0-4 ortho PCB fractie. 
In het eerste dierexperiment (Hoofdstuk 3,4) is de tumor-promoverende potentie van een 
complex, synthetisch mengsel van dioxine-achtige stoffen bestudeerd. De samenstelling van 
het mengsel was gebaseerd op het voorkomen van en de onderlinge verhouding tussen de zes 
meest relevante PHAH's in haring van de Baltische zee en dekte meer dan 90% van de totale 
TEQ's. Om de mogelijkheid van interacties te bestuderen, was PCB 153 (2,2',4,4',5,5'-HxCB) 
aan het mengsel toegevoegd. PCB 153 diende hierbij als een representant van de niet-dioxine-
achtige di-ortho gesubstitueerde PCB's. 
In hoofdstuk 3 zijn de toxicokinetische eigenschappen van de PHAH congeneren 
beschreven. Analyse van concentraties van PHAH's in de lever m.b.v. gaschromatografie en 
massaspectrometrie (GC-MS) wees uit, dat er aanzienlijke verschillen bestaan in de 
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leveraccumulatie (uitgedrukt als percentage van de gegeven dosis) tussen de verschillende 
PCB congeneren. Hierdoor verandert de onderlinge verhouding van de PHAH's in het 
mengsel. Verder werd aangetoond dat door toevoeging van PCB 153 aan het mengsel, 
accumulatie van de dioxine-achtige congeneren in de lever werd verhoogd. Dit wordt 
mogelijk verklaard door het vermogen van PCB 153 om het Ah-receptorniveau in de lever te 
verhogen, met als logisch gevolg een verhoogde inductie van b.v. CYP1A2, dat een hoge 
bindingaffiniteit bezit voor planaire PHAH's. 
In hoofdstuk 4 zijn de tumorpromotie gegevens weergegeven. De promotie van de 
zogenoemde 'Altered Hepatic Foci' (AHF) was significant verhoogd na blootstelling aan de 
PHAH mengsels, maar enigszins minder dan verwacht op basis van de TEQ. De TEQ van het 
PHAH mengsel was berekend aan de hand van de TEF waarden, vastgesteld door de WHO 
(Ahlborg et al, 1994). Een gedeeltelijke verklaring voor het gevonden verschil in de 
ontwikkeling van AHF tussen ratten blootgesteld aan de PHAH mengsels en de equipotente 
dosis 2,3,7,8-TCDD, is een verschil tussen de TEF waarden van de WHO (Ahlborg et al, 
1994) die gebruikt zijn voor de berekening van de TEQ enerzijds en de relatieve potenties 
(REP's) van de individuele congeneren die feitelijk op tumorpromotie gegevens zijn 
gebaseerd anderzijds. Bovendien kunnen mogelijk de gevonden verschillen in 
toxicokinetische eigenschappen en interactieve effecten op de depositie van de congeneren 
{Hoofdstuk 3), de voorspelde toxische potentie van PHAH mengsels bei'nvloeden. Er zijn geen 
interactieve effecten van PCB 153 gevonden op de ontwikkeling van AHF of the EROD 
inductie. 
De conclusie op basis van deze resultaten is, dat met behulp van het TEF-concept de 
tumor-promoverende potentie van de onderzochte dioxine-achtige PHAH mengsels redelijk te 
voorspellen was, de afwijking bedroeg minder dan een factor 2. Interactie van PCB 153 met 
de planaire PHAH's is waargenomen op kinetisch niveau. 
Hoofdstuk 5 beschrijft het tweede dierexperiment, waarbij de bijdrage van zowel de 
dioxine-achtige als de niet-dioxine-achtige PCB congeneren aan de totale tumor-
promoverende potentie van een complex PCB mengsel is bestudeerd. Voor dit doel is het 
commerciele PCB mengsel Aroclor 1260 gefractioneerd in een 0-1 ortho en een 2-4 ortho 
PCB fractie. De fracties zijn afzonderlijk getest en als een gereconstitueerd 0-4 ortho PCB 
mengsel. 
Met behulp van GC-MS analyse kon worden bevestigd dat er geen planaire, dioxine-
achtige stoffen aanwezig waren in de 2-4 ortho PCB fractie. Bovendien bleek de 2-4 ortho 
fractie niet in staat CALUX activiteit te induceren in vitro, wat impliceert dat deze fractie 
geen dioxine-achtige potentie bezit {Hoofdstuk 2). Een opmerkelijke bevinding was dat de 2-4 
ortho PCB fractie ongeveer 80% van het totale effect van de 0-4 ortho fractie op de AHF 
ontwikkeling kon verklaren. In tegenstelling tot wat algemeen aangenomen wordt, droegen de 
dioxine-achtige PCB congeneren niet significant bij aan het effect op de ontwikkeling van 
AHF. Er zijn geen interactieve effecten waargenomen tussen de 0-1 of de 2-4 ortho PCB 
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fractie op de AHF ontwikkeling of de toxicokinetiek. PCB 153, toegevoegd als extra 
experimentele behandeling, vertoonde een vergelijkbare potentie voor de inductie van AHF 
als de 2-4 ortho fractie van Aroclor 1260. 
Op basis van deze resultaten is geconcludeerd dat het TEF-concept het tumor-
promoverende effect van complexe PCB mengsels fors onderschat, omdat geen rekening 
wordt gehouden met het effect op tumorpromotie van de niet-dioxine-achtige PCB's. 
In hoofdstuk 6 zijn de vitamine A en schildklierhormoon gegevens gepresenteerd van de 
dieren uit zowel het eerste als het tweede dierexperiment (Hoofdstuk 4,5). 
Uit het eerste dierexperiment bleek dat het retinyl-palmitaat gehalte in de lever een zeer 
gevoelige parameter is voor de blootstelling aan dioxine-achtige PHAH's. De retinyl-
palmitaatniveau's in de lever waren fors verlaagd na behandeling met de PHAH mengsels en 
vergelijkbaar met de verlaging die gevonden werd na blootstelling aan 2,3,7,8-TCDD. Echter, 
op het niveau van plasma retinol werd na behandeling met respectievelijk het PHAH mengsel 
en 2,3,7,8-TCDD een tegengesteld effect gevonden. Bovendien veroorzaakten de PHAH 
mengsels in vergelijking met 2,3,7,8-TCDD een relatief sterke verlaging van 
schildklierhormoonniveau's en, in tegenstelling tot 2,3,7,8-TCDD, een verlaging van de ratio 
'totaal thyroxine/vrij thyroxine'. De meest waarschijnlijke oorzaak hiervoor is de vorming van 
hydroxy-metabolieten van bijvoorbeeld PCB 118, aanwezig in het PHAH mengsel. Van 
hydroxy-metabolieten is bekend dat zij het transporteiwit complex (RBP-TTR) van retinol en 
thyroxine kunnen verstoren met als gevolg een drastische verlaging van plasma niveau's van 
zowel vitamine A als thyroxine. Dit effect treedt niet op bij blootstelling aan 2,3,7,8-TCDD, 
dat de vitamine A en schildklierhormoonstatus voornamelijk bei'nvloed via een verstoring van 
het lever metabolisme van deze stoffen. 
In het tweede dierexperiment waren de vitamine A en schildklierhormoonniveau's niet 
significant veranderd. Dit geeft aan dat in geval van PCB blootstelling aan een milieu-
relevante concentratie, geen of slechts marginale effecten kunnen worden verwacht. 
Op basis van deze resultaten kan worden geconcludeerd dat het TEF-concept een zeer 
beperkte voorspellende waarde heeft met betrekking tot de effecten van complexe mengsels 
van PHAH's op retinol en schildklierhormoonniveau's in plasma. Dit is het gevolg van de 
betrokkenheid van verschillende mechanismen en interacties tussen mechanismen, afhankelijk 
van de congeneer samenstelling van het PHAH mengsel. 
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Toepasbaarheid van het TEF-concept 
Het meest opzienbarende resultaat van dit onderzoek is, dat de niet-dioxine-achtige PCB 
fractie van het commerciele PCB mengsel Aroclor 1260 verantwoordelijk bleek voor meer 
dan 80% van het gevonden effect op de ontwikkeling van AHF (Hoofdstuk 5). Op grond van 
dit resultaat is geconcludeerd dat het TEF-concept inadequaat is in zijn voorspelling voor de 
tumor-promoverende potentie van het complexe PCB mengsel, gebruikt in het tweede 
dierexperiment. Echter, de tumor-promoverende potentie van het dioxine-achtige PHAH 
mengsel gebruikt in het eerste experiment, was redelijk goed voorspeld met behulp van het 
TEF-concept: met een afwijking kleiner dan een factor twee (Hoofdstuk 4). De gevonden 
kinetische interacties tussen de congeneren (Hoofdstuk 3) hadden geen significante 
consequenties voor de tumor-promoverende potentie van het PHAH mengsel. 
Een andere bevinding is dat het TEF-concept faalde in zijn voorspelling van het effect 
van het dioxine-achtige PHAH mengsel op het retinolniveau in plasma. Bovendien gaf het 
TEF-concept een onderschatting van het effect op het schildklierhormoonniveau in plasma. 
De gebrekkige voorspelling door het TEF-concept is waarschijnlijk te verklaren door een 
additionele toxiciteit van gehydroxyleerde PCB's, welke kunnen worden gevormd uit 
congeneren in het PHAH mengsel. 
Interactieve effecten 
De in vitro experimenten (Hoofdstuk 2) suggereren de mogelijkheid van interacties 
tussen dioxine-achtige PHAH's en mono- en di-ortho PCB's op basis van competitie voor 
Ah-receptor binding. Echter, competitie tussen stoffen is alleen waarschijnlijk onder 
omstandigheden van Ah-receptor verzadiging en een groot concentratie verschil tussen de 
dioxine-achtige PHAH's en de mono- en/of di-ortho PCB's. Deze condities kunnen makkelijk 
worden gecreeerd in vitro, maar zullen zelden optreden in vivo. In de dierexperimenten zijn de 
voornaamste interacties gevonden op kinetisch niveau. PCB 153 verhoogde de depositie van 
dioxine-achtige PCB's in de lever (Hoofdstuk 3), meest waarschijnlijk door inductie van 
CYP1A2, waarvan bekend is dat het een grote bindingaffiniteit vertoont voor dioxine-achtige 
PHAH's. Er zijn geen interacties aangetoond, op welk niveau dan ook, tussen de dioxine-
achtige en niet-dioxine-achtige PCB fractie van Aroclor 1260. Dit kan mogelijk worden 
verklaard door de lage accumulatie van de congeneren in de lever, waarschijnlijk veroorzaakt 
door de lage TEQ waarde van de dioxine-achtige fractie, wat betekent dat er geen of slechts 
een marginale inductie van CYP1A2 in de lever heeft plaatsgevonden. Op een dergelijk laag 
niveau van accumulatie zullen interactieve effecten dan ook niet zichtbaar zijn. In termen van 
TEQ's was de dioxine-achtige fractie zeker dichter bij de blootstellingniveau's zoals deze 
voorkomen in het milieu, dan het PHAH mengsel van het eerste experiment. Hieruit kan 
worden geconcludeerd dat kinetische interacties geen rol zullen spelen bij milieu relevante 
blootstellingniveau' s. 
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Implicaties voor risicoschatting 
Een belangrijke vraag is nu of, op basis van de hier gepresenteerde resultaten, kan 
worden geconcludeerd dat de huidige benadering voor risicoschatting van complexe mengsels 
van PCDD's, PCDF's en PCB's toereikend is of niet. Op basis van een chronische 
carcinogeniteit studie, uitgevoerd door Kociba e.a. (1978), is voor 2,3,7,8-TCDD een 'No-
Observed-Adverse-Effect-Lever (NOAEL) bepaald van 1 ng/kg/dag. Een NOAEL voor de 
synthetische dioxine-achtige PHAH mengsels ligt waarschijnlijk dicht bij de NOAEL voor 
2,3,7,8-TCDD {Hoofdstuk 3,4), als wordt aangenomen dat de dosis-response curven voor de 
carcinogene potentie van de PHAH mengsels en 2,3,7,8-TCDD hetzelfde verloop hebben. Dit 
impliceert dat de TEF benadering in voldoende mate het potentiele risico voorspelt van 
blootstelling aan dioxine-achtige PHAH's. 
Voor de niet-dioxine-achtige PCB's is het meer gecompliceerd. Het TEF-concept is niet 
toepasbaar voor de risicoschatting van niet-dioxine-achtige PCB's en evenmin is er een 
alternatief beschikbaar voor dit doel. Bovendien is de totale inname van niet-dioxine-achtige 
PCB's niet bekend, omdat er geen congeneer-specifieke analyses beschikbaar zijn met 
betrekking tot het voorkomen van PCB's in voedingsmiddelen en informatie met betrekking 
tot verschillen in congeneer patronen tussen voedingsbestanddelen ontbreekt. Een uitgebreid 
onderzoek is uitgevoerd in Nederland door Liem en Theelen (1997). Zij rapporteerden een 
inname van 20 ng/kg/dag (som van 29 PCB's) in 1994, gebaseerd op een Nederlands dieet. 
Gegeven de aanname dat een niveau van 20 ng/kg/dag in voedsel ongeveer 20-30% van de 
totale inname via voedsel bedraagt, kan een dagelijkse inname voor PCB's worden geschat op 
60-100 ng/kg/dag. Hiervan bestaat meer dan 90% uit 2-4 ortho gesubstitueerde PCB's. In het 
tumorpromotie experiment was een NOAEL voor de 2-4 ortho PCB's uit Aroclor 1260 niet 
bereikt, de laagste test-dosis van 1 mg/kg/week (-140 ng/kg/dag, Hoofdstuk 5) gaf nog steeds 
een verdubbeling in de ontwikkeling van AHF. Als een factor 5 gebruikt wordt om te 
extrapoleren van de 'Lowest-Observed-Adverse-Effect-Level' (LOAEL) naar een NOAEL, 
kan een NOAEL van ongeveer 30 ug/kg/dag worden afgeleid. Voor de berekening van een 
'Tolerable-Daily-Intake'(TDI) voor dioxine-achtige stoffen hanteert de WHO een 
veiligheidsmarge van 100. Als dezelfde veiligheidsmarge wordt gebruikt voor de niet-dioxine-
achtige PCB's kan een TDI van 300 ng/kg/dag worden berekend. Dit is een factor 3-5 boven 
de veronderstelde dagelijkse inname. Hoewel er veel onzekerheden zitten in deze berekening, 
is er waarschijnlijk geen reden tot onmiddellijke ongerustheid omdat ruime veiligheidsmarges 
zijn gebruikt. Echter, de resultaten van dit onderzoek onderstrepen de noodzaak om voor de 
risicobeoordeling te kijken naar zowel de dioxine-achtige als de niet-dioxine-achtige PCB's. 
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Conclusie 
De belangrijkste conclusie van het onderhavige onderzoek is dat het overgrote deel van 
het effect op tumorpromotie door PCB's, wordt veroorzaakt door een niet-dioxine-achtig 
mechanisme. Daarom voorspelt de TEF benadering, hoewel bruikbaar voor de voorspelling 
van effecten van dioxine-achtige stoffen, de tumor-promoverende potentie van complexe 
mengsels van PHAH's zoals deze voorkomen in het milieu niet. Deze conclusie kan 
belangrijke gevolgen hebben voor de risicobeoordeling van complexe PHAH mengsels in 
bijvoorbeeld onze voeding. 
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AHF altered hepatic foci 
Ah-receptor arylhydrocarbon receptor 
bw body weight 
CALUX chemical activated luciferase gene expression 
CALUX-TEQ TCDD-equivalence determined using the CALUX assay 
CYP cytochrome P450 
EC50 concentration causing 50% of the maximum effect 
EROD ethoxyresorufin-0-deethylase 
FT4 free thryroxine 
GJIC gap junctional intercellular communication 
GST-p gluthatione-S-transferase-p 
IC50 concentration causing 50% inhibition 
LOAEL lowest observed adverse effect level 
NDEA N-nitrosodiethylamine 
NOAEL no observed adverse effect level 
OH- hydroxylated 
PCB polychlorinated biphenyl 
PCDD polychlorinated dibenzo-/>-dioxin 
PCDF polychlorinated dibenzofuran 
PHAH polyhalogenated aromatic hydrocarbon 
PROD penthoxyresorufin-O-deethylase 
RBP retinol binding protein (transport protein of retinol) 
RE retinol (transport form of vitamin A) 
REP relative potency 
RP retinyl palmitate (storage form of vitamin A) 
SER smooth endoplasmatic reticulum 
TDI tolerable daily intake 
TEF toxic equivalence factor (relative to TCDD) 
TEQ (TCDD) toxic equivalence 
(T)T3 (total) tri-iodothyronine (active form of thyroid hormone) 
(T)T4 (total) thyroxine (transport form of thyroid hormone) 
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin 
TTR transthyretin (transport protein of thyroxine) 
VF volume fraction of the liver occupied by foci 
WHO World Health Organization 
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Numbering system of chlorobiphenyls 
No. 
1 
2 
3 
4 
5 
6 
7 
e 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
26 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
61 
Stiuctuie 
Monochloiobiphenyls 
2 
3 
4 
Dichlorobiphenyls 
2.2' 
2,3 
2.3' 
2,4 
2.4' 
2.5 
2.6 
3.3' 
3.4 
3.4' 
3.5 
4.4' 
Trichlorobiphenyls 
2.2'.3 
2,2',4 
2.2'.5 
2.2',6 
2,3.3' 
2,3.4 
2,3.4' 
2,3,5 
2.3,6 
2,3',4 
2.3'.5 
2.3'.6 
2.4,4' 
2,4,5 
2,4,6 
2.4',5 
2,4',6 
2'.3.4 
2'.3.5 
3.3',4 
3.3'.5 
3,4,4' 
3.4,5 
3,4'.5 
Tetrachlorobiphenyls 
2.2',3,3' 
2.2',3,4 
2.2'.3.4' 
2,2'.3.5 
2,2'.3.6' 
2,2',3,6 
2.2',3,6' 
2.2'.4,4' 
2.2',4,5 
2,2'.4,5' 
2.2'.4.6 
2,2',4,6' 
No. 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
89 
89 
90 
91 
92 
93 
94 
95 
96 
97 
98 
99 
100 
101 
102 
103 
104 
Structure 
Tetrachlorobiphenyls 
2,2'.5.5' 
2.2',6.6' 
2.2',6.6' 
2,3.3',4 
2.3.3',4' 
2.3,3',5 
2.3,3',5' 
2,3,3',6 
2.3.4,4' 
2.3,4,5 
2,3,4,6 
2,3.4',5 
2,3.4',6 
2,3,5,6 
2.3'.4.4' 
2,3',4,5 
2.3',4,6' 
2.3'.4,6 
2,3'.4',5 
2,3'.4',6 
2,3',5.5' 
2,3'.5',6 
2.4.4'.5 
2,4,4',6 
2'.3.4,5 
3.3',4,4' 
3,3',4.6' 
3,3'.4,5' 
3,3'.5,5' 
3.4.4',5 
Pentachlorobiphenyls 
2,2',3,3',4 
2,2'.3,3',5 
2.2',3.3'.6 
2.2',3.4,4' 
2,2',3,4,5 
2.2'.3.4.5' 
2.2',3,4.6 
2.2'.3,4,6' 
2.2'.3,4',5 
2.2',3,4',6 
2,2',3,5,5' 
2.2',3.5,6 
2,2'.3,6,6' 
2.2',3,5',6 
2,2',3,6.6' 
2.2',3'.4,5 
2.2',3',4,6 
2.2',4,4',6 
2.2'.4,4',6 
2,2',4,5,5' 
2.2',4.5,6' 
2,2',4.5',6 
2,2',4.6.6' 
No 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
165 
156 
157 
158 
159 
160 
Structure 
Pentachlorobiphenyls 
2,3.3'.4,4' 
2.3,3'.4.6 
2.3,3'.4',5 
2.3.3',4.5' 
2.3.3',4.6 
2,3,3',4',6 
2.3,3', 5.5' 
2.3.3',5,6 
2,3.3',5',6 
2.3,4,4',5 
2.3,4.4',6 
2.3.4,5,6 
2.3.4',5.6 
2.3'.4.4'.5 
2.3',4.4',6 
2.3',4.5.6' 
2.3',4,5',6 
2'.3.3'.4.5 
2'.3.4.4'.5 
2'.3,4,6.5' 
2'.3,4.5,6' 
3.3'.4,4'.5 
3,3',4.5,5' 
Hexachlorobiphenyls 
2,2',3,3'.4.4' 
2,2',3,3',4,5 
2.2'.3.3'.4.5' 
2,2'.3.3'.4.6 
2,2'.3.3',4,6' 
2.2',3,3',5,5' 
2.2'.3.3'.5,6 
2.2'.3.3'.5.6' 
2,2'.3.3'.6.6' 
2.2'.3.4,4'.5 
2.2'.3.4,4',5' 
2,2'.3,4.4',6 
2.2',3.4.4',6' 
2,2'.3,4,5.6' 
2,2',3.4,6,6 
2.2',3,4,5,6' 
2.2',3.4,5',6 
2,2'.3,4.6,6' 
2.2',3.4',5.5' 
2,2',3,4',5.6 
2,2'.3.4',5.6' 
2,2',3,4',6',6 
2,2',3,4'.6,6' 
2,2',3.5.5',6 
2.2',3.5.6.6' 
2.2',4,4',5,5' 
2,2'4.4',5.6' 
2.2',4,4',6,6' 
2.3,3',4,4',5 
2,3,3',4,4',5' 
2,3.3',4,4',6 
2,3,3'.4,5,5' 
2.3,3',4,5,6 
No 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
176 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
200 
201 
202 
203 
204 
206 
206 
207 
208 
209 
Structure 
Hexachlorobiphenyls 
2,3,3',4,6',6 
2,3,3'.4',6.5' 
2.3.3',4',5.6 
2.3.3'.4'.5',6 
2,3,3',5,6',6 
2,3,4,4',5,6 
2.3',4,4',6,5' 
2,3'.4,4',5',6 
3.3',4,4',6,5' 
Heptachlorobiphenyts 
2,2',3,3',4,4',5 
2,2',3,3',4,4',6 
2,2'.3,3',4.5,5' 
2,2',3.3' .4,5,6 
2.2'.3.3'.4.6.6' 
2.2'.3.3'.4.5',6 
2,2',3,3'.4,6,6' 
2.2',3.3'.4'.5,6 
2.2',3.3'.5,5',6 
2.2',3,3'.5.6,6' 
2,2',3,4,4',6,5' 
2.2'.3.4,4'.5.6 
2.2'.3.4.4',5.6' 
2.2',3.4,4',5'.6 
2,2',3.4.4',6,6' 
2,2',3.4,5.6'.6 
2,2',3.4,5.6,6' 
2,2',3,4',5,5',6 
2.2'.3,4'.6,6.6' 
2.3,3',4.4',5,6' 
2.3,3',4,4',5,6 
2.3.3',4,4',5'.6 
2,3,3',4,5,5',6 
2.3,3'.4',5.5',6 
Octachlorobiphenyls 
2,2',3.3'.4.4'.6.6' 
2.2',3.3',4,4'.5,6 
2.2',3,3',4,4',5,6' 
2,2',3,3',4.4',6.6' 
2.2',3.3',4.5,5',6 
2.2'.3.3'.4.6.5',6' 
2,2'.3.3'.4.5.6.6' 
2,2',3.3'.4,6',6,6' 
2.2',3,3',6.5'.6.6' 
2.2',3,4.4'.5.5',6 
2.2'.3.4.4'.5,6,6' 
2.3.3',4.4'.5.5'.6 
Nonachlorobrphenyls 
2,2'.3.3',4.4',6.5',6 
2.2'.3,3'.4.4'.6,6,6' 
2.2',3.3',4.5,5',6,6' 
Decachlorobiphenyl 
2.2',3.3',4,4',6,5'.6,6' 
Ref.: Ballschmiter, K., R. Bacher, A. Mennel, R. Fischer, U. Riehle and M. Swerev (1992). The determination 
of chlorinated biphenyls, chlorinated dibenzodioxins and chlorinated dibenzofurans by GC-MS. J. 
High Resolut. Chromatogr. 15, 260-270. 
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